Opioid Data Dashboard Indicator,Data Year,Group,Characteristics,Rate Rate (95% CI),Data Source
Age-adjusted percentage of adults who have self-reported heroin use in the past 12 months,2018,Race and Ethnicity,Black NH,s,Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported heroin use in the past 12 months,2018,Race and Ethnicity,Hispanic,0.2* (0.0 - 0.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported heroin use in the past 12 months,2018,Race and Ethnicity,Other NH,0.4* (-0.1 - 0.9),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported heroin use in the past 12 months,2018,Race and Ethnicity,White NH,0.3 (0.2 - 0.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported heroin use in the past 12 months,2018,Region,NYS Excl NYC,0.3 (0.2 - 0.5),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported heroin use in the past 12 months,2018,Region,New York City,0.2 (0.1 - 0.3),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported heroin use in the past 12 months,2018,Sex,Female,0.1 (0.1 - 0.2),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported heroin use in the past 12 months,2018,Sex,Male,0.4 (0.2 - 0.6),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported heroin use in the past 12 months,2018,Total,New York State,0.3 (0.2 - 0.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2017,Race and Ethnicity,Black NH,4.7 (2.9 - 6.5),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2017,Race and Ethnicity,Hispanic,11.1 (8.9 - 13.3),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2017,Race and Ethnicity,Other NH,4.3 (2.4 - 6.2),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2017,Race and Ethnicity,White NH,3.8 (3.0 - 4.6),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2017,Region,NYS Excl NYC,4.7 (3.8 - 5.6),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2017,Region,New York City,6.0 (5.0 - 7.1),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2017,Sex,Female,5.2 (4.3 - 6.2),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2017,Sex,Male,5.4 (4.4 - 6.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2017,Total,New York State,5.3 (4.6 - 6.0),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2018,Race and Ethnicity,Black NH,4.1 (2.8 - 5.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2018,Race and Ethnicity,Hispanic,8.3 (6.6 - 9.9),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2018,Race and Ethnicity,Other NH,3.4 (2.2 - 4.6),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2018,Race and Ethnicity,White NH,2.8 (2.3 - 3.2),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2018,Region,NYS Excl NYC,3.2 (2.8 - 3.7),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2018,Region,New York City,4.9 (4.1 - 5.7),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2018,Sex,Female,3.7 (3.1 - 4.3),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2018,Sex,Male,4.2 (3.6 - 4.8),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2018,Total,New York State,3.9 (3.5 - 4.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2019,Race and Ethnicity,Black NH,7.1 (4.8 - 9.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2019,Race and Ethnicity,Hispanic,12.7 (10.3 - 15.0),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2019,Race and Ethnicity,Other NH,4.9 (2.4 - 7.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2019,Race and Ethnicity,White NH,3.9 (3.1 - 4.7),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2019,Region,NYS Excl NYC,4.7 (3.9 - 5.5),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2019,Region,New York City,8.0 (6.6 - 9.5),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2019,Sex,Female,6.2 (5.1 - 7.3),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2019,Sex,Male,6.0 (4.9 - 7.1),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2019,Total,New York State,6.1 (5.3 - 6.8),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2020,Race and Ethnicity,Black NH,5.1 (3.2 - 7.0),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2020,Race and Ethnicity,Hispanic,6.1 (4.6 - 7.7),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2020,Race and Ethnicity,Other NH,4.7 (2.8 - 6.6),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2020,Race and Ethnicity,White NH,2.2 (1.7 - 2.7),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2020,Region,NYS Excl NYC,2.7 (2.1 - 3.3),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2020,Region,New York City,5.0 (4.0 - 6.0),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2020,Sex,Female,3.6 (2.9 - 4.3),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2020,Sex,Male,3.6 (2.9 - 4.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2020,Total,New York State,3.6 (3.1 - 4.1),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2021,Race and Ethnicity,Black NH,3.4 (2.0 - 4.8),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2021,Race and Ethnicity,Hispanic,9.4 (6.5 - 12.2),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2021,Race and Ethnicity,Other NH,4.2 (2.2 - 6.1),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2021,Race and Ethnicity,White NH,2.4 (1.7 - 3.1),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2021,Region,NYS Excl NYC,3.6 (2.7 - 4.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2021,Region,New York City,4.8 (3.5 - 6.2),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2021,Sex,Female,2.8 (2.1 - 3.6),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2021,Sex,Male,5.1 (3.9 - 6.3),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2021,Total,New York State,3.9 (3.2 - 4.6),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2022,Race and Ethnicity,Black NH,4.2 (1.8 - 6.5),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2022,Race and Ethnicity,Hispanic,9.8 (6.9 - 12.8),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2022,Race and Ethnicity,Other NH,5.5 (2.8 - 8.3),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2022,Race and Ethnicity,White NH,2.6 (1.4 - 3.7),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2022,Region,NYS Excl NYC,3.0 (1.9 - 4.1),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2022,Region,New York City,7.0 (5.4 - 8.7),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2022,Sex,Female,4.3 (3.1 - 5.5),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2022,Sex,Male,4.7 (3.3 - 6.0),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2022,Total,New York State,4.5 (3.6 - 5.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2023,Race and Ethnicity,Black NH,7.4 (4.6 - 10.2),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2023,Race and Ethnicity,Hispanic,15.1 (12.1 - 18.1),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2023,Race and Ethnicity,Other NH,7.9 (4.7 - 11.1),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2023,Race and Ethnicity,White NH,2.2 (1.6 - 2.8),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2023,Region,NYS Excl NYC,4.3 (3.3 - 5.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2023,Region,New York City,8.8 (7.2 - 10.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2023,Sex,Female,7.0 (5.6 - 8.3),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2023,Sex,Male,5.2 (4.0 - 6.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Age-adjusted percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2023,Total,New York State,6.1 (5.2 - 7.0),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,31.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Black NH,172.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Hispanic,114.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,White NH,184.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2016,Region,NYS Excl NYC,212.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2016,Region,New York City,130.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2016,Sex,Female,156.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2016,Sex,Male,190.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2016,Total,New York State,173.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,38.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Black NH,185,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Hispanic,125.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,White NH,194.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2017,Region,NYS Excl NYC,224.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2017,Region,New York City,146.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2017,Sex,Female,167.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2017,Sex,Male,205.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2017,Total,New York State,186.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,40,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Black NH,192.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Hispanic,138.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,White NH,185.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2018,Region,NYS Excl NYC,214.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2018,Region,New York City,153.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2018,Sex,Female,166.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2018,Sex,Male,203.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2018,Total,New York State,184.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,36.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Black NH,203.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Hispanic,141.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,White NH,176.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2019,Region,NYS Excl NYC,205.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2019,Region,New York City,161,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2019,Sex,Female,164,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2019,Sex,Male,202.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2019,Total,New York State,182.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,28.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Black NH,202.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Hispanic,137.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,White NH,169.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2020,Region,NYS Excl NYC,206.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2020,Region,New York City,143.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2020,Sex,Female,152.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2020,Sex,Male,199.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2020,Total,New York State,175.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,37.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Black NH,227.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Hispanic,152.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,White NH,177.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2021,Region,NYS Excl NYC,212.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2021,Region,New York City,169.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2021,Sex,Female,165.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2021,Sex,Male,220.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2021,Total,New York State,191.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,37.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Black NH,225.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Hispanic,155.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,White NH,165,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2022,Region,NYS Excl NYC,201.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2022,Region,New York City,184.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2022,Sex,Female,166.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2022,Sex,Male,219.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, age-adjusted rate per 100,000 population",2022,Total,New York State,192,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2016,Age Group,0-17 years,119.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2016,Age Group,18-24 years,280.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2016,Age Group,25-44 years,227.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2016,Age Group,45-64 years,164.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2016,Age Group,65+ years,101,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,31.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2016,Race and Ethnicity,Black NH,178.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2016,Race and Ethnicity,Hispanic,116,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2016,Race and Ethnicity,White NH,175.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2016,Region,NYS Excl NYC,202.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2016,Region,New York City,133.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2016,Sex,Female,154.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2016,Sex,Male,192.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2016,Total,New York State,173,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2017,Age Group,0-17 years,128.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2017,Age Group,18-24 years,285.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2017,Age Group,25-44 years,249.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2017,Age Group,45-64 years,178.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2017,Age Group,65+ years,111.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,37.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2017,Race and Ethnicity,Black NH,192.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2017,Race and Ethnicity,Hispanic,127.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2017,Race and Ethnicity,White NH,185,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2017,Region,NYS Excl NYC,214.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2017,Region,New York City,149.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2017,Sex,Female,164.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2017,Sex,Male,209.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2017,Total,New York State,186.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2018,Age Group,0-17 years,123.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2018,Age Group,18-24 years,256.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2018,Age Group,25-44 years,246.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2018,Age Group,45-64 years,185.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2018,Age Group,65+ years,119.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,39.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2018,Race and Ethnicity,Black NH,201.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2018,Race and Ethnicity,Hispanic,139,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2018,Race and Ethnicity,White NH,177.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2018,Region,NYS Excl NYC,204.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2018,Region,New York City,157.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2018,Sex,Female,163.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2018,Sex,Male,207,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2018,Total,New York State,184.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2019,Age Group,0-17 years,121.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2019,Age Group,18-24 years,235.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2019,Age Group,25-44 years,246.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2019,Age Group,45-64 years,187.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2019,Age Group,65+ years,121.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,36.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2019,Race and Ethnicity,Black NH,212.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2019,Race and Ethnicity,Hispanic,142.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2019,Race and Ethnicity,White NH,168.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2019,Region,NYS Excl NYC,196.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2019,Region,New York City,165.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2019,Sex,Female,161,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2019,Sex,Male,206.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2019,Total,New York State,183.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2020,Age Group,0-17 years,102,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2020,Age Group,18-24 years,225.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2020,Age Group,25-44 years,245.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2020,Age Group,45-64 years,186.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2020,Age Group,65+ years,115.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,28.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2020,Race and Ethnicity,Black NH,215.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2020,Race and Ethnicity,Hispanic,138,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2020,Race and Ethnicity,White NH,161.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2020,Region,NYS Excl NYC,197.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2020,Region,New York City,149.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2020,Sex,Female,150,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2020,Sex,Male,204.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2020,Total,New York State,176.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2021,Age Group,0-17 years,132.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2021,Age Group,18-24 years,220.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2021,Age Group,25-44 years,255,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2021,Age Group,45-64 years,207.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2021,Age Group,65+ years,124.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,36,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2021,Race and Ethnicity,Black NH,242.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2021,Race and Ethnicity,Hispanic,154.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2021,Race and Ethnicity,White NH,166.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2021,Region,NYS Excl NYC,202.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2021,Region,New York City,177.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2021,Sex,Female,159.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2021,Sex,Male,224.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2021,Total,New York State,191.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2022,Age Group,0-17 years,131,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2022,Age Group,18-24 years,201.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2022,Age Group,25-44 years,249,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2022,Age Group,45-64 years,223.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2022,Age Group,65+ years,127.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,35.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2022,Race and Ethnicity,Black NH,244.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2022,Race and Ethnicity,Hispanic,156.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2022,Race and Ethnicity,White NH,155.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2022,Region,NYS Excl NYC,191.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2022,Region,New York City,192.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2022,Sex,Female,160.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2022,Sex,Male,224.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any drug overdose, crude rate per 100,000 population",2022,Total,New York State,192.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,3.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Black NH,33.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Hispanic,31,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,White NH,73.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2016,Region,NYS Excl NYC,80.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2016,Region,New York City,32,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2016,Sex,Female,37.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2016,Sex,Male,76.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2016,Total,New York State,56.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Black NH,37.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Hispanic,37.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,White NH,78.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2017,Region,NYS Excl NYC,85.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2017,Region,New York City,37.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2017,Sex,Female,39.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2017,Sex,Male,84.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2017,Total,New York State,62,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,3.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Black NH,41.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Hispanic,39.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,White NH,66.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2018,Region,NYS Excl NYC,72.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2018,Region,New York City,40.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2018,Sex,Female,35.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2018,Sex,Male,77.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2018,Total,New York State,56.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,3.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Black NH,45.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Hispanic,40.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,White NH,60,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2019,Region,NYS Excl NYC,66.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2019,Region,New York City,42.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2019,Sex,Female,33.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2019,Sex,Male,75.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2019,Total,New York State,54.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,3.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Black NH,60.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Hispanic,49.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,White NH,63.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2020,Region,NYS Excl NYC,74.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2020,Region,New York City,49.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2020,Sex,Female,36.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2020,Sex,Male,86.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2020,Total,New York State,61,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,3.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Black NH,76.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Hispanic,56.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,White NH,64.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2021,Region,NYS Excl NYC,73.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2021,Region,New York City,63.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2021,Sex,Female,36.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2021,Sex,Male,99,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2021,Total,New York State,67.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,3.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Black NH,83.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Hispanic,58.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,White NH,55.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2022,Region,NYS Excl NYC,64.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2022,Region,New York City,73.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2022,Sex,Female,37.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2022,Sex,Male,98,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, age-adjusted rate per 100,000 population",2022,Total,New York State,67.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Age Group,0-17 years,4.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Age Group,0-17 years,4.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Age Group,18-24 years,107.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Age Group,18-24 years,107.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Age Group,25-44 years,104.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Age Group,25-44 years,104.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Age Group,45-64 years,55.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Age Group,45-64 years,55.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Age Group,65+ years,21.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Age Group,65+ years,21.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,3.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,3.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Race and Ethnicity,Black NH,36.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Race and Ethnicity,Black NH,36.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Race and Ethnicity,Hispanic,31.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Race and Ethnicity,Hispanic,31.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Race and Ethnicity,White NH,69.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Race and Ethnicity,White NH,69.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Region,NYS Excl NYC,75.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Region,NYS Excl NYC,75.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Region,New York City,34,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Region,New York City,34,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Sex,Female,37.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Sex,Female,37.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Sex,Male,78.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Sex,Male,78.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Total,New York State,57.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2016,Total,New York State,57.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Age Group,0-17 years,4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Age Group,0-17 years,4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Age Group,18-24 years,98.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Age Group,18-24 years,98.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Age Group,25-44 years,120,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Age Group,25-44 years,120,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Age Group,45-64 years,62.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Age Group,45-64 years,62.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Age Group,65+ years,24,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Age Group,65+ years,24,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,3.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,3.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Race and Ethnicity,Black NH,40.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Race and Ethnicity,Black NH,40.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Race and Ethnicity,Hispanic,37.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Race and Ethnicity,Hispanic,37.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Race and Ethnicity,White NH,74.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Race and Ethnicity,White NH,74.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Region,NYS Excl NYC,80.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Region,NYS Excl NYC,80.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Region,New York City,40.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Region,New York City,40.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Sex,Female,40.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Sex,Female,40.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Sex,Male,87.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Sex,Male,87.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Total,New York State,63,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2017,Total,New York State,63,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Age Group,0-17 years,3.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Age Group,0-17 years,3.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Age Group,18-24 years,67.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Age Group,18-24 years,67.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Age Group,25-44 years,108.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Age Group,25-44 years,108.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Age Group,45-64 years,63.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Age Group,45-64 years,63.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Age Group,65+ years,26.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Age Group,65+ years,26.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,3.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,3.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Race and Ethnicity,Black NH,45.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Race and Ethnicity,Black NH,45.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Race and Ethnicity,Hispanic,40.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Race and Ethnicity,Hispanic,40.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Race and Ethnicity,White NH,62.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Race and Ethnicity,White NH,62.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Region,NYS Excl NYC,68.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Region,NYS Excl NYC,68.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Region,New York City,43.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Region,New York City,43.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Sex,Female,36,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Sex,Female,36,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Sex,Male,79.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Sex,Male,79.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Total,New York State,57.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2018,Total,New York State,57.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Age Group,0-17 years,2.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Age Group,0-17 years,2.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Age Group,18-24 years,54.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Age Group,18-24 years,54.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Age Group,25-44 years,104.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Age Group,25-44 years,104.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Age Group,45-64 years,64.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Age Group,45-64 years,64.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Age Group,65+ years,28.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Age Group,65+ years,28.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,3.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,3.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Race and Ethnicity,Black NH,50,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Race and Ethnicity,Black NH,50,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Race and Ethnicity,Hispanic,40.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Race and Ethnicity,Hispanic,40.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Race and Ethnicity,White NH,57.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Race and Ethnicity,White NH,57.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Region,NYS Excl NYC,62.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Region,NYS Excl NYC,62.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Region,New York City,46.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Region,New York City,46.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Sex,Female,34.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Sex,Female,34.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Sex,Male,77.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Sex,Male,77.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Total,New York State,55.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2019,Total,New York State,55.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Age Group,0-17 years,2.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Age Group,0-17 years,2.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Age Group,18-24 years,59.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Age Group,18-24 years,59.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Age Group,25-44 years,113.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Age Group,25-44 years,113.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Age Group,45-64 years,78.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Age Group,45-64 years,78.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Age Group,65+ years,32.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Age Group,65+ years,32.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,3.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,3.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Race and Ethnicity,Black NH,67.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Race and Ethnicity,Black NH,67.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Race and Ethnicity,Hispanic,48.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Race and Ethnicity,Hispanic,48.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Race and Ethnicity,White NH,60.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Race and Ethnicity,White NH,60.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Region,NYS Excl NYC,69.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Region,NYS Excl NYC,69.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Region,New York City,53.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Region,New York City,53.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Sex,Female,37.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Sex,Female,37.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Sex,Male,89.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Sex,Male,89.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Total,New York State,62.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2020,Total,New York State,62.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Age Group,0-17 years,3.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Age Group,0-17 years,3.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Age Group,18-24 years,55.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Age Group,18-24 years,55.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Age Group,25-44 years,118.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Age Group,25-44 years,118.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Age Group,45-64 years,95.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Age Group,45-64 years,95.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Age Group,65+ years,42.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Age Group,65+ years,42.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,3.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,3.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Race and Ethnicity,Black NH,87.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Race and Ethnicity,Black NH,87.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Race and Ethnicity,Hispanic,57.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Race and Ethnicity,Hispanic,57.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Race and Ethnicity,White NH,61.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Race and Ethnicity,White NH,61.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Region,NYS Excl NYC,69.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Region,NYS Excl NYC,69.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Region,New York City,70.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Region,New York City,70.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Sex,Female,37.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Sex,Female,37.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Sex,Male,103.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Sex,Male,103.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Total,New York State,69.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2021,Total,New York State,69.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Age Group,0-17 years,3.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Age Group,0-17 years,3.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Age Group,18-24 years,43.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Age Group,18-24 years,43.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Age Group,25-44 years,112.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Age Group,25-44 years,112.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Age Group,45-64 years,104,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Age Group,45-64 years,104,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Age Group,65+ years,46.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Age Group,65+ years,46.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,3.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,3.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Race and Ethnicity,Black NH,97.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Race and Ethnicity,Black NH,97.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Race and Ethnicity,Hispanic,59.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Race and Ethnicity,Hispanic,59.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Race and Ethnicity,White NH,53.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Race and Ethnicity,White NH,53.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Region,NYS Excl NYC,61.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Region,NYS Excl NYC,61.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Region,New York City,81.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Region,New York City,81.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Sex,Female,38,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Sex,Female,38,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Sex,Male,103.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Sex,Male,103.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Total,New York State,69.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving any opioid overdose, crude rate per 100,000 population",2022,Total,New York State,69.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,1.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Black NH,16.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Hispanic,17.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,White NH,49.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2016,Region,NYS Excl NYC,54.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2016,Region,New York City,15.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2016,Sex,Female,20.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2016,Sex,Male,51.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2016,Total,New York State,35.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,1.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Black NH,20.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Hispanic,22.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,White NH,52.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2017,Region,NYS Excl NYC,58.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2017,Region,New York City,19.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2017,Sex,Female,22.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2017,Sex,Male,56.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2017,Total,New York State,39.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,1.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Black NH,22.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Hispanic,24.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,White NH,43.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2018,Region,NYS Excl NYC,48.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2018,Region,New York City,21.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2018,Sex,Female,19.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2018,Sex,Male,51.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2018,Total,New York State,35.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,1.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Black NH,23.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Hispanic,22.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,White NH,36.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2019,Region,NYS Excl NYC,41.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2019,Region,New York City,21.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2019,Sex,Female,17.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2019,Sex,Male,46.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2019,Total,New York State,31.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,1.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Black NH,29.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Hispanic,26.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,White NH,35.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2020,Region,NYS Excl NYC,41.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2020,Region,New York City,24.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2020,Sex,Female,17.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2020,Sex,Male,47.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2020,Total,New York State,32.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,1.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Black NH,37.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Hispanic,26.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,White NH,31,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2021,Region,NYS Excl NYC,35.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2021,Region,New York City,29.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2021,Sex,Female,15.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2021,Sex,Male,48.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2021,Total,New York State,32,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,1.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Black NH,34.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Hispanic,24,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,White NH,23.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2022,Region,NYS Excl NYC,27,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2022,Region,New York City,30.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2022,Sex,Female,14.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2022,Sex,Male,42.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, age-adjusted rate per 100,000 population",2022,Total,New York State,28.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Age Group,0-17 years,0.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Age Group,0-17 years,0.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Age Group,18-24 years,81.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Age Group,18-24 years,81.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Age Group,25-44 years,75.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Age Group,25-44 years,75.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Age Group,45-64 years,24.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Age Group,45-64 years,24.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Age Group,65+ years,3.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Age Group,65+ years,3.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,1.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,1.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Race and Ethnicity,Black NH,18.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Race and Ethnicity,Black NH,18.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Race and Ethnicity,Hispanic,17.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Race and Ethnicity,Hispanic,17.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Race and Ethnicity,White NH,44.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Race and Ethnicity,White NH,44.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Region,NYS Excl NYC,49.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Region,NYS Excl NYC,49.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Region,New York City,17,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Region,New York City,17,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Sex,Female,19.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Sex,Female,19.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Sex,Male,52,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Sex,Male,52,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Total,New York State,35.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2016,Total,New York State,35.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Age Group,0-17 years,0.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Age Group,0-17 years,0.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Age Group,18-24 years,72,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Age Group,18-24 years,72,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Age Group,25-44 years,86.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Age Group,25-44 years,86.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Age Group,45-64 years,29.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Age Group,45-64 years,29.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Age Group,65+ years,5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Age Group,65+ years,5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,1.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,1.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Race and Ethnicity,Black NH,21.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Race and Ethnicity,Black NH,21.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Race and Ethnicity,Hispanic,22.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Race and Ethnicity,Hispanic,22.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Race and Ethnicity,White NH,47.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Race and Ethnicity,White NH,47.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Region,NYS Excl NYC,52.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Region,NYS Excl NYC,52.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Region,New York City,20.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Region,New York City,20.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Sex,Female,21.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Sex,Female,21.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Sex,Male,57.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Sex,Male,57.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Total,New York State,39.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2017,Total,New York State,39.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Age Group,0-17 years,0.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Age Group,0-17 years,0.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Age Group,18-24 years,48.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Age Group,18-24 years,48.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Age Group,25-44 years,77.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Age Group,25-44 years,77.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Age Group,45-64 years,31.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Age Group,45-64 years,31.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Age Group,65+ years,7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Age Group,65+ years,7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,1.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,1.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Race and Ethnicity,Black NH,24.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Race and Ethnicity,Black NH,24.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Race and Ethnicity,Hispanic,24.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Race and Ethnicity,Hispanic,24.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Race and Ethnicity,White NH,39.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Race and Ethnicity,White NH,39.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Region,NYS Excl NYC,44.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Region,NYS Excl NYC,44.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Region,New York City,23.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Region,New York City,23.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Sex,Female,19,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Sex,Female,19,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Sex,Male,52,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Sex,Male,52,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Total,New York State,35.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2018,Total,New York State,35.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Age Group,0-17 years,0.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Age Group,0-17 years,0.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Age Group,18-24 years,34.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Age Group,18-24 years,34.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Age Group,25-44 years,69.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Age Group,25-44 years,69.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Age Group,45-64 years,31.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Age Group,45-64 years,31.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Age Group,65+ years,7.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Age Group,65+ years,7.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,1.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,1.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Race and Ethnicity,Black NH,25.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Race and Ethnicity,Black NH,25.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Race and Ethnicity,Hispanic,22.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Race and Ethnicity,Hispanic,22.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Race and Ethnicity,White NH,33.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Race and Ethnicity,White NH,33.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Region,NYS Excl NYC,38,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Region,NYS Excl NYC,38,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Region,New York City,23.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Region,New York City,23.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Sex,Female,17,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Sex,Female,17,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Sex,Male,47.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Sex,Male,47.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Total,New York State,31.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2019,Total,New York State,31.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Age Group,0-17 years,0.2*,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Age Group,0-17 years,0.2*,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Age Group,18-24 years,29,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Age Group,18-24 years,29,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Age Group,25-44 years,67.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Age Group,25-44 years,67.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Age Group,45-64 years,37.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Age Group,45-64 years,37.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Age Group,65+ years,10.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Age Group,65+ years,10.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,1.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,1.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Race and Ethnicity,Black NH,33.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Race and Ethnicity,Black NH,33.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Race and Ethnicity,Hispanic,25.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Race and Ethnicity,Hispanic,25.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Race and Ethnicity,White NH,32.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Race and Ethnicity,White NH,32.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Region,NYS Excl NYC,37.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Region,NYS Excl NYC,37.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Region,New York City,26.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Region,New York City,26.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Sex,Female,17,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Sex,Female,17,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Sex,Male,49.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Sex,Male,49.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Total,New York State,32.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2020,Total,New York State,32.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Age Group,0-17 years,0.2*,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Age Group,0-17 years,0.2*,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Age Group,18-24 years,22.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Age Group,18-24 years,22.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Age Group,25-44 years,61,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Age Group,25-44 years,61,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Age Group,45-64 years,44.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Age Group,45-64 years,44.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Age Group,65+ years,16,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Age Group,65+ years,16,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,1.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,1.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Race and Ethnicity,Black NH,43.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Race and Ethnicity,Black NH,43.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Race and Ethnicity,Hispanic,26.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Race and Ethnicity,Hispanic,26.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Race and Ethnicity,White NH,28.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Race and Ethnicity,White NH,28.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Region,NYS Excl NYC,32.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Region,NYS Excl NYC,32.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Region,New York City,33.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Region,New York City,33.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Sex,Female,15.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Sex,Female,15.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Sex,Male,51.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Sex,Male,51.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Total,New York State,32.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2021,Total,New York State,32.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Age Group,0-17 years,s,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Age Group,0-17 years,s,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Age Group,18-24 years,14.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Age Group,18-24 years,14.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Age Group,25-44 years,50,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Age Group,25-44 years,50,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Age Group,45-64 years,44.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Age Group,45-64 years,44.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Age Group,65+ years,16.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Age Group,65+ years,16.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,1.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,1.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Race and Ethnicity,Black NH,40.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Race and Ethnicity,Black NH,40.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Race and Ethnicity,Hispanic,24.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Race and Ethnicity,Hispanic,24.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Race and Ethnicity,White NH,22,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Race and Ethnicity,White NH,22,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Region,NYS Excl NYC,25.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Region,NYS Excl NYC,25.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Region,New York City,34.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Region,New York City,34.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Sex,Female,14.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Sex,Female,14.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Sex,Male,44.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Sex,Male,44.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Total,New York State,29.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving heroin overdose, crude rate per 100,000 population",2022,Total,New York State,29.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,1.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Black NH,17.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Hispanic,13.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Race and Ethnicity,White NH,24.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Region,NYS Excl NYC,26,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Region,New York City,15.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Sex,Female,16.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Sex,Male,25.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Total,New York State,21.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,1.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Black NH,17.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Hispanic,15.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Race and Ethnicity,White NH,26,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Region,NYS Excl NYC,27.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Region,New York City,17.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Sex,Female,17.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Sex,Male,28,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Total,New York State,22.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,2.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Black NH,18.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Hispanic,15.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Race and Ethnicity,White NH,22.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Region,NYS Excl NYC,23.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Region,New York City,18.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Sex,Female,15.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Sex,Male,26.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Total,New York State,21.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,1.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Black NH,22.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Hispanic,17.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Race and Ethnicity,White NH,22.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Region,NYS Excl NYC,24.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Region,New York City,21,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Sex,Female,16.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Sex,Male,28.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Total,New York State,22.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,1.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Black NH,30.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Hispanic,23.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Race and Ethnicity,White NH,28.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Region,NYS Excl NYC,33.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Region,New York City,25.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Sex,Female,19.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Sex,Male,38.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Total,New York State,28.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Black NH,38.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Hispanic,30.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Race and Ethnicity,White NH,33.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Region,NYS Excl NYC,38,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Region,New York City,33.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Sex,Female,20.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Sex,Male,50.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Total,New York State,35.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,2.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Black NH,49.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Hispanic,34.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Race and Ethnicity,White NH,31.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Region,NYS Excl NYC,37.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Region,New York City,42.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Sex,Female,23.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Sex,Male,55.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Total,New York State,39.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Age Group,0-17 years,3.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Age Group,18-24 years,25.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Age Group,25-44 years,29.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Age Group,45-64 years,30.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Age Group,65+ years,17.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,1.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Race and Ethnicity,Black NH,18.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Race and Ethnicity,Hispanic,13.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Race and Ethnicity,White NH,24.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Region,NYS Excl NYC,26.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Region,New York City,17,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Sex,Female,18.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Sex,Male,26.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Total,New York State,22.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Age Group,0-17 years,3.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Age Group,18-24 years,26.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Age Group,25-44 years,33.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Age Group,45-64 years,33,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Age Group,65+ years,18.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,1.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Race and Ethnicity,Black NH,18.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Race and Ethnicity,Hispanic,15,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Race and Ethnicity,White NH,26.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Region,NYS Excl NYC,27.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Region,New York City,19.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Sex,Female,18.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Sex,Male,29.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Total,New York State,23.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Age Group,0-17 years,2.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Age Group,18-24 years,19,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Age Group,25-44 years,31,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Age Group,45-64 years,31.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Age Group,65+ years,19.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,2.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Race and Ethnicity,Black NH,21,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Race and Ethnicity,Hispanic,15.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Race and Ethnicity,White NH,23.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Region,NYS Excl NYC,24,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Region,New York City,20,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Sex,Female,17,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Sex,Male,27.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Total,New York State,22.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Age Group,0-17 years,2.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Age Group,18-24 years,19.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Age Group,25-44 years,35,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Age Group,45-64 years,32.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Age Group,65+ years,20.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,1.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Race and Ethnicity,Black NH,24.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Race and Ethnicity,Hispanic,17.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Race and Ethnicity,White NH,23.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Region,NYS Excl NYC,24.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Region,New York City,22.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Sex,Female,17.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Sex,Male,30.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Total,New York State,23.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Age Group,0-17 years,2.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Age Group,18-24 years,30.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Age Group,25-44 years,46,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Age Group,45-64 years,40.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Age Group,65+ years,22.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Race and Ethnicity,Black NH,34,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Race and Ethnicity,Hispanic,23,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Race and Ethnicity,White NH,28.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Region,NYS Excl NYC,32.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Region,New York City,27.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Sex,Female,20.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Sex,Male,40.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Total,New York State,30.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Age Group,0-17 years,2.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Age Group,18-24 years,33,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Age Group,25-44 years,57.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Age Group,45-64 years,50.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Age Group,65+ years,26.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,2.3,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Race and Ethnicity,Black NH,43.6,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Race and Ethnicity,Hispanic,31.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Race and Ethnicity,White NH,32.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Region,NYS Excl NYC,36.8,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Region,New York City,37.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Sex,Female,22.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Sex,Male,52.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Total,New York State,36.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Age Group,0-17 years,3.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Age Group,18-24 years,28.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Age Group,25-44 years,62.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Age Group,45-64 years,59.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Age Group,65+ years,30.1,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,2.5,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Race and Ethnicity,Black NH,57,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Race and Ethnicity,Hispanic,34.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Race and Ethnicity,White NH,31.2,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Region,NYS Excl NYC,36.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Region,New York City,46.7,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Sex,Female,23.9,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Sex,Male,58.4,Data Source: SPARCS Data as of July 2024
"All emergency department visits (including outpatients and admitted patients) involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Total,New York State,40.8,Data Source: SPARCS Data as of July 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2012,Age Group,18 - 24 years,92.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2012,Age Group,25 - 34 years,208.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2012,Age Group,35 - 44 years,289.2,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2012,Age Group,45 - 54 years,405.8,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2012,Age Group,55 - 64 years,470.2,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2012,Age Group,65+ years,495.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2012,Age Group by Sex,Female & 18 - 24 years,107.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2012,Age Group by Sex,Female & 25 - 34 years,247.2,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2012,Age Group by Sex,Female & 35 - 44 years,348.2,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2012,Age Group by Sex,Female & 45 - 54 years,491.8,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2012,Age Group by Sex,Female & 55 - 64 years,556.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2012,Age Group by Sex,Female & 65+ years,597,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2012,Age Group by Sex,Male & 18 - 24 years,78.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2012,Age Group by Sex,Male & 25 - 34 years,169.4,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2012,Age Group by Sex,Male & 35 - 44 years,227.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2012,Age Group by Sex,Male & 45 - 54 years,314.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2012,Age Group by Sex,Male & 55 - 64 years,374.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2012,Age Group by Sex,Male & 65+ years,355.2,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2012,Region,NYS Excl NYC,310.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2012,Region,New York City,205.4,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2012,Sex,Female,327.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2012,Sex,Male,200,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2012,Total,New York State,265.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2013,Age Group,18 - 24 years,91.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2013,Age Group,25 - 34 years,208.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2013,Age Group,35 - 44 years,293.2,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2013,Age Group,45 - 54 years,405.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2013,Age Group,55 - 64 years,478.4,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2013,Age Group,65+ years,502.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2013,Age Group by Sex,Female & 18 - 24 years,105.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2013,Age Group by Sex,Female & 25 - 34 years,247.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2013,Age Group by Sex,Female & 35 - 44 years,354.4,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2013,Age Group by Sex,Female & 45 - 54 years,492.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2013,Age Group by Sex,Female & 55 - 64 years,566.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2013,Age Group by Sex,Female & 65+ years,605,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2013,Age Group by Sex,Male & 18 - 24 years,77.8,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2013,Age Group by Sex,Male & 25 - 34 years,169.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2013,Age Group by Sex,Male & 35 - 44 years,229.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2013,Age Group by Sex,Male & 45 - 54 years,313.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2013,Age Group by Sex,Male & 55 - 64 years,381.4,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2013,Age Group by Sex,Male & 65+ years,360.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2013,Region,NYS Excl NYC,317.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2013,Region,New York City,206.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2013,Sex,Female,333.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2013,Sex,Male,203,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2013,Total,New York State,270,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2014,Age Group,18 - 24 years,88.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2014,Age Group,25 - 34 years,204.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2014,Age Group,35 - 44 years,292.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2014,Age Group,45 - 54 years,402.4,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2014,Age Group,55 - 64 years,478.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2014,Age Group,65+ years,502.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2014,Age Group by Sex,Female & 18 - 24 years,102.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2014,Age Group by Sex,Female & 25 - 34 years,241.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2014,Age Group by Sex,Female & 35 - 44 years,351.2,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2014,Age Group by Sex,Female & 45 - 54 years,488.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2014,Age Group by Sex,Female & 55 - 64 years,567.2,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2014,Age Group by Sex,Female & 65+ years,605.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2014,Age Group by Sex,Male & 18 - 24 years,75.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2014,Age Group by Sex,Male & 25 - 34 years,166.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2014,Age Group by Sex,Male & 35 - 44 years,230.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2014,Age Group by Sex,Male & 45 - 54 years,311,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2014,Age Group by Sex,Male & 55 - 64 years,381.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2014,Age Group by Sex,Male & 65+ years,362.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2014,Region,NYS Excl NYC,318.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2014,Region,New York City,206.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2014,Sex,Female,332.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2014,Sex,Male,203.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2014,Total,New York State,270.2,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2015,Age Group,18 - 24 years,90.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2015,Age Group,25 - 34 years,211,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2015,Age Group,35 - 44 years,300,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2015,Age Group,45 - 54 years,408.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2015,Age Group,55 - 64 years,487.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2015,Age Group,65+ years,503.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2015,Age Group by Sex,Female & 18 - 24 years,105.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2015,Age Group by Sex,Female & 25 - 34 years,250.8,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2015,Age Group by Sex,Female & 35 - 44 years,360.4,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2015,Age Group by Sex,Female & 45 - 54 years,498,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2015,Age Group by Sex,Female & 55 - 64 years,579.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2015,Age Group by Sex,Female & 65+ years,604.8,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2015,Age Group by Sex,Male & 18 - 24 years,76.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2015,Age Group by Sex,Male & 25 - 34 years,170.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2015,Age Group by Sex,Male & 35 - 44 years,237.4,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2015,Age Group by Sex,Male & 45 - 54 years,313.8,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2015,Age Group by Sex,Male & 55 - 64 years,387.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2015,Age Group by Sex,Male & 65+ years,365.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2015,Region,NYS Excl NYC,328.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2015,Region,New York City,207.4,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2015,Sex,Female,340.8,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2015,Sex,Male,208.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2015,Total,New York State,276.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2016,Age Group,18 - 24 years,88.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2016,Age Group,25 - 34 years,211.8,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2016,Age Group,35 - 44 years,308,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2016,Age Group,45 - 54 years,407.2,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2016,Age Group,55 - 64 years,497.8,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2016,Age Group,65+ years,513.4,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2016,Age Group by Sex,Female & 18 - 24 years,102.8,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2016,Age Group by Sex,Female & 25 - 34 years,252,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2016,Age Group by Sex,Female & 35 - 44 years,370.2,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2016,Age Group by Sex,Female & 45 - 54 years,496.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2016,Age Group by Sex,Female & 55 - 64 years,588.8,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2016,Age Group by Sex,Female & 65+ years,600.4,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2016,Age Group by Sex,Male & 18 - 24 years,75.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2016,Age Group by Sex,Male & 25 - 34 years,171.4,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2016,Age Group by Sex,Male & 35 - 44 years,243.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2016,Age Group by Sex,Male & 45 - 54 years,312.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2016,Age Group by Sex,Male & 55 - 64 years,398.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2016,Age Group by Sex,Male & 65+ years,396.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2016,Region,NYS Excl NYC,337.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2016,Region,New York City,207.8,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2016,Sex,Female,344,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2016,Sex,Male,216,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2016,Total,New York State,281.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2017,Age Group,18 - 24 years,83.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2017,Age Group,25 - 34 years,205.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2017,Age Group,35 - 44 years,303.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2017,Age Group,45 - 54 years,392.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2017,Age Group,55 - 64 years,487.3,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2017,Age Group,65+ years,507.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2017,Age Group by Sex,Female & 18 - 24 years,96.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2017,Age Group by Sex,Female & 25 - 34 years,244.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2017,Age Group by Sex,Female & 35 - 44 years,365,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2017,Age Group by Sex,Female & 45 - 54 years,480.8,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2017,Age Group by Sex,Female & 55 - 64 years,578.8,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2017,Age Group by Sex,Female & 65+ years,593.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2017,Age Group by Sex,Male & 18 - 24 years,71.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2017,Age Group by Sex,Male & 25 - 34 years,165.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2017,Age Group by Sex,Male & 35 - 44 years,240.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2017,Age Group by Sex,Male & 45 - 54 years,299,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2017,Age Group by Sex,Male & 55 - 64 years,387.8,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2017,Age Group by Sex,Male & 65+ years,392.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2017,Region,NYS Excl NYC,330.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2017,Region,New York City,205.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2017,Sex,Female,338.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2017,Sex,Male,211.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2017,Total,New York State,277.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2018,Age Group,18 - 24 years,80.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2018,Age Group,25 - 34 years,198.4,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2018,Age Group,35 - 44 years,298.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2018,Age Group,45 - 54 years,375.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2018,Age Group,55 - 64 years,473.4,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2018,Age Group,65+ years,499.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2018,Age Group by Sex,Female & 18 - 24 years,91.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2018,Age Group by Sex,Female & 25 - 34 years,235.2,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2018,Age Group by Sex,Female & 35 - 44 years,359.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2018,Age Group by Sex,Female & 45 - 54 years,461.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2018,Age Group by Sex,Female & 55 - 64 years,563.8,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2018,Age Group by Sex,Female & 65+ years,583.2,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2018,Age Group by Sex,Male & 18 - 24 years,68.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2018,Age Group by Sex,Male & 25 - 34 years,161.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2018,Age Group by Sex,Male & 35 - 44 years,236.3,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2018,Age Group by Sex,Male & 45 - 54 years,285,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2018,Age Group by Sex,Male & 55 - 64 years,374.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2018,Age Group by Sex,Male & 65+ years,389.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2018,Region,NYS Excl NYC,322.3,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2018,Region,New York City,203.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2018,Sex,Female,331.4,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2018,Sex,Male,207.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2018,Total,New York State,271.3,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2019,Age Group,18 - 24 years,75,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2019,Age Group,25 - 34 years,192,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2019,Age Group,35 - 44 years,295,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2019,Age Group,45 - 54 years,354.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2019,Age Group,55 - 64 years,457.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2019,Age Group,65+ years,504.4,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2019,Age Group by Sex,Female & 18 - 24 years,85,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2019,Age Group by Sex,Female & 25 - 34 years,226.8,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2019,Age Group by Sex,Female & 35 - 44 years,353.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2019,Age Group by Sex,Female & 45 - 54 years,436,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2019,Age Group by Sex,Female & 55 - 64 years,546.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2019,Age Group by Sex,Female & 65+ years,586.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2019,Age Group by Sex,Male & 18 - 24 years,65.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2019,Age Group by Sex,Male & 25 - 34 years,157.3,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2019,Age Group by Sex,Male & 35 - 44 years,234.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2019,Age Group by Sex,Male & 45 - 54 years,268.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2019,Age Group by Sex,Male & 55 - 64 years,361.2,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2019,Age Group by Sex,Male & 65+ years,395.2,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2019,Region,NYS Excl NYC,315.4,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2019,Region,New York City,198.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2019,Sex,Female,323.8,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2019,Sex,Male,203.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2019,Total,New York State,265.2,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2020,Age Group,18 - 24 years,70.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2020,Age Group,25 - 34 years,188.4,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2020,Age Group,35 - 44 years,305.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2020,Age Group,45 - 54 years,347.3,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2020,Age Group,55 - 64 years,455.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2020,Age Group,65+ years,509.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2020,Age Group by Sex,Female & 18 - 24 years,80.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2020,Age Group by Sex,Female & 25 - 34 years,223.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2020,Age Group by Sex,Female & 35 - 44 years,370.8,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2020,Age Group by Sex,Female & 45 - 54 years,429.8,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2020,Age Group by Sex,Female & 55 - 64 years,550.4,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2020,Age Group by Sex,Female & 65+ years,593.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2020,Age Group by Sex,Male & 18 - 24 years,60.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2020,Age Group by Sex,Male & 25 - 34 years,152.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2020,Age Group by Sex,Male & 35 - 44 years,237.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2020,Age Group by Sex,Male & 45 - 54 years,260,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2020,Age Group by Sex,Male & 55 - 64 years,353.2,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2020,Age Group by Sex,Male & 65+ years,398.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2020,Region,NYS Excl NYC,318.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2020,Region,New York City,193.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2020,Sex,Female,325.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2020,Sex,Male,200.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2020,Total,New York State,264.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2021,Age Group,18 - 24 years,68.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2021,Age Group,25 - 34 years,185.3,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2021,Age Group,35 - 44 years,285.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2021,Age Group,45 - 54 years,340.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2021,Age Group,55 - 64 years,421.4,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2021,Age Group,65+ years,473.2,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2021,Age Group by Sex,Female & 18 - 24 years,78.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2021,Age Group by Sex,Female & 25 - 34 years,217.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2021,Age Group by Sex,Female & 35 - 44 years,348.8,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2021,Age Group by Sex,Female & 45 - 54 years,425.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2021,Age Group by Sex,Female & 55 - 64 years,515.3,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2021,Age Group by Sex,Female & 65+ years,558.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2021,Age Group by Sex,Male & 18 - 24 years,59.4,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2021,Age Group by Sex,Male & 25 - 34 years,152.4,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2021,Age Group by Sex,Male & 35 - 44 years,222.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2021,Age Group by Sex,Male & 45 - 54 years,252.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2021,Age Group by Sex,Male & 55 - 64 years,321.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2021,Age Group by Sex,Male & 65+ years,363.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2021,Region,NYS Excl NYC,304.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2021,Region,New York City,184.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2021,Sex,Female,313.2,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2021,Sex,Male,191.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2021,Total,New York State,253.8,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2022,Age Group,18 - 24 years,64.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2022,Age Group,25 - 34 years,178.2,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2022,Age Group,35 - 44 years,281,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2022,Age Group,45 - 54 years,332,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2022,Age Group,55 - 64 years,409.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2022,Age Group,65+ years,464.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2022,Age Group by Sex,Female & 18 - 24 years,72.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2022,Age Group by Sex,Female & 25 - 34 years,208.3,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2022,Age Group by Sex,Female & 35 - 44 years,341.3,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2022,Age Group by Sex,Female & 45 - 54 years,413.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2022,Age Group by Sex,Female & 55 - 64 years,501.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2022,Age Group by Sex,Female & 65+ years,548.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2022,Age Group by Sex,Male & 18 - 24 years,56.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2022,Age Group by Sex,Male & 25 - 34 years,147.8,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2022,Age Group by Sex,Male & 35 - 44 years,219.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2022,Age Group by Sex,Male & 45 - 54 years,247.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2022,Age Group by Sex,Male & 55 - 64 years,311.3,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2022,Age Group by Sex,Male & 65+ years,356.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2022,Region,NYS Excl NYC,297.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2022,Region,New York City,182.4,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2022,Sex,Female,307,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2022,Sex,Male,188.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2022,Total,New York State,249.2,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2023,Age Group,18 - 24 years,59.8,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2023,Age Group,25 - 34 years,166.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2023,Age Group,35 - 44 years,273.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2023,Age Group,45 - 54 years,324,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2023,Age Group,55 - 64 years,395.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2023,Age Group,65+ years,457.2,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2023,Age Group by Sex,Female & 18 - 24 years,66.2,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2023,Age Group by Sex,Female & 25 - 34 years,192.4,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2023,Age Group by Sex,Female & 35 - 44 years,330.2,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2023,Age Group by Sex,Female & 45 - 54 years,403.4,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2023,Age Group by Sex,Female & 55 - 64 years,485.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2023,Age Group by Sex,Female & 65+ years,540.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2023,Age Group by Sex,Male & 18 - 24 years,53.3,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2023,Age Group by Sex,Male & 25 - 34 years,140.3,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2023,Age Group by Sex,Male & 35 - 44 years,216.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2023,Age Group by Sex,Male & 45 - 54 years,241.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2023,Age Group by Sex,Male & 55 - 64 years,299.9,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2023,Age Group by Sex,Male & 65+ years,351.5,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2023,Region,NYS Excl NYC,291.1,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2023,Region,New York City,177.7,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2023,Sex,Female,299.6,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2023,Sex,Male,185,Data Source: NYS PMP Data as of April 2024
"Benzodiazepine prescription, crude rate per 1,000 population",2023,Total,New York State,243.7,Data Source: NYS PMP Data as of April 2024
"Cocaine use in the past year, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Black NH,1.8 (0.9 - 3.6),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Hispanic,2.4 (1.6 - 3.5),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Other NH,1.0 (0.5 - 2.0),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2015-2016,Race and Ethnicity,White NH,3.0 (2.4 - 3.8),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2015-2016,Sex,Female,1.8 (1.4 - 2.4),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2015-2016,Sex,Male,3.3 (2.6 - 4.1),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2015-2016,Total,New York State,2.5 (2.1 - 3.0),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Black NH,2.9 (1.4 - 5.9),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Hispanic,2.3 (1.4 - 3.5),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Other NH,1.2 (0.6 - 2.2),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2016-2017,Race and Ethnicity,White NH,2.9 (2.2 - 3.9),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2016-2017,Sex,Female,1.8 (1.3 - 2.5),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2016-2017,Sex,Male,3.5 (2.7 - 4.6),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2016-2017,Total,New York State,2.6 (2.1 - 3.3),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Black NH,2.5 (1.3 - 4.6),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Hispanic,2.1 (1.3 - 3.4),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Other NH,2.0 (1.0 - 3.7),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2017-2018,Race and Ethnicity,White NH,3.1 (2.4 - 4.0),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2017-2018,Sex,Female,2.0 (1.4 - 2.8),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2017-2018,Sex,Male,3.5 (2.7 - 4.5),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2017-2018,Total,New York State,2.7 (2.2 - 3.3),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Black NH,2.2 (1.2 - 4.0),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Hispanic,2.4 (1.5 - 3.7),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Other NH,2.1 (1.1 - 3.9),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2018-2019,Race and Ethnicity,White NH,2.8 (2.1 - 3.7),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2018-2019,Sex,Female,1.8 (1.4 - 2.4),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2018-2019,Sex,Male,3.4 (2.6 - 4.4),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2018-2019,Total,New York State,2.6 (2.1 - 3.1),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2019-2020,Race and Ethnicity,Black NH,.,Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2019-2020,Race and Ethnicity,Hispanic,.,Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2019-2020,Race and Ethnicity,Other NH,.,Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2019-2020,Race and Ethnicity,White NH,.,Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2019-2020,Sex,Female,.,Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2019-2020,Sex,Male,.,Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2019-2020,Total,New York State,.,Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2021-2022,Race and Ethnicity,Black NH,2.1 (1.0 - 4.6),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2021-2022,Race and Ethnicity,Hispanic,2.3 (1.2 - 4.2),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2021-2022,Race and Ethnicity,Other NH,0.8 (0.4 - 1.8),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2021-2022,Race and Ethnicity,White NH,2.6 (1.8 - 3.7),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2021-2022,Sex,Female,1.4 (0.9 - 2.1),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2021-2022,Sex,Male,3.2 (2.2 - 4.6),Data Source: National Survey on Drug Use and Health
"Cocaine use in the past year, among persons aged 12 years or older",2021-2022,Total,New York State,2.3 (1.7 - 3.0),Data Source: National Survey on Drug Use and Health
"Drug use (excluding alcohol) disorder in the past year, among persons aged 12 years or older",2021-2022,Age Group,12-17 years,6.7 (4.7 - 9.6),Data Source: National Survey on Drug Use and Health
"Drug use (excluding alcohol) disorder in the past year, among persons aged 12 years or older",2021-2022,Age Group,18-25 years,14.3 (11.3 - 17.9),Data Source: National Survey on Drug Use and Health
"Drug use (excluding alcohol) disorder in the past year, among persons aged 12 years or older",2021-2022,Age Group,26-34 years,12.7 (9.8 - 16.2),Data Source: National Survey on Drug Use and Health
"Drug use (excluding alcohol) disorder in the past year, among persons aged 12 years or older",2021-2022,Age Group,35+ years,5.5 (4.1 - 7.2),Data Source: National Survey on Drug Use and Health
"Drug use (excluding alcohol) disorder in the past year, among persons aged 12 years or older",2021-2022,Race and Ethnicity,Black NH,10.3 (7.1 - 14.6),Data Source: National Survey on Drug Use and Health
"Drug use (excluding alcohol) disorder in the past year, among persons aged 12 years or older",2021-2022,Race and Ethnicity,Hispanic,9.9 (7.3 - 13.4),Data Source: National Survey on Drug Use and Health
"Drug use (excluding alcohol) disorder in the past year, among persons aged 12 years or older",2021-2022,Race and Ethnicity,Other NH,5.9 (3.7 - 9.2),Data Source: National Survey on Drug Use and Health
"Drug use (excluding alcohol) disorder in the past year, among persons aged 12 years or older",2021-2022,Race and Ethnicity,White NH,6.6 (5.1 - 8.7),Data Source: National Survey on Drug Use and Health
"Drug use (excluding alcohol) disorder in the past year, among persons aged 12 years or older",2021-2022,Sex,Female,6.1 (4.9 - 7.7),Data Source: National Survey on Drug Use and Health
"Drug use (excluding alcohol) disorder in the past year, among persons aged 12 years or older",2021-2022,Sex,Male,9.3 (7.3 - 11.8),Data Source: National Survey on Drug Use and Health
"Drug use (excluding alcohol) disorder in the past year, among persons aged 12 years or older",2021-2022,Total,New York State,7.7 (6.4 - 9.2),Data Source: National Survey on Drug Use and Health
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2016,Age Group,0-17 years,2,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2016,Age Group,18-24 years,326.5,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2016,Age Group,25-44 years,460.8,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2016,Age Group,45-64 years,234.6,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2016,Age Group,65+ years,30.5,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,16,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2016,Race and Ethnicity,Black NH,196.6,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2016,Race and Ethnicity,Hispanic,206.9,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2016,Race and Ethnicity,White NH,224,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2016,Region,NYS Excl NYC,206.6,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2016,Region,New York City,245.2,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2016,Sex,Female,127,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2016,Sex,Male,325.3,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2016,Total,New York State,223.3,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2017,Age Group,0-17 years,2,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2017,Age Group,18-24 years,250.4,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2017,Age Group,25-44 years,464.6,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2017,Age Group,45-64 years,254.6,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2017,Age Group,65+ years,35,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,16.5,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2017,Race and Ethnicity,Black NH,219.9,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2017,Race and Ethnicity,Hispanic,216.5,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2017,Race and Ethnicity,White NH,211.1,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2017,Region,NYS Excl NYC,193.5,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2017,Region,New York City,261.2,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2017,Sex,Female,127.4,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2017,Sex,Male,323.6,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2017,Total,New York State,222.7,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2018,Age Group,0-17 years,1.3,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2018,Age Group,18-24 years,190.9,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2018,Age Group,25-44 years,441.5,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2018,Age Group,45-64 years,250.4,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2018,Age Group,65+ years,40.1,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,15.5,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2018,Race and Ethnicity,Black NH,218.2,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2018,Race and Ethnicity,Hispanic,225.2,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2018,Race and Ethnicity,White NH,191.4,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2018,Region,NYS Excl NYC,172.6,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2018,Region,New York City,260.1,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2018,Sex,Female,116.9,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2018,Sex,Male,308.9,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2018,Total,New York State,210.2,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2019,Age Group,0-17 years,0.8,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2019,Age Group,18-24 years,141.6,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2019,Age Group,25-44 years,404.9,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2019,Age Group,45-64 years,227.6,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2019,Age Group,65+ years,42.7,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,16,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2019,Race and Ethnicity,Black NH,198.1,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2019,Race and Ethnicity,Hispanic,210.6,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2019,Race and Ethnicity,White NH,165.5,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2019,Region,NYS Excl NYC,154,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2019,Region,New York City,237.9,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2019,Sex,Female,101.6,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2019,Sex,Male,283.7,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2019,Total,New York State,190,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2020,Age Group,0-17 years,1.1,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2020,Age Group,18-24 years,99.4,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2020,Age Group,25-44 years,295.8,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2020,Age Group,45-64 years,146.9,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2020,Age Group,65+ years,31.4,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,9.6,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2020,Race and Ethnicity,Black NH,134.4,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2020,Race and Ethnicity,Hispanic,142.8,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2020,Race and Ethnicity,White NH,120.3,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2020,Region,NYS Excl NYC,119,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2020,Region,New York City,152.7,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2020,Sex,Female,66.9,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2020,Sex,Male,204,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2020,Total,New York State,133.5,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2021,Age Group,0-17 years,0.9,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2021,Age Group,18-24 years,85.5,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2021,Age Group,25-44 years,272.6,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2021,Age Group,45-64 years,153.8,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2021,Age Group,65+ years,39.4,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,9.4,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2021,Race and Ethnicity,Black NH,151.9,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2021,Race and Ethnicity,Hispanic,135.2,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2021,Race and Ethnicity,White NH,106.8,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2021,Region,NYS Excl NYC,110.3,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2021,Region,New York City,152.3,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2021,Sex,Female,62.8,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2021,Sex,Male,196.8,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2021,Total,New York State,128.2,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2022,Age Group,0-17 years,1.7,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2022,Age Group,18-24 years,77.8,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2022,Age Group,25-44 years,269,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2022,Age Group,45-64 years,178.3,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2022,Age Group,65+ years,44.2,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,9.5,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2022,Race and Ethnicity,Black NH,162.9,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2022,Race and Ethnicity,Hispanic,151.1,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2022,Race and Ethnicity,White NH,95.4,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2022,Region,NYS Excl NYC,99,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2022,Region,New York City,180.5,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2022,Sex,Female,66.8,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2022,Sex,Male,203.5,Data Source: SPARCS Data as of July 2024
"ED visits (outpatients) and hospital discharges involving opioid abuse, dependence and unspecified use, crude rate per 100,000 population",2022,Total,New York State,133.6,Data Source: SPARCS Data as of July 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2020,Age Group,18 - 24 years,53.8,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2020,Age Group,25 - 34 years,68.3,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2020,Age Group,35 - 44 years,91.9,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2020,Age Group,45 - 54 years,104.4,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2020,Age Group,55 - 64 years,139.2,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2020,Age Group,65+ years,172.7,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2020,Age Group by Sex,Female & 18 - 24 years,64.4,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2020,Age Group by Sex,Female & 25 - 34 years,86.6,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2020,Age Group by Sex,Female & 35 - 44 years,110.4,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2020,Age Group by Sex,Female & 45 - 54 years,116.2,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2020,Age Group by Sex,Female & 55 - 64 years,143.2,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2020,Age Group by Sex,Female & 65+ years,175.6,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2020,Age Group by Sex,Male & 18 - 24 years,43.3,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2020,Age Group by Sex,Male & 25 - 34 years,50,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2020,Age Group by Sex,Male & 35 - 44 years,72.7,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2020,Age Group by Sex,Male & 45 - 54 years,91.9,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2020,Age Group by Sex,Male & 55 - 64 years,134.9,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2020,Age Group by Sex,Male & 65+ years,169,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2020,Region,NYS Excl NYC,107.7,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2020,Region,New York City,63.5,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2020,Sex,Female,99.8,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2020,Sex,Male,77,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2020,Total,New York State,88.7,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2021,Age Group,18 - 24 years,57.3,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2021,Age Group,25 - 34 years,72,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2021,Age Group,35 - 44 years,92.2,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2021,Age Group,45 - 54 years,110.3,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2021,Age Group,55 - 64 years,137.4,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2021,Age Group,65+ years,168.7,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2021,Age Group by Sex,Female & 18 - 24 years,67.2,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2021,Age Group by Sex,Female & 25 - 34 years,90.7,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2021,Age Group by Sex,Female & 35 - 44 years,113.2,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2021,Age Group by Sex,Female & 45 - 54 years,126,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2021,Age Group by Sex,Female & 55 - 64 years,144,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2021,Age Group by Sex,Female & 65+ years,173.7,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2021,Age Group by Sex,Male & 18 - 24 years,47.4,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2021,Age Group by Sex,Male & 25 - 34 years,53.2,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2021,Age Group by Sex,Male & 35 - 44 years,71.1,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2021,Age Group by Sex,Male & 45 - 54 years,94,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2021,Age Group by Sex,Male & 55 - 64 years,130.3,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2021,Age Group by Sex,Male & 65+ years,162.3,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2021,Region,NYS Excl NYC,108.3,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2021,Region,New York City,66.7,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2021,Sex,Female,102.7,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2021,Sex,Male,77.8,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2021,Total,New York State,90.6,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2022,Age Group,18 - 24 years,52.5,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2022,Age Group,25 - 34 years,66.1,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2022,Age Group,35 - 44 years,86.9,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2022,Age Group,45 - 54 years,104.6,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2022,Age Group,55 - 64 years,133.5,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2022,Age Group,65+ years,167.5,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2022,Age Group by Sex,Female & 18 - 24 years,60.6,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2022,Age Group by Sex,Female & 25 - 34 years,82.5,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2022,Age Group by Sex,Female & 35 - 44 years,106.5,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2022,Age Group by Sex,Female & 45 - 54 years,120.1,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2022,Age Group by Sex,Female & 55 - 64 years,140.4,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2022,Age Group by Sex,Female & 65+ years,172.5,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2022,Age Group by Sex,Male & 18 - 24 years,44.5,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2022,Age Group by Sex,Male & 25 - 34 years,49.4,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2022,Age Group by Sex,Male & 35 - 44 years,67,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2022,Age Group by Sex,Male & 45 - 54 years,88.4,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2022,Age Group by Sex,Male & 55 - 64 years,126.1,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2022,Age Group by Sex,Male & 65+ years,161.1,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2022,Region,NYS Excl NYC,104.7,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2022,Region,New York City,64.7,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2022,Sex,Female,99.2,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2022,Sex,Male,75.6,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2022,Total,New York State,87.7,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2023,Age Group,18 - 24 years,50.5,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2023,Age Group,25 - 34 years,63.6,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2023,Age Group,35 - 44 years,84,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2023,Age Group,45 - 54 years,101.4,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2023,Age Group,55 - 64 years,130.4,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2023,Age Group,65+ years,166.3,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2023,Age Group by Sex,Female & 18 - 24 years,57.9,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2023,Age Group by Sex,Female & 25 - 34 years,78.9,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2023,Age Group by Sex,Female & 35 - 44 years,102.7,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2023,Age Group by Sex,Female & 45 - 54 years,116.7,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2023,Age Group by Sex,Female & 55 - 64 years,137.7,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2023,Age Group by Sex,Female & 65+ years,171,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2023,Age Group by Sex,Male & 18 - 24 years,43.1,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2023,Age Group by Sex,Male & 25 - 34 years,48.1,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2023,Age Group by Sex,Male & 35 - 44 years,65.1,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2023,Age Group by Sex,Male & 45 - 54 years,85.6,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2023,Age Group by Sex,Male & 55 - 64 years,122.6,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2023,Age Group by Sex,Male & 65+ years,160.2,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2023,Region,NYS Excl NYC,103,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2023,Region,New York City,63.8,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2023,Sex,Female,97.5,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2023,Sex,Male,74.8,Data Source: NYS PMP Data as of April 2024
"Episodes when an opioid-naïve patient received an initial opioid prescription, crude rate per 1,000 population",2023,Total,New York State,86.5,Data Source: NYS PMP Data as of April 2024
"Heroin use in the past year, among persons aged 12 years or older",2015-2016,Sex,Female,0.1 (0.0 - 0.2),Data Source: National Survey on Drug Use and Health
"Heroin use in the past year, among persons aged 12 years or older",2015-2016,Sex,Male,0.7 (0.4 - 1.2),Data Source: National Survey on Drug Use and Health
"Heroin use in the past year, among persons aged 12 years or older",2015-2016,Total,New York State,0.4 (0.2 - 0.6),Data Source: National Survey on Drug Use and Health
"Heroin use in the past year, among persons aged 12 years or older",2016-2017,Sex,Female,0.1 (0.0 - 0.2),Data Source: National Survey on Drug Use and Health
"Heroin use in the past year, among persons aged 12 years or older",2016-2017,Sex,Male,0.4 (0.2 - 0.9),Data Source: National Survey on Drug Use and Health
"Heroin use in the past year, among persons aged 12 years or older",2016-2017,Total,New York State,0.3 (0.1 - 0.5),Data Source: National Survey on Drug Use and Health
"Heroin use in the past year, among persons aged 12 years or older",2017-2018,Sex,Female,0.1 (0.1 - 0.3),Data Source: National Survey on Drug Use and Health
"Heroin use in the past year, among persons aged 12 years or older",2017-2018,Sex,Male,0.3 (0.1 - 0.5),Data Source: National Survey on Drug Use and Health
"Heroin use in the past year, among persons aged 12 years or older",2017-2018,Total,New York State,0.2 (0.1 - 0.3),Data Source: National Survey on Drug Use and Health
"Heroin use in the past year, among persons aged 12 years or older",2018-2019,Sex,Female,0.1 (0.0 - 0.3),Data Source: National Survey on Drug Use and Health
"Heroin use in the past year, among persons aged 12 years or older",2018-2019,Sex,Male,0.3 (0.1 - 0.6),Data Source: National Survey on Drug Use and Health
"Heroin use in the past year, among persons aged 12 years or older",2018-2019,Total,New York State,0.2 (0.1 - 0.3),Data Source: National Survey on Drug Use and Health
"Heroin use in the past year, among persons aged 12 years or older",2019-2020,Sex,Female,.,Data Source: National Survey on Drug Use and Health
"Heroin use in the past year, among persons aged 12 years or older",2019-2020,Sex,Male,.,Data Source: National Survey on Drug Use and Health
"Heroin use in the past year, among persons aged 12 years or older",2019-2020,Total,New York State,.,Data Source: National Survey on Drug Use and Health
"Heroin use in the past year, among persons aged 12 years or older",2021-2022,Sex,Female,0.2 (0.1 - 0.7),Data Source: National Survey on Drug Use and Health
"Heroin use in the past year, among persons aged 12 years or older",2021-2022,Sex,Male,0.6 (0.3 - 1.3),Data Source: National Survey on Drug Use and Health
"Heroin use in the past year, among persons aged 12 years or older",2021-2022,Total,New York State,0.4 (0.2 - 0.8),Data Source: National Survey on Drug Use and Health
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,12.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Black NH,88,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Hispanic,53.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,White NH,59.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2016,Region,NYS Excl NYC,66.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2016,Region,New York City,66.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2016,Sex,Female,60.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2016,Sex,Male,70.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2016,Total,New York State,65.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,15.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Black NH,89.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Hispanic,55.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,White NH,60.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2017,Region,NYS Excl NYC,69.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2017,Region,New York City,70.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2017,Sex,Female,64.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2017,Sex,Male,73.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2017,Total,New York State,68.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,17.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Black NH,96.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Hispanic,63.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,White NH,61.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2018,Region,NYS Excl NYC,70.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2018,Region,New York City,76.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2018,Sex,Female,66.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2018,Sex,Male,77.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2018,Total,New York State,72.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,17.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Black NH,96.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Hispanic,65.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,White NH,60.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2019,Region,NYS Excl NYC,69.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2019,Region,New York City,77.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2019,Sex,Female,66.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2019,Sex,Male,78.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2019,Total,New York State,72.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,12.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Black NH,90.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Hispanic,60.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,White NH,57,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2020,Region,NYS Excl NYC,67.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2020,Region,New York City,67.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2020,Sex,Female,60.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2020,Sex,Male,73,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2020,Total,New York State,66.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,17.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Black NH,87.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Hispanic,59,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,White NH,54.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2021,Region,NYS Excl NYC,64.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2021,Region,New York City,70.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2021,Sex,Female,61.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2021,Sex,Male,72.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2021,Total,New York State,66.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,15.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Black NH,84.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Hispanic,57.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,White NH,49.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2022,Region,NYS Excl NYC,59.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2022,Region,New York City,74.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2022,Sex,Female,59.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2022,Sex,Male,71.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, age-adjusted rate per 100,000 population",2022,Total,New York State,65,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2016,Age Group,0-17 years,24.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2016,Age Group,18-44 years,76.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2016,Age Group,45-64 years,93.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2016,Age Group,65+ years,63.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,12.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2016,Race and Ethnicity,Black NH,93.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2016,Race and Ethnicity,Hispanic,52,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2016,Race and Ethnicity,White NH,61.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2016,Region,NYS Excl NYC,66.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2016,Region,New York City,69.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2016,Sex,Female,62.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2016,Sex,Male,73.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2016,Total,New York State,67.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2017,Age Group,0-17 years,28.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2017,Age Group,18-44 years,79.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2017,Age Group,45-64 years,99.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2017,Age Group,65+ years,66.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,15.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2017,Race and Ethnicity,Black NH,95.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2017,Race and Ethnicity,Hispanic,55,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2017,Race and Ethnicity,White NH,62.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2017,Region,NYS Excl NYC,70.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2017,Region,New York City,74,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2017,Sex,Female,66.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2017,Sex,Male,77.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2017,Total,New York State,71.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2018,Age Group,0-17 years,28.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2018,Age Group,18-44 years,81.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2018,Age Group,45-64 years,104.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2018,Age Group,65+ years,73.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,17.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2018,Race and Ethnicity,Black NH,103.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2018,Race and Ethnicity,Hispanic,62.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2018,Race and Ethnicity,White NH,63.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2018,Region,NYS Excl NYC,71.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2018,Region,New York City,80.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2018,Sex,Female,69.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2018,Sex,Male,81.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2018,Total,New York State,75.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2019,Age Group,0-17 years,27.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2019,Age Group,18-44 years,83.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2019,Age Group,45-64 years,102.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2019,Age Group,65+ years,76.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,17.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2019,Race and Ethnicity,Black NH,103.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2019,Race and Ethnicity,Hispanic,64.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2019,Race and Ethnicity,White NH,62.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2019,Region,NYS Excl NYC,70.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2019,Region,New York City,82.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2019,Sex,Female,69.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2019,Sex,Male,82.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2019,Total,New York State,75.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2020,Age Group,0-17 years,29.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2020,Age Group,18-44 years,75.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2020,Age Group,45-64 years,92.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2020,Age Group,65+ years,72.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,12.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2020,Race and Ethnicity,Black NH,97.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2020,Race and Ethnicity,Hispanic,59.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2020,Race and Ethnicity,White NH,58.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2020,Region,NYS Excl NYC,68.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2020,Region,New York City,71.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2020,Sex,Female,63,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2020,Sex,Male,77.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2020,Total,New York State,69.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2021,Age Group,0-17 years,35.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2021,Age Group,18-44 years,72.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2021,Age Group,45-64 years,93,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2021,Age Group,65+ years,70.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,17.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2021,Race and Ethnicity,Black NH,96.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2021,Race and Ethnicity,Hispanic,58.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2021,Race and Ethnicity,White NH,55.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2021,Region,NYS Excl NYC,64.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2021,Region,New York City,76.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2021,Sex,Female,63.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2021,Sex,Male,76.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2021,Total,New York State,69.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2022,Age Group,0-17 years,31.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2022,Age Group,18-44 years,69.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2022,Age Group,45-64 years,96.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2022,Age Group,65+ years,69.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,15.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2022,Race and Ethnicity,Black NH,94.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2022,Race and Ethnicity,Hispanic,58,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2022,Race and Ethnicity,White NH,51.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2022,Region,NYS Excl NYC,60.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2022,Region,New York City,79.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2022,Sex,Female,61.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2022,Sex,Male,76.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any drug overdose, crude rate per 100,000 population",2022,Total,New York State,68.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,1.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Black NH,11.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Hispanic,12.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,White NH,16,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2016,Region,NYS Excl NYC,16.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2016,Region,New York City,12.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2016,Sex,Female,10.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2016,Sex,Male,18.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2016,Total,New York State,14.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Black NH,12.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Hispanic,13.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,White NH,16,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2017,Region,NYS Excl NYC,16.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2017,Region,New York City,13.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2017,Sex,Female,11.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2017,Sex,Male,19.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2017,Total,New York State,15.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Black NH,13.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Hispanic,14.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,White NH,14.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2018,Region,NYS Excl NYC,15.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2018,Region,New York City,14.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2018,Sex,Female,10.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2018,Sex,Male,18.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2018,Total,New York State,14.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,1.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Black NH,12.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Hispanic,13.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,White NH,13.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2019,Region,NYS Excl NYC,13.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2019,Region,New York City,14.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2019,Sex,Female,9.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2019,Sex,Male,17.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2019,Total,New York State,13.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,0.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Black NH,17.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Hispanic,15.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,White NH,13.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2020,Region,NYS Excl NYC,14.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2020,Region,New York City,16.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2020,Sex,Female,10,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2020,Sex,Male,20,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2020,Total,New York State,14.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,0.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Black NH,17.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Hispanic,17,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,White NH,12.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2021,Region,NYS Excl NYC,13.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2021,Region,New York City,18,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2021,Sex,Female,9.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2021,Sex,Male,20.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2021,Total,New York State,15.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Black NH,20.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Hispanic,17.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,White NH,10.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2022,Region,NYS Excl NYC,12.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2022,Region,New York City,21.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2022,Sex,Female,9.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2022,Sex,Male,22.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, age-adjusted rate per 100,000 population",2022,Total,New York State,15.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2016,Age Group,0-17 years,1.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2016,Age Group,18-44 years,18.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2016,Age Group,45-64 years,23.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2016,Age Group,65+ years,15.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,1.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2016,Race and Ethnicity,Black NH,13,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2016,Race and Ethnicity,Hispanic,11.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2016,Race and Ethnicity,White NH,16.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2016,Region,NYS Excl NYC,17.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2016,Region,New York City,13.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2016,Sex,Female,12,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2016,Sex,Male,19.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2016,Total,New York State,15.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2017,Age Group,0-17 years,1.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2017,Age Group,18-44 years,18.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2017,Age Group,45-64 years,26.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2017,Age Group,65+ years,16.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,1.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2017,Race and Ethnicity,Black NH,13.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2017,Race and Ethnicity,Hispanic,12.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2017,Race and Ethnicity,White NH,17.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2017,Region,NYS Excl NYC,17.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2017,Region,New York City,15.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2017,Sex,Female,12.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2017,Sex,Male,21,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2017,Total,New York State,16.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2018,Age Group,0-17 years,0.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2018,Age Group,18-44 years,16.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2018,Age Group,45-64 years,25.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2018,Age Group,65+ years,17.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,1.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2018,Race and Ethnicity,Black NH,15.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2018,Race and Ethnicity,Hispanic,13.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2018,Race and Ethnicity,White NH,15.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2018,Region,NYS Excl NYC,15.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2018,Region,New York City,16.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2018,Sex,Female,12,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2018,Sex,Male,19.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2018,Total,New York State,15.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2019,Age Group,0-17 years,0.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2019,Age Group,18-44 years,15.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2019,Age Group,45-64 years,23.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2019,Age Group,65+ years,17.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,1.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2019,Race and Ethnicity,Black NH,14,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2019,Race and Ethnicity,Hispanic,13.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2019,Race and Ethnicity,White NH,14,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2019,Region,NYS Excl NYC,14,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2019,Region,New York City,16.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2019,Sex,Female,10.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2019,Sex,Male,19.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2019,Total,New York State,14.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2020,Age Group,0-17 years,0.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2020,Age Group,18-44 years,17.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2020,Age Group,45-64 years,25.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2020,Age Group,65+ years,17.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,1.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2020,Race and Ethnicity,Black NH,19.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2020,Race and Ethnicity,Hispanic,14.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2020,Race and Ethnicity,White NH,14,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2020,Region,NYS Excl NYC,14.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2020,Region,New York City,18.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2020,Sex,Female,11.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2020,Sex,Male,21.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2020,Total,New York State,16.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2021,Age Group,0-17 years,1.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2021,Age Group,18-44 years,17.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2021,Age Group,45-64 years,26.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2021,Age Group,65+ years,18.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,0.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2021,Race and Ethnicity,Black NH,20.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2021,Race and Ethnicity,Hispanic,17.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2021,Race and Ethnicity,White NH,13.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2021,Region,NYS Excl NYC,13.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2021,Region,New York City,20.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2021,Sex,Female,10.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2021,Sex,Male,22.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2021,Total,New York State,16.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2022,Age Group,0-17 years,1.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2022,Age Group,18-44 years,16.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2022,Age Group,45-64 years,30.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2022,Age Group,65+ years,19.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2022,Race and Ethnicity,Black NH,24.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2022,Race and Ethnicity,Hispanic,17.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2022,Race and Ethnicity,White NH,11.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2022,Region,NYS Excl NYC,12.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2022,Region,New York City,24.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2022,Sex,Female,10.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2022,Sex,Male,24.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving any opioid overdose, crude rate per 100,000 population",2022,Total,New York State,17.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,0.5*,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Black NH,4.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Hispanic,4.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,White NH,6.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2016,Region,NYS Excl NYC,7.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2016,Region,New York City,4.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2016,Sex,Female,3.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2016,Sex,Male,8.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2016,Total,New York State,6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,0.4*,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Black NH,4.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Hispanic,5.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,White NH,6.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2017,Region,NYS Excl NYC,7.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2017,Region,New York City,5.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2017,Sex,Female,3.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2017,Sex,Male,9.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2017,Total,New York State,6.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,s,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Black NH,5.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Hispanic,6.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,White NH,6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2018,Region,NYS Excl NYC,6.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2018,Region,New York City,6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2018,Sex,Female,3.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2018,Sex,Male,9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2018,Total,New York State,6.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,0.3*,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Black NH,4.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Hispanic,6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,White NH,5.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2019,Region,NYS Excl NYC,5.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2019,Region,New York City,5.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2019,Sex,Female,2.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2019,Sex,Male,8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2019,Total,New York State,5.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,0.5*,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Black NH,6.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Hispanic,6.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,White NH,5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2020,Region,NYS Excl NYC,5.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2020,Region,New York City,6.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2020,Sex,Female,2.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2020,Sex,Male,8.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2020,Total,New York State,5.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,s,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Black NH,6.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Hispanic,6.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,White NH,4.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2021,Region,NYS Excl NYC,4.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2021,Region,New York City,6.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2021,Sex,Female,2.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2021,Sex,Male,8.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2021,Total,New York State,5.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,s,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Black NH,7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Hispanic,5.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,White NH,3.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2022,Region,NYS Excl NYC,3.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2022,Region,New York City,6.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2022,Sex,Female,2.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2022,Sex,Male,7.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, age-adjusted rate per 100,000 population",2022,Total,New York State,4.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2016,Age Group,0-17 years,0.1*,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2016,Age Group,18-44 years,11.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2016,Age Group,45-64 years,6.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2016,Age Group,65+ years,1.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,0.5*,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2016,Race and Ethnicity,Black NH,4.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2016,Race and Ethnicity,Hispanic,5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2016,Race and Ethnicity,White NH,6.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2016,Region,NYS Excl NYC,7.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2016,Region,New York City,4.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2016,Sex,Female,3.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2016,Sex,Male,9.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2016,Total,New York State,6.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2017,Age Group,0-17 years,0.2*,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2017,Age Group,18-44 years,10.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2017,Age Group,45-64 years,8.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2017,Age Group,65+ years,2.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,0.4*,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2017,Race and Ethnicity,Black NH,5.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2017,Race and Ethnicity,Hispanic,5.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2017,Race and Ethnicity,White NH,6.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2017,Region,NYS Excl NYC,7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2017,Region,New York City,5.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2017,Sex,Female,3.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2017,Sex,Male,9.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2017,Total,New York State,6.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2018,Age Group,0-17 years,s,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2018,Age Group,18-44 years,9.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2018,Age Group,45-64 years,8.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2018,Age Group,65+ years,2.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,s,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2018,Race and Ethnicity,Black NH,6.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2018,Race and Ethnicity,Hispanic,6.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2018,Race and Ethnicity,White NH,5.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2018,Region,NYS Excl NYC,6.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2018,Region,New York City,6.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2018,Sex,Female,3.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2018,Sex,Male,9.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2018,Total,New York State,6.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2019,Age Group,0-17 years,s,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2019,Age Group,18-44 years,8.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2019,Age Group,45-64 years,7.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2019,Age Group,65+ years,2.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,0.4*,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2019,Race and Ethnicity,Black NH,5.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2019,Race and Ethnicity,Hispanic,6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2019,Race and Ethnicity,White NH,4.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2019,Region,NYS Excl NYC,5.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2019,Region,New York City,5.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2019,Sex,Female,2.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2019,Sex,Male,8.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2019,Total,New York State,5.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2020,Age Group,0-17 years,s,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2020,Age Group,18-44 years,8.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2020,Age Group,45-64 years,8.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2020,Age Group,65+ years,3.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,0.5*,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2020,Race and Ethnicity,Black NH,7.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2020,Race and Ethnicity,Hispanic,6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2020,Race and Ethnicity,White NH,4.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2020,Region,NYS Excl NYC,5.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2020,Region,New York City,6.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2020,Sex,Female,2.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2020,Sex,Male,9.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2020,Total,New York State,5.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2021,Age Group,0-17 years,s,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2021,Age Group,18-44 years,7.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2021,Age Group,45-64 years,8.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2021,Age Group,65+ years,4.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,s,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2021,Race and Ethnicity,Black NH,7.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2021,Race and Ethnicity,Hispanic,6.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2021,Race and Ethnicity,White NH,3.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2021,Region,NYS Excl NYC,4.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2021,Region,New York City,7.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2021,Sex,Female,2.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2021,Sex,Male,9.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2021,Total,New York State,5.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2022,Age Group,0-17 years,s,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2022,Age Group,18-44 years,5.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2022,Age Group,45-64 years,10,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2022,Age Group,65+ years,4.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,s,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2022,Race and Ethnicity,Black NH,8.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2022,Race and Ethnicity,Hispanic,5.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2022,Race and Ethnicity,White NH,3.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2022,Region,NYS Excl NYC,3.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2022,Region,New York City,8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2022,Sex,Female,2.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2022,Sex,Male,8.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving heroin overdose, crude rate per 100,000 population",2022,Total,New York State,5.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,0.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Black NH,7.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Hispanic,7.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Race and Ethnicity,White NH,9.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Region,NYS Excl NYC,9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Region,New York City,8.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Sex,Female,7.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Sex,Male,9.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Total,New York State,8.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,0.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Black NH,7.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Hispanic,8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Race and Ethnicity,White NH,9.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Region,NYS Excl NYC,9.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Region,New York City,8.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Sex,Female,7.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Sex,Male,10.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Total,New York State,8.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,1.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Black NH,8.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Hispanic,7.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Race and Ethnicity,White NH,8.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Region,NYS Excl NYC,8.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Region,New York City,8.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Sex,Female,7.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Sex,Male,9.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Total,New York State,8.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,0.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Black NH,7.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Hispanic,7.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Race and Ethnicity,White NH,8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Region,NYS Excl NYC,7.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Region,New York City,9.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Sex,Female,6.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Sex,Male,9.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Total,New York State,8.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,0.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Black NH,10.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Hispanic,9.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Race and Ethnicity,White NH,8.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Region,NYS Excl NYC,9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Region,New York City,10.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Sex,Female,7.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Sex,Male,11.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Total,New York State,9.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,0.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Black NH,10.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Hispanic,10.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Race and Ethnicity,White NH,8.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Region,NYS Excl NYC,8.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Region,New York City,11.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Sex,Female,7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Sex,Male,12.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Total,New York State,9.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,0.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Black NH,13.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Hispanic,11.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Race and Ethnicity,White NH,7.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Region,NYS Excl NYC,8.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Region,New York City,14.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Sex,Female,7.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Sex,Male,14.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Total,New York State,10.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Age Group,0-17 years,0.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Age Group,18-44 years,7.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Age Group,45-64 years,16.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Age Group,65+ years,13.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,0.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Race and Ethnicity,Black NH,8.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Race and Ethnicity,Hispanic,6.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Race and Ethnicity,White NH,10.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Region,NYS Excl NYC,10,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Region,New York City,9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Sex,Female,9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Sex,Male,10.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Total,New York State,9.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Age Group,0-17 years,1.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Age Group,18-44 years,7.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Age Group,45-64 years,18.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Age Group,65+ years,14.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,0.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Race and Ethnicity,Black NH,8.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Race and Ethnicity,Hispanic,7.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Race and Ethnicity,White NH,10.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Region,NYS Excl NYC,10.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Region,New York City,9.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Sex,Female,9.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Sex,Male,11.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Total,New York State,10.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Age Group,0-17 years,0.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Age Group,18-44 years,7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Age Group,45-64 years,17.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Age Group,65+ years,14.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,1.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Race and Ethnicity,Black NH,9.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Race and Ethnicity,Hispanic,7.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Race and Ethnicity,White NH,9.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Region,NYS Excl NYC,9.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Region,New York City,9.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Sex,Female,8.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Sex,Male,10.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Total,New York State,9.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Age Group,0-17 years,0.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Age Group,18-44 years,7.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Age Group,45-64 years,15.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Age Group,65+ years,14.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Race and Ethnicity,Black NH,8.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Race and Ethnicity,Hispanic,7.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Race and Ethnicity,White NH,9.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Region,NYS Excl NYC,8.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Region,New York City,10.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Sex,Female,8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Sex,Male,10.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Total,New York State,9.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Age Group,0-17 years,0.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Age Group,18-44 years,9.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Age Group,45-64 years,16.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Age Group,65+ years,14.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,0.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Race and Ethnicity,Black NH,11.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Race and Ethnicity,Hispanic,9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Race and Ethnicity,White NH,9.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Region,NYS Excl NYC,9.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Region,New York City,11.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Sex,Female,8.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Sex,Male,12.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Total,New York State,10.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Age Group,0-17 years,1.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Age Group,18-44 years,9.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Age Group,45-64 years,17.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Age Group,65+ years,14.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,0.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Race and Ethnicity,Black NH,12.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Race and Ethnicity,Hispanic,10.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Race and Ethnicity,White NH,9.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Region,NYS Excl NYC,9.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Region,New York City,12.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Sex,Female,8.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Sex,Male,13.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Total,New York State,10.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Age Group,0-17 years,1.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Age Group,18-44 years,10.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Age Group,45-64 years,20.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Age Group,65+ years,15.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,0.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Race and Ethnicity,Black NH,15.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Race and Ethnicity,Hispanic,11.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Race and Ethnicity,White NH,8.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Region,NYS Excl NYC,9.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Region,New York City,16.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Sex,Female,8.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Sex,Male,16.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid overdose excluding heroin (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Total,New York State,12.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2016,Age Group,0-17 years,1.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2016,Age Group,18-24 years,172.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2016,Age Group,25-44 years,263.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2016,Age Group,45-64 years,144.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2016,Age Group,65+ years,28.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,10.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2016,Race and Ethnicity,Black NH,118.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2016,Race and Ethnicity,Hispanic,125.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2016,Race and Ethnicity,White NH,130.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2016,Region,NYS Excl NYC,125,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2016,Region,New York City,139,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2016,Sex,Female,75.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2016,Sex,Male,190.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2016,Total,New York State,131,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2017,Age Group,0-17 years,1.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2017,Age Group,18-24 years,134.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2017,Age Group,25-44 years,260.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2017,Age Group,45-64 years,158.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2017,Age Group,65+ years,31.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,9.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2017,Race and Ethnicity,Black NH,128.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2017,Race and Ethnicity,Hispanic,131.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2017,Race and Ethnicity,White NH,124.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2017,Region,NYS Excl NYC,122,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2017,Region,New York City,141.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2017,Sex,Female,75.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2017,Sex,Male,188.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2017,Total,New York State,130.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2018,Age Group,0-17 years,1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2018,Age Group,18-24 years,104.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2018,Age Group,25-44 years,244.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2018,Age Group,45-64 years,153.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2018,Age Group,65+ years,33,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,9.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2018,Race and Ethnicity,Black NH,127.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2018,Race and Ethnicity,Hispanic,133.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2018,Race and Ethnicity,White NH,113.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2018,Region,NYS Excl NYC,110.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2018,Region,New York City,137.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2018,Sex,Female,70.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2018,Sex,Male,177.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2018,Total,New York State,122,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2019,Age Group,0-17 years,0.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2019,Age Group,18-24 years,77.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2019,Age Group,25-44 years,217.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2019,Age Group,45-64 years,133.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2019,Age Group,65+ years,35.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,10.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2019,Race and Ethnicity,Black NH,111,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2019,Race and Ethnicity,Hispanic,118.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2019,Race and Ethnicity,White NH,99.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2019,Region,NYS Excl NYC,100.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2019,Region,New York City,116,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2019,Sex,Female,61.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2019,Sex,Male,156.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2019,Total,New York State,107.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2020,Age Group,0-17 years,1.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2020,Age Group,18-24 years,52.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2020,Age Group,25-44 years,148.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2020,Age Group,45-64 years,82.5,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2020,Age Group,65+ years,27.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,5.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2020,Race and Ethnicity,Black NH,71.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2020,Race and Ethnicity,Hispanic,74.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2020,Race and Ethnicity,White NH,68.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2020,Region,NYS Excl NYC,75.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2020,Region,New York City,66.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2020,Sex,Female,41.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2020,Sex,Male,103.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2020,Total,New York State,71.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2021,Age Group,0-17 years,1.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2021,Age Group,18-24 years,41.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2021,Age Group,25-44 years,127,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2021,Age Group,45-64 years,82.4,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2021,Age Group,65+ years,30,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,4.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2021,Race and Ethnicity,Black NH,76,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2021,Race and Ethnicity,Hispanic,68.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2021,Race and Ethnicity,White NH,59.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2021,Region,NYS Excl NYC,67.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2021,Region,New York City,61.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2021,Sex,Female,36,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2021,Sex,Male,95.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2021,Total,New York State,64.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2022,Age Group,0-17 years,1.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2022,Age Group,18-24 years,35.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2022,Age Group,25-44 years,117.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2022,Age Group,45-64 years,93.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2022,Age Group,65+ years,32.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,5.6,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2022,Race and Ethnicity,Black NH,87.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2022,Race and Ethnicity,Hispanic,76.2,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2022,Race and Ethnicity,White NH,51.9,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2022,Region,NYS Excl NYC,59.1,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2022,Region,New York City,73.8,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2022,Sex,Female,36.3,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2022,Sex,Male,95.7,Data Source: SPARCS Data as of July 2024
"Hospital discharges involving opioid use (including abuse, poisoning, dependence and unspecified use), crude rate per 100,000 population",2022,Total,New York State,65.3,Data Source: SPARCS Data as of July 2024
"Illicit drug dependence in the past year, among persons aged 12 years or older",2015-2016,Age Group,12-17 years,1.6 (1.1 - 2.3),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2015-2016,Age Group,18-25 years,6.0 (4.7 - 7.5),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2015-2016,Age Group,26-34 years,3.6 (2.4 - 5.4),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2015-2016,Age Group,35+ years,1.2 (0.8 - 1.8),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Black NH,2.8 (1.8 - 4.4),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Hispanic,2.8 (1.9 - 4.1),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Other NH,1.0 (0.5 - 2.1),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2015-2016,Race and Ethnicity,White NH,2.1 (1.7 - 2.7),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2015-2016,Sex,Female,1.3 (0.9 - 1.8),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2015-2016,Sex,Male,3.3 (2.6 - 4.1),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2015-2016,Total,New York State,2.2 (1.8 - 2.7),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2016-2017,Age Group,12-17 years,1.3 (0.9 - 1.9),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2016-2017,Age Group,18-25 years,5.7 (4.4 - 7.5),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2016-2017,Age Group,26-34 years,3.4 (2.4 - 5.0),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2016-2017,Age Group,35+ years,1.1 (0.7 - 1.6),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Black NH,3.3 (1.9 - 5.4),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Hispanic,2.0 (1.2 - 3.3),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Other NH,1.0 (0.5 - 2.2),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2016-2017,Race and Ethnicity,White NH,1.9 (1.6 - 2.4),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2016-2017,Sex,Female,1.2 (0.9 - 1.6),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2016-2017,Sex,Male,3.0 (2.4 - 3.8),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2016-2017,Total,New York State,2.0 (1.7 - 2.4),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2017-2018,Age Group,12-17 years,0.8 (0.3 - 1.7),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2017-2018,Age Group,18-25 years,6.9 (5.6 - 8.5),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2017-2018,Age Group,26-34 years,3.8 (2.3 - 6.1),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2017-2018,Age Group,35+ years,1.0 (0.6 - 1.6),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Black NH,2.5 (1.3 - 4.5),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Hispanic,2.1 (1.2 - 3.5),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Other NH,1.0 (0.4 - 2.3),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2017-2018,Race and Ethnicity,White NH,2.3 (1.8 - 2.9),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2017-2018,Sex,Female,1.1 (0.8 - 1.6),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2017-2018,Sex,Male,3.2 (2.4 - 4.3),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2017-2018,Total,New York State,2.1 (1.7 - 2.7),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2018-2019,Age Group,12-17 years,1.8 (1.1 - 3.0),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2018-2019,Age Group,18-25 years,6.6 (5.3 - 8.1),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2018-2019,Age Group,26-34 years,4.4 (2.8 - 6.8),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2018-2019,Age Group,35+ years,1.0 (0.7 - 1.5),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Black NH,2.2 (1.4 - 3.3),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Hispanic,2.2 (1.2 - 3.8),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Other NH,1.7 (0.9 - 3.0),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2018-2019,Race and Ethnicity,White NH,2.4 (1.8 - 3.2),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2018-2019,Sex,Female,1.4 (1.0 - 2.0),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2018-2019,Sex,Male,3.2 (2.4 - 4.3),Data Source: National Survey on Drug Use and Health
"Illicit drug dependence in the past year, among persons aged 12 years or older",2018-2019,Total,New York State,2.3 (1.8 - 2.9),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2015-2016,Age Group,12-17 years,8.7 (7.2 - 10.6),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2015-2016,Age Group,18-25 years,25.5 (22.9 - 28.2),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2015-2016,Age Group,26-34 years,19.8 (17.0 - 23.0),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2015-2016,Age Group,35+ years,6.3 (5.3 - 7.5),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Black NH,9.8 (7.6 - 12.4),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Hispanic,11.3 (9.3 - 13.7),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Other NH,6.0 (4.4 - 8.1),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2015-2016,Race and Ethnicity,White NH,12.2 (10.9 - 13.7),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2015-2016,Sex,Female,8.7 (7.6 - 9.9),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2015-2016,Sex,Male,13.7 (12.0 - 15.5),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2015-2016,Total,New York State,11.1 (10.1 - 12.1),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2016-2017,Age Group,12-17 years,8.1 (6.7 - 9.8),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2016-2017,Age Group,18-25 years,25.0 (22.1 - 28.2),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2016-2017,Age Group,26-34 years,18.7 (15.8 - 22.1),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2016-2017,Age Group,35+ years,7.1 (5.7 - 8.7),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Black NH,12.0 (9.5 - 15.0),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Hispanic,11.9 (9.7 - 14.5),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Other NH,6.2 (4.5 - 8.5),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2016-2017,Race and Ethnicity,White NH,11.8 (10.3 - 13.6),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2016-2017,Sex,Female,8.6 (7.5 - 10.0),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2016-2017,Sex,Male,14.1 (12.3 - 16.1),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2016-2017,Total,New York State,11.2 (10.1 - 12.5),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2017-2018,Age Group,12-17 years,8.0 (6.6 - 9.7),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2017-2018,Age Group,18-25 years,26.3 (23.8 - 29.1),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2017-2018,Age Group,26-34 years,18.5 (15.5 - 21.9),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2017-2018,Age Group,35+ years,7.1 (5.8 - 8.7),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Black NH,12.7 (10.2 - 15.7),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Hispanic,11.2 (8.8 - 14.2),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Other NH,7.5 (5.5 - 10.1),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2017-2018,Race and Ethnicity,White NH,11.8 (10.4 - 13.5),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2017-2018,Sex,Female,9.5 (8.2 - 10.9),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2017-2018,Sex,Male,13.4 (11.8 - 15.2),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2017-2018,Total,New York State,11.4 (10.2 - 12.6),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2018-2019,Age Group,12-17 years,8.8 (7.2 - 10.7),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2018-2019,Age Group,18-25 years,26.6 (24.2 - 29.2),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2018-2019,Age Group,26-34 years,21.6 (18.5 - 25.1),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2018-2019,Age Group,35+ years,7.8 (6.4 - 9.4),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Black NH,13.5 (11.2 - 16.3),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Hispanic,11.5 (9.2 - 14.4),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Other NH,8.2 (6.3 - 10.6),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2018-2019,Race and Ethnicity,White NH,13.0 (11.3 - 15.0),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2018-2019,Sex,Female,9.6 (8.2 - 11.1),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2018-2019,Sex,Male,15.3 (13.5 - 17.3),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2018-2019,Total,New York State,12.3 (11.1 - 13.7),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2019-2020,Age Group,12-17 years,.,Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2019-2020,Age Group,18-25 years,.,Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2019-2020,Age Group,26-34 years,.,Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2019-2020,Age Group,35+ years,.,Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2019-2020,Race and Ethnicity,Black NH,.,Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2019-2020,Race and Ethnicity,Hispanic,.,Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2019-2020,Race and Ethnicity,Other NH,.,Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2019-2020,Race and Ethnicity,White NH,.,Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2019-2020,Sex,Female,.,Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2019-2020,Sex,Male,.,Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2019-2020,Total,New York State,.,Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2021-2022,Age Group,12-17 years,8.2 (5.5 - 12.1),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2021-2022,Age Group,18-25 years,25.5 (21.3 - 30.1),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2021-2022,Age Group,26-34 years,27.4 (23.1 - 32.2),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2021-2022,Age Group,35+ years,14.7 (12.7 - 16.9),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2021-2022,Race and Ethnicity,Black NH,23.4 (18.0 - 29.8),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2021-2022,Race and Ethnicity,Hispanic,16.6 (13.1 - 20.8),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2021-2022,Race and Ethnicity,Other NH,11.8 (8.0 - 17.2),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2021-2022,Race and Ethnicity,White NH,17.1 (15.2 - 19.3),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2021-2022,Sex,Female,14.3 (12.0 - 16.9),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2021-2022,Sex,Male,20.6 (17.9 - 23.5),Data Source: National Survey on Drug Use and Health
"Illicit drug use in the past month, among persons aged 12 years or older",2021-2022,Total,New York State,17.3 (15.6 - 19.2),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2015-2016,Age Group,12-17 years,1.8 (1.2 - 2.8),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2015-2016,Age Group,18-25 years,6.6 (5.4 - 8.1),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2015-2016,Age Group,26-34 years,6.2 (4.9 - 7.9),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2015-2016,Age Group,35+ years,2.1 (1.5 - 2.9),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Black NH,1.7 (0.8 - 3.4),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Hispanic,3.9 (2.9 - 5.4),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Other NH,1.1 (0.6 - 2.0),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2015-2016,Race and Ethnicity,White NH,3.9 (3.2 - 4.8),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2015-2016,Sex,Female,2.8 (2.2 - 3.6),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2015-2016,Sex,Male,3.8 (3.1 - 4.8),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2015-2016,Total,New York State,3.3 (2.8 - 3.9),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2016-2017,Age Group,12-17 years,1.3 (0.9 - 2.0),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2016-2017,Age Group,18-25 years,6.8 (5.4 - 8.5),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2016-2017,Age Group,26-34 years,6.3 (4.8 - 8.2),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2016-2017,Age Group,35+ years,2.3 (1.6 - 3.4),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Black NH,3.2 (1.7 - 5.9),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Hispanic,4.3 (2.9 - 6.3),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Other NH,1.8 (1.0 - 3.1),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2016-2017,Race and Ethnicity,White NH,3.5 (2.9 - 4.4),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2016-2017,Sex,Female,2.8 (2.2 - 3.7),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2016-2017,Sex,Male,4.1 (3.1 - 5.3),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2016-2017,Total,New York State,3.4 (2.8 - 4.2),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2017-2018,Age Group,12-17 years,1.5 (1.0 - 2.3),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2017-2018,Age Group,18-25 years,7.4 (6.0 - 9.2),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2017-2018,Age Group,26-34 years,5.5 (3.9 - 7.7),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2017-2018,Age Group,35+ years,2.2 (1.6 - 3.2),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Black NH,3.4 (2.2 - 5.3),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Hispanic,3.7 (2.3 - 5.6),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Other NH,2.4 (1.4 - 4.0),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2017-2018,Race and Ethnicity,White NH,3.4 (2.7 - 4.3),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2017-2018,Sex,Female,2.8 (2.2 - 3.7),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2017-2018,Sex,Male,3.8 (2.9 - 5.0),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2017-2018,Total,New York State,3.3 (2.8 - 4.0),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2018-2019,Age Group,12-17 years,1.8 (1.2 - 2.7),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2018-2019,Age Group,18-25 years,6.6 (5.4 - 8.1),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2018-2019,Age Group,26-34 years,5.9 (4.4 - 7.9),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2018-2019,Age Group,35+ years,1.9 (1.3 - 2.8),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Black NH,2.5 (1.4 - 4.2),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Hispanic,3.4 (2.2 - 5.0),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Other NH,2.1 (1.3 - 3.5),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2018-2019,Race and Ethnicity,White NH,3.4 (2.6 - 4.3),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2018-2019,Sex,Female,2.4 (1.8 - 3.2),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2018-2019,Sex,Male,3.8 (3.0 - 4.9),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2018-2019,Total,New York State,3.1 (2.5 - 3.8),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2019-2020,Age Group,12-17 years,.,Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2019-2020,Age Group,18-25 years,.,Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2019-2020,Age Group,26-34 years,.,Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2019-2020,Age Group,35+ years,.,Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2019-2020,Race and Ethnicity,Black NH,.,Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2019-2020,Race and Ethnicity,Hispanic,.,Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2019-2020,Race and Ethnicity,Other NH,.,Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2019-2020,Race and Ethnicity,White NH,.,Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2019-2020,Sex,Female,.,Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2019-2020,Sex,Male,.,Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2019-2020,Total,New York State,.,Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2021-2022,Age Group,12-17 years,1.0 (0.4 - 2.6),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2021-2022,Age Group,18-25 years,5.9 (4.1 - 8.3),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2021-2022,Age Group,26-34 years,3.6 (2.2 - 6.1),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2021-2022,Age Group,35+ years,3.2 (2.4 - 4.2),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2021-2022,Race and Ethnicity,Black NH,5.0 (2.9 - 8.5),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2021-2022,Race and Ethnicity,Hispanic,3.1 (1.9 - 5.0),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2021-2022,Race and Ethnicity,Other NH,1.6 (0.8 - 3.2),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2021-2022,Race and Ethnicity,White NH,3.4 (2.5 - 4.7),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2021-2022,Sex,Female,2.0 (1.5 - 2.8),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2021-2022,Sex,Male,4.8 (3.7 - 6.3),Data Source: National Survey on Drug Use and Health
"Illicit drug use other than cannabis in the past month, among persons aged 12 years or older",2021-2022,Total,New York State,3.4 (2.8 - 4.1),Data Source: National Survey on Drug Use and Health
"Methamphetamine use in the past year, among persons aged 12 years or older",2015-2016,Total,New York State,0.2 (0.1 - 0.5),Data Source: National Survey on Drug Use and Health
"Methamphetamine use in the past year, among persons aged 12 years or older",2016-2017,Total,New York State,0.1 (0.0 - 0.2),Data Source: National Survey on Drug Use and Health
"Methamphetamine use in the past year, among persons aged 12 years or older",2017-2018,Sex,Female,0.1 (0.0 - 0.2),Data Source: National Survey on Drug Use and Health
"Methamphetamine use in the past year, among persons aged 12 years or older",2017-2018,Sex,Male,0.3 (0.1 - 0.6),Data Source: National Survey on Drug Use and Health
"Methamphetamine use in the past year, among persons aged 12 years or older",2017-2018,Total,New York State,0.2 (0.1 - 0.3),Data Source: National Survey on Drug Use and Health
"Methamphetamine use in the past year, among persons aged 12 years or older",2018-2019,Sex,Female,0.0 (0.0 - 0.1),Data Source: National Survey on Drug Use and Health
"Methamphetamine use in the past year, among persons aged 12 years or older",2018-2019,Sex,Male,0.2 (0.1 - 0.5),Data Source: National Survey on Drug Use and Health
"Methamphetamine use in the past year, among persons aged 12 years or older",2018-2019,Total,New York State,0.1 (0.1 - 0.3),Data Source: National Survey on Drug Use and Health
"Methamphetamine use in the past year, among persons aged 12 years or older",2019-2020,Sex,Female,.,Data Source: National Survey on Drug Use and Health
"Methamphetamine use in the past year, among persons aged 12 years or older",2019-2020,Sex,Male,.,Data Source: National Survey on Drug Use and Health
"Methamphetamine use in the past year, among persons aged 12 years or older",2019-2020,Total,New York State,.,Data Source: National Survey on Drug Use and Health
"Methamphetamine use in the past year, among persons aged 12 years or older",2021-2022,Sex,Female,0.1 (0.0 - 0.4),Data Source: National Survey on Drug Use and Health
"Methamphetamine use in the past year, among persons aged 12 years or older",2021-2022,Sex,Male,0.6 (0.2 - 1.4),Data Source: National Survey on Drug Use and Health
"Methamphetamine use in the past year, among persons aged 12 years or older",2021-2022,Total,New York State,0.3 (0.1 - 0.7),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2015-2016,Age Group,12-17 years,3.9 (2.9 - 5.3),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2015-2016,Age Group,18-25 years,14.9 (12.8 - 17.4),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2015-2016,Age Group,26-34 years,12.9 (10.7 - 15.5),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2015-2016,Age Group,35+ years,4.7 (3.8 - 5.8),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Black NH,7.0 (5.1 - 9.4),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Hispanic,9.6 (7.7 - 11.8),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Other NH,4.6 (3.1 - 6.9),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2015-2016,Race and Ethnicity,White NH,7.0 (5.9 - 8.4),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2015-2016,Sex,Female,4.7 (3.9 - 5.7),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2015-2016,Sex,Male,10.0 (8.8 - 11.3),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2015-2016,Total,New York State,7.2 (6.4 - 8.1),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2016-2017,Age Group,12-17 years,3.6 (2.6 - 4.9),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2016-2017,Age Group,18-25 years,14.2 (11.9 - 16.8),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2016-2017,Age Group,26-34 years,11.5 (9.2 - 14.3),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2016-2017,Age Group,35+ years,5.3 (4.4 - 6.4),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Black NH,7.5 (5.3 - 10.7),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Hispanic,7.5 (5.7 - 9.7),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Other NH,3.7 (2.4 - 5.6),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2016-2017,Race and Ethnicity,White NH,7.7 (6.6 - 9.1),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2016-2017,Sex,Female,4.9 (4.2 - 5.6),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2016-2017,Sex,Male,9.8 (8.5 - 11.3),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2016-2017,Total,New York State,7.2 (6.5 - 8.1),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2017-2018,Age Group,12-17 years,3.0 (2.2 - 4.2),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2017-2018,Age Group,18-25 years,13.6 (11.7 - 15.8),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2017-2018,Age Group,26-34 years,10.2 (7.8 - 13.2),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2017-2018,Age Group,35+ years,4.9 (3.8 - 6.2),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Black NH,6.5 (4.4 - 9.4),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Hispanic,6.6 (4.8 - 8.9),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Other NH,3.7 (2.4 - 5.6),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2017-2018,Race and Ethnicity,White NH,7.3 (6.2 - 8.5),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2017-2018,Sex,Female,4.8 (4.0 - 5.8),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2017-2018,Sex,Male,8.7 (7.3 - 10.3),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2017-2018,Total,New York State,6.7 (5.8 - 7.6),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2018-2019,Age Group,12-17 years,3.8 (2.9 - 5.1),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2018-2019,Age Group,18-25 years,13.7 (11.9 - 15.7),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2018-2019,Age Group,26-34 years,12.2 (9.6 - 15.4),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2018-2019,Age Group,35+ years,3.9 (3.0 - 5.0),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Black NH,6.5 (4.8 - 8.7),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Hispanic,6.7 (5.0 - 9.0),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Other NH,5.3 (3.7 - 7.5),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2018-2019,Race and Ethnicity,White NH,6.4 (5.4 - 7.7),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2018-2019,Sex,Female,4.6 (3.8 - 5.4),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2018-2019,Sex,Male,8.3 (7.1 - 9.8),Data Source: National Survey on Drug Use and Health
"Needing illicit drug or alcohol treatment in the past year, but not receiving illicit drug or alcohol treatment at a specialty facility, among persons aged 12 years or older",2018-2019,Total,New York State,6.4 (5.6 - 7.3),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2015-2016,Age Group,12-17 years,2.5 (1.8 - 3.6),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2015-2016,Age Group,18-25 years,7.3 (5.9 - 9.0),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2015-2016,Age Group,26-34 years,3.7 (2.5 - 5.4),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2015-2016,Age Group,35+ years,0.9 (0.6 - 1.4),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Black NH,2.9 (2.0 - 4.3),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Hispanic,3.1 (2.2 - 4.4),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Other NH,1.2 (0.6 - 2.3),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2015-2016,Race and Ethnicity,White NH,2.1 (1.7 - 2.7),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2015-2016,Sex,Female,1.3 (0.9 - 1.8),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2015-2016,Sex,Male,3.4 (2.8 - 4.2),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2015-2016,Total,New York State,2.3 (2.0 - 2.7),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2016-2017,Age Group,12-17 years,2.7 (1.9 - 3.8),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2016-2017,Age Group,18-25 years,7.4 (5.7 - 9.7),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2016-2017,Age Group,26-34 years,3.6 (2.5 - 5.2),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2016-2017,Age Group,35+ years,1.0 (0.7 - 1.6),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Black NH,3.6 (2.3 - 5.8),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Hispanic,2.8 (1.9 - 4.0),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Other NH,1.2 (0.6 - 2.3),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2016-2017,Race and Ethnicity,White NH,2.2 (1.7 - 2.7),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2016-2017,Sex,Female,1.4 (1.0 - 1.8),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2016-2017,Sex,Male,3.5 (2.8 - 4.3),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2016-2017,Total,New York State,2.4 (2.0 - 2.8),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2017-2018,Age Group,12-17 years,2.1 (1.4 - 3.1),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2017-2018,Age Group,18-25 years,7.6 (6.2 - 9.4),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2017-2018,Age Group,26-34 years,4.3 (2.8 - 6.5),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2017-2018,Age Group,35+ years,1.0 (0.6 - 1.7),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Black NH,2.8 (1.6 - 4.8),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Hispanic,2.6 (1.7 - 4.0),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Other NH,1.6 (1.0 - 2.7),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2017-2018,Race and Ethnicity,White NH,2.4 (1.9 - 3.1),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2017-2018,Sex,Female,1.5 (1.1 - 2.0),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2017-2018,Sex,Male,3.5 (2.6 - 4.5),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2017-2018,Total,New York State,2.4 (2.0 - 3.0),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2018-2019,Age Group,12-17 years,2.8 (2.0 - 4.1),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2018-2019,Age Group,18-25 years,7.4 (6.0 - 9.2),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2018-2019,Age Group,26-34 years,5.2 (3.5 - 7.5),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2018-2019,Age Group,35+ years,1.2 (0.7 - 1.8),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Black NH,3.0 (2.0 - 4.4),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Hispanic,2.4 (1.5 - 3.9),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Other NH,2.7 (1.6 - 4.3),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2018-2019,Race and Ethnicity,White NH,2.7 (2.0 - 3.6),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2018-2019,Sex,Female,1.9 (1.4 - 2.5),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2018-2019,Sex,Male,3.5 (2.7 - 4.7),Data Source: National Survey on Drug Use and Health
"Needing illicit drug treatment in the past year, but not receiving illicit drug treatment at a specialty facility, among persons aged 12 years or older",2018-2019,Total,New York State,2.7 (2.2 - 3.3),Data Source: National Survey on Drug Use and Health
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group,18 - 24 years,197,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group,18 - 24 years,197,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group,25 - 34 years,390.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group,25 - 34 years,390.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group,35 - 44 years,552,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group,35 - 44 years,552,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group,45 - 54 years,791.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group,45 - 54 years,791.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group,55 - 64 years,827.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group,55 - 64 years,827.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group,65+ years,753.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group,65+ years,753.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group by Sex,Female & 18 - 24 years,228.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group by Sex,Female & 18 - 24 years,228.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group by Sex,Female & 25 - 34 years,440.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group by Sex,Female & 25 - 34 years,440.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group by Sex,Female & 35 - 44 years,591.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group by Sex,Female & 35 - 44 years,591.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group by Sex,Female & 45 - 54 years,813.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group by Sex,Female & 45 - 54 years,813.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group by Sex,Female & 55 - 64 years,823.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group by Sex,Female & 55 - 64 years,823.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group by Sex,Female & 65+ years,819.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group by Sex,Female & 65+ years,819.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group by Sex,Male & 18 - 24 years,166.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group by Sex,Male & 18 - 24 years,166.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group by Sex,Male & 25 - 34 years,339.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group by Sex,Male & 25 - 34 years,339.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group by Sex,Male & 35 - 44 years,510.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group by Sex,Male & 35 - 44 years,510.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group by Sex,Male & 45 - 54 years,769.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group by Sex,Male & 45 - 54 years,769.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group by Sex,Male & 55 - 64 years,831.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group by Sex,Male & 55 - 64 years,831.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group by Sex,Male & 65+ years,661.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Age Group by Sex,Male & 65+ years,661.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Region,NYS Excl NYC,591,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Region,NYS Excl NYC,591,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Region,New York City,316.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Region,New York City,316.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Sex,Female,514.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Sex,Female,514.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Sex,Male,431.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Sex,Male,431.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Total,New York State,474.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2012,Total,New York State,474.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group,18 - 24 years,184.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group,18 - 24 years,184.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group,25 - 34 years,371.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group,25 - 34 years,371.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group,35 - 44 years,555.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group,35 - 44 years,555.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group,45 - 54 years,812.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group,45 - 54 years,812.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group,55 - 64 years,900.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group,55 - 64 years,900.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group,65+ years,861.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group,65+ years,861.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group by Sex,Female & 18 - 24 years,217.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group by Sex,Female & 18 - 24 years,217.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group by Sex,Female & 25 - 34 years,427.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group by Sex,Female & 25 - 34 years,427.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group by Sex,Female & 35 - 44 years,604.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group by Sex,Female & 35 - 44 years,604.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group by Sex,Female & 45 - 54 years,850,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group by Sex,Female & 45 - 54 years,850,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group by Sex,Female & 55 - 64 years,909.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group by Sex,Female & 55 - 64 years,909.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group by Sex,Female & 65+ years,952.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group by Sex,Female & 65+ years,952.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group by Sex,Male & 18 - 24 years,152.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group by Sex,Male & 18 - 24 years,152.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group by Sex,Male & 25 - 34 years,314.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group by Sex,Male & 25 - 34 years,314.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group by Sex,Male & 35 - 44 years,503.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group by Sex,Male & 35 - 44 years,503.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group by Sex,Male & 45 - 54 years,772.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group by Sex,Male & 45 - 54 years,772.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group by Sex,Male & 55 - 64 years,889.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group by Sex,Male & 55 - 64 years,889.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group by Sex,Male & 65+ years,736.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Age Group by Sex,Male & 65+ years,736.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Region,NYS Excl NYC,621.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Region,NYS Excl NYC,621.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Region,New York City,337,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Region,New York City,337,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Sex,Female,553.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Sex,Female,553.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Sex,Male,444.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Sex,Male,444.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Total,New York State,500.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2013,Total,New York State,500.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group,18 - 24 years,165.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group,18 - 24 years,165.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group,25 - 34 years,331.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group,25 - 34 years,331.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group,35 - 44 years,517.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group,35 - 44 years,517.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group,45 - 54 years,772.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group,45 - 54 years,772.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group,55 - 64 years,893.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group,55 - 64 years,893.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group,65+ years,857.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group,65+ years,857.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group by Sex,Female & 18 - 24 years,194.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group by Sex,Female & 18 - 24 years,194.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group by Sex,Female & 25 - 34 years,385,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group by Sex,Female & 25 - 34 years,385,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group by Sex,Female & 35 - 44 years,565.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group by Sex,Female & 35 - 44 years,565.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group by Sex,Female & 45 - 54 years,813.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group by Sex,Female & 45 - 54 years,813.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group by Sex,Female & 55 - 64 years,903.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group by Sex,Female & 55 - 64 years,903.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group by Sex,Female & 65+ years,947.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group by Sex,Female & 65+ years,947.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group by Sex,Male & 18 - 24 years,137.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group by Sex,Male & 18 - 24 years,137.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group by Sex,Male & 25 - 34 years,276.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group by Sex,Male & 25 - 34 years,276.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group by Sex,Male & 35 - 44 years,467.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group by Sex,Male & 35 - 44 years,467.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group by Sex,Male & 45 - 54 years,730,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group by Sex,Male & 45 - 54 years,730,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group by Sex,Male & 55 - 64 years,883.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group by Sex,Male & 55 - 64 years,883.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group by Sex,Male & 65+ years,734.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Age Group by Sex,Male & 65+ years,734.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Region,NYS Excl NYC,604.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Region,NYS Excl NYC,604.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Region,New York City,322.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Region,New York City,322.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Sex,Female,535.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Sex,Female,535.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Sex,Male,427.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Sex,Male,427.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Total,New York State,483.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2014,Total,New York State,483.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group,18 - 24 years,156.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group,18 - 24 years,156.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group,25 - 34 years,313.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group,25 - 34 years,313.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group,35 - 44 years,508.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group,35 - 44 years,508.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group,45 - 54 years,765,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group,45 - 54 years,765,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group,55 - 64 years,907,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group,55 - 64 years,907,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group,65+ years,853,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group,65+ years,853,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group by Sex,Female & 18 - 24 years,183.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group by Sex,Female & 18 - 24 years,183.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group by Sex,Female & 25 - 34 years,366.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group by Sex,Female & 25 - 34 years,366.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group by Sex,Female & 35 - 44 years,557.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group by Sex,Female & 35 - 44 years,557.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group by Sex,Female & 45 - 54 years,808.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group by Sex,Female & 45 - 54 years,808.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group by Sex,Female & 55 - 64 years,916.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group by Sex,Female & 55 - 64 years,916.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group by Sex,Female & 65+ years,937,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group by Sex,Female & 65+ years,937,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group by Sex,Male & 18 - 24 years,129.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group by Sex,Male & 18 - 24 years,129.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group by Sex,Male & 25 - 34 years,259.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group by Sex,Male & 25 - 34 years,259.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group by Sex,Male & 35 - 44 years,456.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group by Sex,Male & 35 - 44 years,456.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group by Sex,Male & 45 - 54 years,718.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group by Sex,Male & 45 - 54 years,718.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group by Sex,Male & 55 - 64 years,896.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group by Sex,Male & 55 - 64 years,896.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group by Sex,Male & 65+ years,739.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Age Group by Sex,Male & 65+ years,739.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Region,NYS Excl NYC,606.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Region,NYS Excl NYC,606.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Region,New York City,319.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Region,New York City,319.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Sex,Female,534.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Sex,Female,534.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Sex,Male,428.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Sex,Male,428.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Total,New York State,482.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2015,Total,New York State,482.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group,18 - 24 years,132.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group,18 - 24 years,132.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group,25 - 34 years,266.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group,25 - 34 years,266.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group,35 - 44 years,465.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group,35 - 44 years,465.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group,45 - 54 years,708.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group,45 - 54 years,708.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group,55 - 64 years,888.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group,55 - 64 years,888.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group,65+ years,837.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group,65+ years,837.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group by Sex,Female & 18 - 24 years,155.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group by Sex,Female & 18 - 24 years,155.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group by Sex,Female & 25 - 34 years,313.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group by Sex,Female & 25 - 34 years,313.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group by Sex,Female & 35 - 44 years,514.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group by Sex,Female & 35 - 44 years,514.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group by Sex,Female & 45 - 54 years,751.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group by Sex,Female & 45 - 54 years,751.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group by Sex,Female & 55 - 64 years,890,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group by Sex,Female & 55 - 64 years,890,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group by Sex,Female & 65+ years,889.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group by Sex,Female & 65+ years,889.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group by Sex,Male & 18 - 24 years,109.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group by Sex,Male & 18 - 24 years,109.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group by Sex,Male & 25 - 34 years,218.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group by Sex,Male & 25 - 34 years,218.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group by Sex,Male & 35 - 44 years,414.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group by Sex,Male & 35 - 44 years,414.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group by Sex,Male & 45 - 54 years,663.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group by Sex,Male & 45 - 54 years,663.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group by Sex,Male & 55 - 64 years,887.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group by Sex,Male & 55 - 64 years,887.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group by Sex,Male & 65+ years,766.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Age Group by Sex,Male & 65+ years,766.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Region,NYS Excl NYC,580.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Region,NYS Excl NYC,580.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Region,New York City,295.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Region,New York City,295.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Sex,Female,501.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Sex,Female,501.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Sex,Male,411.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Sex,Male,411.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Total,New York State,457.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2016,Total,New York State,457.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group,18 - 24 years,110.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group,18 - 24 years,110.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group,25 - 34 years,217.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group,25 - 34 years,217.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group,35 - 44 years,411.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group,35 - 44 years,411.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group,45 - 54 years,636,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group,45 - 54 years,636,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group,55 - 64 years,840.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group,55 - 64 years,840.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group,65+ years,805.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group,65+ years,805.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group by Sex,Female & 18 - 24 years,130.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group by Sex,Female & 18 - 24 years,130.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group by Sex,Female & 25 - 34 years,260.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group by Sex,Female & 25 - 34 years,260.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group by Sex,Female & 35 - 44 years,460.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group by Sex,Female & 35 - 44 years,460.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group by Sex,Female & 45 - 54 years,680.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group by Sex,Female & 45 - 54 years,680.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group by Sex,Female & 55 - 64 years,847.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group by Sex,Female & 55 - 64 years,847.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group by Sex,Female & 65+ years,851.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group by Sex,Female & 65+ years,851.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group by Sex,Male & 18 - 24 years,91.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group by Sex,Male & 18 - 24 years,91.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group by Sex,Male & 25 - 34 years,174.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group by Sex,Male & 25 - 34 years,174.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group by Sex,Male & 35 - 44 years,361.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group by Sex,Male & 35 - 44 years,361.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group by Sex,Male & 45 - 54 years,588.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group by Sex,Male & 45 - 54 years,588.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group by Sex,Male & 55 - 64 years,832.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group by Sex,Male & 55 - 64 years,832.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group by Sex,Male & 65+ years,743.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Age Group by Sex,Male & 65+ years,743.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Region,NYS Excl NYC,538.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Region,NYS Excl NYC,538.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Region,New York City,269.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Region,New York City,269.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Sex,Female,465.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Sex,Female,465.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Sex,Male,377.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Sex,Male,377.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Total,New York State,422.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2017,Total,New York State,422.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group,18 - 24 years,93.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group,18 - 24 years,93.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group,25 - 34 years,175.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group,25 - 34 years,175.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group,35 - 44 years,353.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group,35 - 44 years,353.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group,45 - 54 years,552,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group,45 - 54 years,552,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group,55 - 64 years,767.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group,55 - 64 years,767.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group,65+ years,754.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group,65+ years,754.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group by Sex,Female & 18 - 24 years,111,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group by Sex,Female & 18 - 24 years,111,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group by Sex,Female & 25 - 34 years,212.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group by Sex,Female & 25 - 34 years,212.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group by Sex,Female & 35 - 44 years,400.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group by Sex,Female & 35 - 44 years,400.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group by Sex,Female & 45 - 54 years,596,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group by Sex,Female & 45 - 54 years,596,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group by Sex,Female & 55 - 64 years,778.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group by Sex,Female & 55 - 64 years,778.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group by Sex,Female & 65+ years,792.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group by Sex,Female & 65+ years,792.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group by Sex,Male & 18 - 24 years,75.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group by Sex,Male & 18 - 24 years,75.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group by Sex,Male & 25 - 34 years,138.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group by Sex,Male & 25 - 34 years,138.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group by Sex,Male & 35 - 44 years,304.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group by Sex,Male & 35 - 44 years,304.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group by Sex,Male & 45 - 54 years,505.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group by Sex,Male & 45 - 54 years,505.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group by Sex,Male & 55 - 64 years,756.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group by Sex,Male & 55 - 64 years,756.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group by Sex,Male & 65+ years,702.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Age Group by Sex,Male & 65+ years,702.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Region,NYS Excl NYC,484.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Region,NYS Excl NYC,484.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Region,New York City,240.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Region,New York City,240.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Sex,Female,419.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Sex,Female,419.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Sex,Male,337.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Sex,Male,337.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Total,New York State,380.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2018,Total,New York State,380.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group,18 - 24 years,80.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group,18 - 24 years,80.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group,25 - 34 years,147.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group,25 - 34 years,147.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group,35 - 44 years,311.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group,35 - 44 years,311.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group,45 - 54 years,479.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group,45 - 54 years,479.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group,55 - 64 years,715.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group,55 - 64 years,715.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group,65+ years,740.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group,65+ years,740.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group by Sex,Female & 18 - 24 years,93.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group by Sex,Female & 18 - 24 years,93.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group by Sex,Female & 25 - 34 years,177.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group by Sex,Female & 25 - 34 years,177.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group by Sex,Female & 35 - 44 years,356.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group by Sex,Female & 35 - 44 years,356.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group by Sex,Female & 45 - 54 years,521.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group by Sex,Female & 45 - 54 years,521.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group by Sex,Female & 55 - 64 years,728.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group by Sex,Female & 55 - 64 years,728.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group by Sex,Female & 65+ years,772.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group by Sex,Female & 65+ years,772.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group by Sex,Male & 18 - 24 years,67,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group by Sex,Male & 18 - 24 years,67,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group by Sex,Male & 25 - 34 years,116.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group by Sex,Male & 25 - 34 years,116.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group by Sex,Male & 35 - 44 years,264.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group by Sex,Male & 35 - 44 years,264.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group by Sex,Male & 45 - 54 years,433.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group by Sex,Male & 45 - 54 years,433.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group by Sex,Male & 55 - 64 years,700.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group by Sex,Male & 55 - 64 years,700.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group by Sex,Male & 65+ years,698.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Age Group by Sex,Male & 65+ years,698.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Region,NYS Excl NYC,448.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Region,NYS Excl NYC,448.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Region,New York City,218.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Region,New York City,218.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Sex,Female,387,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Sex,Female,387,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Sex,Male,310.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Sex,Male,310.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Total,New York State,349.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2019,Total,New York State,349.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group,18 - 24 years,66.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group,18 - 24 years,66.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group,25 - 34 years,123.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group,25 - 34 years,123.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group,35 - 44 years,273,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group,35 - 44 years,273,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group,45 - 54 years,414.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group,45 - 54 years,414.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group,55 - 64 years,656.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group,55 - 64 years,656.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group,65+ years,694.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group,65+ years,694.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group by Sex,Female & 18 - 24 years,78.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group by Sex,Female & 18 - 24 years,78.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group by Sex,Female & 25 - 34 years,149.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group by Sex,Female & 25 - 34 years,149.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group by Sex,Female & 35 - 44 years,314.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group by Sex,Female & 35 - 44 years,314.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group by Sex,Female & 45 - 54 years,453.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group by Sex,Female & 45 - 54 years,453.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group by Sex,Female & 55 - 64 years,671.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group by Sex,Female & 55 - 64 years,671.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group by Sex,Female & 65+ years,717.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group by Sex,Female & 65+ years,717.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group by Sex,Male & 18 - 24 years,54.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group by Sex,Male & 18 - 24 years,54.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group by Sex,Male & 25 - 34 years,97.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group by Sex,Male & 25 - 34 years,97.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group by Sex,Male & 35 - 44 years,229.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group by Sex,Male & 35 - 44 years,229.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group by Sex,Male & 45 - 54 years,373.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group by Sex,Male & 45 - 54 years,373.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group by Sex,Male & 55 - 64 years,639.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group by Sex,Male & 55 - 64 years,639.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group by Sex,Male & 65+ years,663.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Age Group by Sex,Male & 65+ years,663.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Region,NYS Excl NYC,410.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Region,NYS Excl NYC,410.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Region,New York City,189.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Region,New York City,189.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Sex,Female,349.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Sex,Female,349.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Sex,Male,280.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Sex,Male,280.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Total,New York State,315.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2020,Total,New York State,315.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group,18 - 24 years,69,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group,18 - 24 years,69,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group,25 - 34 years,120.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group,25 - 34 years,120.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group,35 - 44 years,248.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group,35 - 44 years,248.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group,45 - 54 years,398.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group,45 - 54 years,398.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group,55 - 64 years,605.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group,55 - 64 years,605.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group,65+ years,646,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group,65+ years,646,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group by Sex,Female & 18 - 24 years,79.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group by Sex,Female & 18 - 24 years,79.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group by Sex,Female & 25 - 34 years,146.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group by Sex,Female & 25 - 34 years,146.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group by Sex,Female & 35 - 44 years,292,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group by Sex,Female & 35 - 44 years,292,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group by Sex,Female & 45 - 54 years,444.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group by Sex,Female & 45 - 54 years,444.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group by Sex,Female & 55 - 64 years,632.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group by Sex,Female & 55 - 64 years,632.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group by Sex,Female & 65+ years,673.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group by Sex,Female & 65+ years,673.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group by Sex,Male & 18 - 24 years,58.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group by Sex,Male & 18 - 24 years,58.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group by Sex,Male & 25 - 34 years,95.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group by Sex,Male & 25 - 34 years,95.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group by Sex,Male & 35 - 44 years,203.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group by Sex,Male & 35 - 44 years,203.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group by Sex,Male & 45 - 54 years,350.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group by Sex,Male & 45 - 54 years,350.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group by Sex,Male & 55 - 64 years,576.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group by Sex,Male & 55 - 64 years,576.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group by Sex,Male & 65+ years,610.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Age Group by Sex,Male & 65+ years,610.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Region,NYS Excl NYC,388.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Region,NYS Excl NYC,388.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Region,New York City,183.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Region,New York City,183.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Sex,Female,335.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Sex,Female,335.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Sex,Male,264.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Sex,Male,264.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Total,New York State,301.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2021,Total,New York State,301.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group,18 - 24 years,63,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group,18 - 24 years,63,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group,25 - 34 years,107,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group,25 - 34 years,107,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group,35 - 44 years,225.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group,35 - 44 years,225.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group,45 - 54 years,365.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group,45 - 54 years,365.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group,55 - 64 years,569.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group,55 - 64 years,569.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group,65+ years,628.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group,65+ years,628.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group by Sex,Female & 18 - 24 years,71.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group by Sex,Female & 18 - 24 years,71.4,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group by Sex,Female & 25 - 34 years,128.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group by Sex,Female & 25 - 34 years,128.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group by Sex,Female & 35 - 44 years,267.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group by Sex,Female & 35 - 44 years,267.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group by Sex,Female & 45 - 54 years,410.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group by Sex,Female & 45 - 54 years,410.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group by Sex,Female & 55 - 64 years,598,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group by Sex,Female & 55 - 64 years,598,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group by Sex,Female & 65+ years,655.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group by Sex,Female & 65+ years,655.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group by Sex,Male & 18 - 24 years,54.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group by Sex,Male & 18 - 24 years,54.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group by Sex,Male & 25 - 34 years,85,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group by Sex,Male & 25 - 34 years,85,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group by Sex,Male & 35 - 44 years,182.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group by Sex,Male & 35 - 44 years,182.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group by Sex,Male & 45 - 54 years,318.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group by Sex,Male & 45 - 54 years,318.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group by Sex,Male & 55 - 64 years,539.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group by Sex,Male & 55 - 64 years,539.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group by Sex,Male & 65+ years,595.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Age Group by Sex,Male & 65+ years,595.3,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Region,NYS Excl NYC,368.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Region,NYS Excl NYC,368.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Region,New York City,173.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Region,New York City,173.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Sex,Female,319.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Sex,Female,319.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Sex,Male,251.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Sex,Male,251.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Total,New York State,286,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2022,Total,New York State,286,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group,18 - 24 years,59.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group,18 - 24 years,59.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group,25 - 34 years,98.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group,25 - 34 years,98.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group,35 - 44 years,205.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group,35 - 44 years,205.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group,45 - 54 years,339.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group,45 - 54 years,339.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group,55 - 64 years,538,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group,55 - 64 years,538,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group,65+ years,616.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group,65+ years,616.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group by Sex,Female & 18 - 24 years,67.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group by Sex,Female & 18 - 24 years,67.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group by Sex,Female & 25 - 34 years,118.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group by Sex,Female & 25 - 34 years,118.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group by Sex,Female & 35 - 44 years,244.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group by Sex,Female & 35 - 44 years,244.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group by Sex,Female & 45 - 54 years,385.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group by Sex,Female & 45 - 54 years,385.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group by Sex,Female & 55 - 64 years,568.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group by Sex,Female & 55 - 64 years,568.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group by Sex,Female & 65+ years,642.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group by Sex,Female & 65+ years,642.6,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group by Sex,Male & 18 - 24 years,51.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group by Sex,Male & 18 - 24 years,51.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group by Sex,Male & 25 - 34 years,78.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group by Sex,Male & 25 - 34 years,78.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group by Sex,Male & 35 - 44 years,165.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group by Sex,Male & 35 - 44 years,165.9,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group by Sex,Male & 45 - 54 years,291.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group by Sex,Male & 45 - 54 years,291.1,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group by Sex,Male & 55 - 64 years,505.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group by Sex,Male & 55 - 64 years,505.8,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group by Sex,Male & 65+ years,583.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Age Group by Sex,Male & 65+ years,583.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Region,NYS Excl NYC,352.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Region,NYS Excl NYC,352.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Region,New York City,166.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Region,New York City,166.7,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Sex,Female,307.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Sex,Female,307.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Sex,Male,240.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Sex,Male,240.2,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Total,New York State,274.5,Data Source: NYS PMP Data as of April 2024
"Opioid analgesics prescription, crude rate per 1,000 population",2023,Total,New York State,274.5,Data Source: NYS PMP Data as of April 2024
"Opioid use disorder in the past year, among persons aged 12 years or older",2021-2022,Age Group,12-17 years,0.8 (0.4 - 1.6),Data Source: National Survey on Drug Use and Health
"Opioid use disorder in the past year, among persons aged 12 years or older",2021-2022,Age Group,18-25 years,0.7 (0.3 - 1.8),Data Source: National Survey on Drug Use and Health
"Opioid use disorder in the past year, among persons aged 12 years or older",2021-2022,Age Group,26-34 years,1.1 (0.4 - 2.6),Data Source: National Survey on Drug Use and Health
"Opioid use disorder in the past year, among persons aged 12 years or older",2021-2022,Age Group,35+ years,1.6 (1.0 - 2.4),Data Source: National Survey on Drug Use and Health
"Opioid use disorder in the past year, among persons aged 12 years or older",2021-2022,Race and Ethnicity,Black NH,2.5 (1.2 - 4.9),Data Source: National Survey on Drug Use and Health
"Opioid use disorder in the past year, among persons aged 12 years or older",2021-2022,Race and Ethnicity,Hispanic,1.2 (0.5 - 2.5),Data Source: National Survey on Drug Use and Health
"Opioid use disorder in the past year, among persons aged 12 years or older",2021-2022,Race and Ethnicity,Other NH,2.2 (0.9 - 5.6),Data Source: National Survey on Drug Use and Health
"Opioid use disorder in the past year, among persons aged 12 years or older",2021-2022,Race and Ethnicity,White NH,0.9 (0.5 - 1.7),Data Source: National Survey on Drug Use and Health
"Opioid use disorder in the past year, among persons aged 12 years or older",2021-2022,Sex,Female,1.5 (0.9 - 2.5),Data Source: National Survey on Drug Use and Health
"Opioid use disorder in the past year, among persons aged 12 years or older",2021-2022,Sex,Male,1.1 (0.6 - 1.9),Data Source: National Survey on Drug Use and Health
"Opioid use disorder in the past year, among persons aged 12 years or older",2021-2022,Total,New York State,1.3 (0.9 - 1.9),Data Source: National Survey on Drug Use and Health
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2010,Race and Ethnicity,Asian/PI NH,1.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2010,Race and Ethnicity,Black NH,6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2010,Race and Ethnicity,Hispanic,5.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2010,Race and Ethnicity,White NH,8.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2010,Region,NYS Excl NYC,7.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2010,Region,New York City,6.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2010,Sex,Female,4.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2010,Sex,Male,9.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2010,Total,New York State,7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2011,Race and Ethnicity,Asian/PI NH,1.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2011,Race and Ethnicity,Black NH,6.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2011,Race and Ethnicity,Hispanic,6.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2011,Race and Ethnicity,White NH,11.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2011,Region,NYS Excl NYC,10.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2011,Region,New York City,7.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2011,Sex,Female,5.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2011,Sex,Male,12.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2011,Total,New York State,9.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2012,Race and Ethnicity,Asian/PI NH,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2012,Race and Ethnicity,Black NH,7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2012,Race and Ethnicity,Hispanic,7.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2012,Race and Ethnicity,White NH,11.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2012,Region,NYS Excl NYC,10.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2012,Region,New York City,7.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2012,Sex,Female,5.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2012,Sex,Male,12.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2012,Total,New York State,9.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2013,Race and Ethnicity,Asian/PI NH,1.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2013,Race and Ethnicity,Black NH,7.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2013,Race and Ethnicity,Hispanic,8.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2013,Race and Ethnicity,White NH,13.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2013,Region,NYS Excl NYC,13,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2013,Region,New York City,8.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2013,Sex,Female,6.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2013,Sex,Male,14.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2013,Total,New York State,10.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2014,Race and Ethnicity,Asian/PI NH,1.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2014,Race and Ethnicity,Black NH,7.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2014,Race and Ethnicity,Hispanic,7.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2014,Race and Ethnicity,White NH,14.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2014,Region,NYS Excl NYC,13.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2014,Region,New York City,8.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2014,Sex,Female,7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2014,Sex,Male,15.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2014,Total,New York State,11.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2015,Race and Ethnicity,Asian/PI NH,2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2015,Race and Ethnicity,Black NH,8.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2015,Race and Ethnicity,Hispanic,10.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2015,Race and Ethnicity,White NH,17.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2015,Region,NYS Excl NYC,16.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2015,Region,New York City,10.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2015,Sex,Female,7.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2015,Sex,Male,19.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2015,Total,New York State,13.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,2.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Black NH,15.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Hispanic,15.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,White NH,23.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2016,Region,NYS Excl NYC,22.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2016,Region,New York City,15,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2016,Sex,Female,10.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2016,Sex,Male,27,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2016,Total,New York State,18.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,2.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Black NH,17.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Hispanic,16.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,White NH,25.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2017,Region,NYS Excl NYC,24.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2017,Region,New York City,15.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2017,Sex,Female,10.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2017,Sex,Male,29.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2017,Total,New York State,19.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,2.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Black NH,16.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Hispanic,16.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,White NH,22.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2018,Region,NYS Excl NYC,21.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2018,Region,New York City,15,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2018,Sex,Female,10.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2018,Sex,Male,26.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2018,Total,New York State,18.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,3.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Black NH,18.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Hispanic,18.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,White NH,20.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2019,Region,NYS Excl NYC,20.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2019,Region,New York City,16,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2019,Sex,Female,10.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2019,Sex,Male,26.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2019,Total,New York State,18.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Black NH,29.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Hispanic,23.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,White NH,27.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2020,Region,NYS Excl NYC,28.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2020,Region,New York City,21.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2020,Sex,Female,13.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2020,Sex,Male,36.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2020,Total,New York State,24.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,3.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Black NH,39.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Hispanic,31.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,White NH,30.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2021,Region,NYS Excl NYC,31.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2021,Region,New York City,27.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2021,Sex,Female,16.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2021,Sex,Male,41.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2021,Total,New York State,28.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,3.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Black NH,49.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Hispanic,35.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,White NH,30.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2022,Region,NYS Excl NYC,32.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2022,Region,New York City,31.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2022,Sex,Female,16.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2022,Sex,Male,47.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, age-adjusted rate per 100,000 population",2022,Total,New York State,31.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2010,Age Group,0-17 years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2010,Age Group,18-24 years,6.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2010,Age Group,25-44 years,10.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2010,Age Group,45-64 years,12.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2010,Age Group,65+ years,3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2010,Race and Ethnicity,Asian/PI NH,1.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2010,Race and Ethnicity,Black NH,6.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2010,Race and Ethnicity,Hispanic,5.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2010,Race and Ethnicity,White NH,9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2010,Region,NYS Excl NYC,7.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2010,Region,New York City,7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2010,Sex,Female,4.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2010,Sex,Male,9.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2010,Total,New York State,7.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2011,Age Group,0-17 years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2011,Age Group,18-24 years,9.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2011,Age Group,25-44 years,14.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2011,Age Group,45-64 years,15.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2011,Age Group,65+ years,2.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2011,Race and Ethnicity,Asian/PI NH,1.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2011,Race and Ethnicity,Black NH,7.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2011,Race and Ethnicity,Hispanic,6.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2011,Race and Ethnicity,White NH,12,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2011,Region,NYS Excl NYC,10.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2011,Region,New York City,8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2011,Sex,Female,6.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2011,Sex,Male,13,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2011,Total,New York State,9.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2012,Age Group,0-17 years,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2012,Age Group,18-24 years,8.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2012,Age Group,25-44 years,14.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2012,Age Group,45-64 years,15.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2012,Age Group,65+ years,3.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2012,Race and Ethnicity,Asian/PI NH,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2012,Race and Ethnicity,Black NH,7.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2012,Race and Ethnicity,Hispanic,6.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2012,Race and Ethnicity,White NH,12,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2012,Region,NYS Excl NYC,10.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2012,Region,New York City,8.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2012,Sex,Female,6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2012,Sex,Male,13.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2012,Total,New York State,9.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2013,Age Group,0-17 years,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2013,Age Group,18-24 years,10.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2013,Age Group,25-44 years,15.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2013,Age Group,45-64 years,18.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2013,Age Group,65+ years,5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2013,Race and Ethnicity,Asian/PI NH,1.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2013,Race and Ethnicity,Black NH,8.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2013,Race and Ethnicity,Hispanic,8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2013,Race and Ethnicity,White NH,14,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2013,Region,NYS Excl NYC,13,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2013,Region,New York City,8.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2013,Sex,Female,7.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2013,Sex,Male,15.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2013,Total,New York State,11.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2014,Age Group,0-17 years,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2014,Age Group,18-24 years,11,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2014,Age Group,25-44 years,17.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2014,Age Group,45-64 years,18.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2014,Age Group,65+ years,4.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2014,Race and Ethnicity,Asian/PI NH,1.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2014,Race and Ethnicity,Black NH,8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2014,Race and Ethnicity,Hispanic,7.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2014,Race and Ethnicity,White NH,14.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2014,Region,NYS Excl NYC,13.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2014,Region,New York City,9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2014,Sex,Female,7.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2014,Sex,Male,15.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2014,Total,New York State,11.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2015,Age Group,0-17 years,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2015,Age Group,18-24 years,14,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2015,Age Group,25-44 years,22.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2015,Age Group,45-64 years,21.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2015,Age Group,65+ years,4.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2015,Race and Ethnicity,Asian/PI NH,2.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2015,Race and Ethnicity,Black NH,9.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2015,Race and Ethnicity,Hispanic,10.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2015,Race and Ethnicity,White NH,17.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2015,Region,NYS Excl NYC,16.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2015,Region,New York City,10.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2015,Sex,Female,8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2015,Sex,Male,20.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2015,Total,New York State,13.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2016,Age Group,0-17 years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2016,Age Group,18-24 years,19.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2016,Age Group,25-44 years,32.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2016,Age Group,45-64 years,27.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2016,Age Group,65+ years,6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,2.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2016,Race and Ethnicity,Black NH,16.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2016,Race and Ethnicity,Hispanic,15.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2016,Race and Ethnicity,White NH,22.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2016,Region,NYS Excl NYC,21.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2016,Region,New York City,15.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2016,Sex,Female,10.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2016,Sex,Male,27.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2016,Total,New York State,19,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2017,Age Group,0-17 years,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2017,Age Group,18-24 years,16,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2017,Age Group,25-44 years,35.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2017,Age Group,45-64 years,30.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2017,Age Group,65+ years,6.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,2.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2017,Race and Ethnicity,Black NH,19.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2017,Race and Ethnicity,Hispanic,16.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2017,Race and Ethnicity,White NH,24.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2017,Region,NYS Excl NYC,23.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2017,Region,New York City,16.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2017,Sex,Female,10.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2017,Sex,Male,30.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2017,Total,New York State,20.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2018,Age Group,0-17 years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2018,Age Group,18-24 years,13.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2018,Age Group,25-44 years,31.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2018,Age Group,45-64 years,29.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2018,Age Group,65+ years,7.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,2.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2018,Race and Ethnicity,Black NH,18.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2018,Race and Ethnicity,Hispanic,16.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2018,Race and Ethnicity,White NH,21.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2018,Region,NYS Excl NYC,20.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2018,Region,New York City,16.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2018,Sex,Female,10.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2018,Sex,Male,27.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2018,Total,New York State,18.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2019,Age Group,0-17 years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2019,Age Group,18-24 years,11.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2019,Age Group,25-44 years,31.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2019,Age Group,45-64 years,29.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2019,Age Group,65+ years,7.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,3.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2019,Race and Ethnicity,Black NH,19.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2019,Race and Ethnicity,Hispanic,18.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2019,Race and Ethnicity,White NH,20.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2019,Region,NYS Excl NYC,19.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2019,Region,New York City,17.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2019,Sex,Female,10.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2019,Sex,Male,27.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2019,Total,New York State,18.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2020,Age Group,0-17 years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2020,Age Group,18-24 years,16.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2020,Age Group,25-44 years,42.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2020,Age Group,45-64 years,39.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2020,Age Group,65+ years,9.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,3.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2020,Race and Ethnicity,Black NH,32.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2020,Race and Ethnicity,Hispanic,23.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2020,Race and Ethnicity,White NH,26.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2020,Region,NYS Excl NYC,26.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2020,Region,New York City,23.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2020,Sex,Female,13.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2020,Sex,Male,37.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2020,Total,New York State,25.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2021,Age Group,0-17 years,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2021,Age Group,18-24 years,14.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2021,Age Group,25-44 years,48.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2021,Age Group,45-64 years,50.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2021,Age Group,65+ years,11.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,3.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2021,Race and Ethnicity,Black NH,44.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2021,Race and Ethnicity,Hispanic,31.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2021,Race and Ethnicity,White NH,29.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2021,Region,NYS Excl NYC,29.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2021,Region,New York City,29.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2021,Sex,Female,16.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2021,Sex,Male,43.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2021,Total,New York State,29.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2022,Age Group,0-17 years,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2022,Age Group,18-24 years,13.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2022,Age Group,25-44 years,51.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2022,Age Group,45-64 years,56.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2022,Age Group,65+ years,15.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,3.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2022,Race and Ethnicity,Black NH,55.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2022,Race and Ethnicity,Hispanic,35.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2022,Race and Ethnicity,White NH,29.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2022,Region,NYS Excl NYC,31.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2022,Region,New York City,34,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2022,Sex,Female,16.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2022,Sex,Male,49.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any drug, crude rate per 100,000 population",2022,Total,New York State,32.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2010,Race and Ethnicity,Asian/PI NH,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2010,Race and Ethnicity,Black NH,2.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2010,Race and Ethnicity,Hispanic,3.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2010,Race and Ethnicity,White NH,6.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2010,Region,NYS Excl NYC,5.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2010,Region,New York City,4.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2010,Sex,Female,3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2010,Sex,Male,6.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2010,Total,New York State,4.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2011,Race and Ethnicity,Asian/PI NH,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2011,Race and Ethnicity,Black NH,3.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2011,Race and Ethnicity,Hispanic,4.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2011,Race and Ethnicity,White NH,8.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2011,Region,NYS Excl NYC,7.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2011,Region,New York City,5.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2011,Sex,Female,3.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2011,Sex,Male,8.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2011,Total,New York State,6.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2012,Race and Ethnicity,Asian/PI NH,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2012,Race and Ethnicity,Black NH,4.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2012,Race and Ethnicity,Hispanic,5.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2012,Race and Ethnicity,White NH,9.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2012,Region,NYS Excl NYC,7.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2012,Region,New York City,6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2012,Sex,Female,3.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2012,Sex,Male,9.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2012,Total,New York State,6.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2013,Race and Ethnicity,Asian/PI NH,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2013,Race and Ethnicity,Black NH,4.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2013,Race and Ethnicity,Hispanic,6.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2013,Race and Ethnicity,White NH,10.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2013,Region,NYS Excl NYC,10,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2013,Region,New York City,5.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2013,Sex,Female,4.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2013,Sex,Male,11.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2013,Total,New York State,7.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2014,Race and Ethnicity,Asian/PI NH,0.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2014,Race and Ethnicity,Black NH,4.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2014,Race and Ethnicity,Hispanic,5.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2014,Race and Ethnicity,White NH,11.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2014,Region,NYS Excl NYC,10.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2014,Region,New York City,6.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2014,Sex,Female,5.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2014,Sex,Male,11.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2014,Total,New York State,8.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2015,Race and Ethnicity,Asian/PI NH,1.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2015,Race and Ethnicity,Black NH,5.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2015,Race and Ethnicity,Hispanic,8.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2015,Race and Ethnicity,White NH,14.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2015,Region,NYS Excl NYC,13.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2015,Region,New York City,7.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2015,Sex,Female,5.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2015,Sex,Male,16.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2015,Total,New York State,10.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,1.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Black NH,10.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Hispanic,12.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,White NH,20.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2016,Region,NYS Excl NYC,19.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2016,Region,New York City,11.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2016,Sex,Female,8.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2016,Sex,Male,22.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2016,Total,New York State,15.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,1.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Black NH,12.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Hispanic,14,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,White NH,21.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2017,Region,NYS Excl NYC,20.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2017,Region,New York City,12.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2017,Sex,Female,8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2017,Sex,Male,25.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2017,Total,New York State,16.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Black NH,10.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Hispanic,14.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,White NH,18.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2018,Region,NYS Excl NYC,18.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2018,Region,New York City,11.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2018,Sex,Female,8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2018,Sex,Male,22.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2018,Total,New York State,15,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,1.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Black NH,13.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Hispanic,16.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,White NH,17.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2019,Region,NYS Excl NYC,17.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2019,Region,New York City,12.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2019,Sex,Female,8.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2019,Sex,Male,21.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2019,Total,New York State,14.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,2.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Black NH,24.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Hispanic,21.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,White NH,24,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2020,Region,NYS Excl NYC,24.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2020,Region,New York City,18.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2020,Sex,Female,10.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2020,Sex,Male,31.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2020,Total,New York State,21.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Black NH,32.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Hispanic,27.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,White NH,26,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2021,Region,NYS Excl NYC,26.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2021,Region,New York City,22.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2021,Sex,Female,13.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2021,Sex,Male,36.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2021,Total,New York State,24.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,2.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Black NH,41.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Hispanic,30.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,White NH,25.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2022,Region,NYS Excl NYC,27.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2022,Region,New York City,26.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2022,Sex,Female,13.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2022,Sex,Male,40.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, age-adjusted rate per 100,000 population",2022,Total,New York State,26.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Age Group,0-17 years,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Age Group,0-17 years,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Age Group,18-24 years,5.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Age Group,18-24 years,5.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Age Group,25-44 years,7.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Age Group,25-44 years,7.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Age Group,45-64 years,8.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Age Group,45-64 years,8.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Age Group,65+ years,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Age Group,65+ years,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Race and Ethnicity,Asian/PI NH,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Race and Ethnicity,Asian/PI NH,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Race and Ethnicity,Black NH,3.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Race and Ethnicity,Black NH,3.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Race and Ethnicity,Hispanic,3.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Race and Ethnicity,Hispanic,3.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Race and Ethnicity,White NH,6.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Race and Ethnicity,White NH,6.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Region,NYS Excl NYC,5.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Region,NYS Excl NYC,5.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Region,New York City,4.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Region,New York City,4.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Sex,Female,3.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Sex,Female,3.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Sex,Male,7.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Sex,Male,7.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Total,New York State,5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2010,Total,New York State,5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Age Group,0-17 years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Age Group,0-17 years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Age Group,18-24 years,7.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Age Group,18-24 years,7.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Age Group,25-44 years,10.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Age Group,25-44 years,10.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Age Group,45-64 years,10.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Age Group,45-64 years,10.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Age Group,65+ years,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Age Group,65+ years,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Race and Ethnicity,Asian/PI NH,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Race and Ethnicity,Asian/PI NH,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Race and Ethnicity,Black NH,4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Race and Ethnicity,Black NH,4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Race and Ethnicity,Hispanic,4.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Race and Ethnicity,Hispanic,4.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Race and Ethnicity,White NH,8.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Race and Ethnicity,White NH,8.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Region,NYS Excl NYC,7.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Region,NYS Excl NYC,7.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Region,New York City,5.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Region,New York City,5.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Sex,Female,4.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Sex,Female,4.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Sex,Male,9.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Sex,Male,9.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Total,New York State,6.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2011,Total,New York State,6.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Age Group,0-17 years,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Age Group,0-17 years,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Age Group,18-24 years,7.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Age Group,18-24 years,7.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Age Group,25-44 years,11.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Age Group,25-44 years,11.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Age Group,45-64 years,11,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Age Group,45-64 years,11,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Age Group,65+ years,1.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Age Group,65+ years,1.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Race and Ethnicity,Asian/PI NH,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Race and Ethnicity,Asian/PI NH,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Race and Ethnicity,Black NH,4.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Race and Ethnicity,Black NH,4.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Race and Ethnicity,Hispanic,5.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Race and Ethnicity,Hispanic,5.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Race and Ethnicity,White NH,9.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Race and Ethnicity,White NH,9.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Region,NYS Excl NYC,7.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Region,NYS Excl NYC,7.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Region,New York City,6.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Region,New York City,6.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Sex,Female,4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Sex,Female,4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Sex,Male,10.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Sex,Male,10.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Total,New York State,7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2012,Total,New York State,7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Age Group,0-17 years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Age Group,0-17 years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Age Group,18-24 years,9.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Age Group,18-24 years,9.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Age Group,25-44 years,12.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Age Group,25-44 years,12.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Age Group,45-64 years,12.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Age Group,45-64 years,12.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Age Group,65+ years,2.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Age Group,65+ years,2.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Race and Ethnicity,Asian/PI NH,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Race and Ethnicity,Asian/PI NH,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Race and Ethnicity,Black NH,4.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Race and Ethnicity,Black NH,4.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Race and Ethnicity,Hispanic,6.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Race and Ethnicity,Hispanic,6.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Race and Ethnicity,White NH,10.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Race and Ethnicity,White NH,10.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Region,NYS Excl NYC,9.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Region,NYS Excl NYC,9.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Region,New York City,6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Region,New York City,6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Sex,Female,4.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Sex,Female,4.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Sex,Male,11.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Sex,Male,11.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Total,New York State,8.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2013,Total,New York State,8.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Age Group,0-17 years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Age Group,0-17 years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Age Group,18-24 years,9.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Age Group,18-24 years,9.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Age Group,25-44 years,14.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Age Group,25-44 years,14.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Age Group,45-64 years,12.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Age Group,45-64 years,12.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Age Group,65+ years,1.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Age Group,65+ years,1.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Race and Ethnicity,Asian/PI NH,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Race and Ethnicity,Asian/PI NH,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Race and Ethnicity,Black NH,5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Race and Ethnicity,Black NH,5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Race and Ethnicity,Hispanic,5.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Race and Ethnicity,Hispanic,5.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Race and Ethnicity,White NH,11.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Race and Ethnicity,White NH,11.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Region,NYS Excl NYC,10.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Region,NYS Excl NYC,10.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Region,New York City,6.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Region,New York City,6.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Sex,Female,5.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Sex,Female,5.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Sex,Male,12.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Sex,Male,12.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Total,New York State,8.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2014,Total,New York State,8.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Age Group,0-17 years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Age Group,0-17 years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Age Group,18-24 years,12.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Age Group,18-24 years,12.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Age Group,25-44 years,19.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Age Group,25-44 years,19.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Age Group,45-64 years,15.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Age Group,45-64 years,15.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Age Group,65+ years,2.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Age Group,65+ years,2.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Race and Ethnicity,Asian/PI NH,1.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Race and Ethnicity,Asian/PI NH,1.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Race and Ethnicity,Black NH,6.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Race and Ethnicity,Black NH,6.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Race and Ethnicity,Hispanic,8.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Race and Ethnicity,Hispanic,8.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Race and Ethnicity,White NH,13.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Race and Ethnicity,White NH,13.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Region,NYS Excl NYC,13.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Region,NYS Excl NYC,13.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Region,New York City,7.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Region,New York City,7.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Sex,Female,5.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Sex,Female,5.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Sex,Male,16.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Sex,Male,16.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Total,New York State,10.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2015,Total,New York State,10.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Age Group,0-17 years,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Age Group,0-17 years,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Age Group,18-24 years,17.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Age Group,18-24 years,17.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Age Group,25-44 years,28.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Age Group,25-44 years,28.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Age Group,45-64 years,21.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Age Group,45-64 years,21.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Age Group,65+ years,3.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Age Group,65+ years,3.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,1.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,1.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Race and Ethnicity,Black NH,11.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Race and Ethnicity,Black NH,11.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Race and Ethnicity,Hispanic,13.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Race and Ethnicity,Hispanic,13.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Race and Ethnicity,White NH,19.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Race and Ethnicity,White NH,19.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Region,NYS Excl NYC,18.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Region,NYS Excl NYC,18.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Region,New York City,12.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Region,New York City,12.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Sex,Female,8.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Sex,Female,8.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Sex,Male,23.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Sex,Male,23.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Total,New York State,15.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2016,Total,New York State,15.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Age Group,0-17 years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Age Group,0-17 years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Age Group,18-24 years,14.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Age Group,18-24 years,14.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Age Group,25-44 years,30.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Age Group,25-44 years,30.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Age Group,45-64 years,23.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Age Group,45-64 years,23.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Age Group,65+ years,3.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Age Group,65+ years,3.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,2.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,2.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Race and Ethnicity,Black NH,13.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Race and Ethnicity,Black NH,13.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Race and Ethnicity,Hispanic,14,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Race and Ethnicity,Hispanic,14,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Race and Ethnicity,White NH,20.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Race and Ethnicity,White NH,20.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Region,NYS Excl NYC,19.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Region,NYS Excl NYC,19.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Region,New York City,12.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Region,New York City,12.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Sex,Female,8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Sex,Female,8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Sex,Male,25.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Sex,Male,25.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Total,New York State,16.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2017,Total,New York State,16.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Age Group,0-17 years,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Age Group,0-17 years,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Age Group,18-24 years,11.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Age Group,18-24 years,11.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Age Group,25-44 years,27.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Age Group,25-44 years,27.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Age Group,45-64 years,22.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Age Group,45-64 years,22.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Age Group,65+ years,4.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Age Group,65+ years,4.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,1.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,1.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Race and Ethnicity,Black NH,12.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Race and Ethnicity,Black NH,12.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Race and Ethnicity,Hispanic,14.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Race and Ethnicity,Hispanic,14.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Race and Ethnicity,White NH,17.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Race and Ethnicity,White NH,17.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Region,NYS Excl NYC,17.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Region,NYS Excl NYC,17.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Region,New York City,12.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Region,New York City,12.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Sex,Female,8.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Sex,Female,8.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Sex,Male,22.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Sex,Male,22.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Total,New York State,15.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2018,Total,New York State,15.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Age Group,0-17 years,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Age Group,0-17 years,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Age Group,18-24 years,9.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Age Group,18-24 years,9.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Age Group,25-44 years,27.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Age Group,25-44 years,27.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Age Group,45-64 years,22.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Age Group,45-64 years,22.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Age Group,65+ years,5.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Age Group,65+ years,5.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,1.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,1.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Race and Ethnicity,Black NH,14.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Race and Ethnicity,Black NH,14.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Race and Ethnicity,Hispanic,16.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Race and Ethnicity,Hispanic,16.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Race and Ethnicity,White NH,16.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Race and Ethnicity,White NH,16.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Region,NYS Excl NYC,16.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Region,NYS Excl NYC,16.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Region,New York City,13.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Region,New York City,13.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Sex,Female,8.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Sex,Female,8.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Sex,Male,22.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Sex,Male,22.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Total,New York State,15.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2019,Total,New York State,15.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Age Group,0-17 years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Age Group,0-17 years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Age Group,18-24 years,14.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Age Group,18-24 years,14.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Age Group,25-44 years,37.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Age Group,25-44 years,37.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Age Group,45-64 years,32.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Age Group,45-64 years,32.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Age Group,65+ years,7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Age Group,65+ years,7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,2.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,2.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Race and Ethnicity,Black NH,26.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Race and Ethnicity,Black NH,26.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Race and Ethnicity,Hispanic,21.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Race and Ethnicity,Hispanic,21.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Race and Ethnicity,White NH,22.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Race and Ethnicity,White NH,22.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Region,NYS Excl NYC,22.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Region,NYS Excl NYC,22.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Region,New York City,19.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Region,New York City,19.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Sex,Female,11,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Sex,Female,11,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Sex,Male,32.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Sex,Male,32.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Total,New York State,21.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2020,Total,New York State,21.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Age Group,0-17 years,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Age Group,0-17 years,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Age Group,18-24 years,12.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Age Group,18-24 years,12.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Age Group,25-44 years,42.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Age Group,25-44 years,42.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Age Group,45-64 years,41.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Age Group,45-64 years,41.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Age Group,65+ years,8.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Age Group,65+ years,8.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,2.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,2.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Race and Ethnicity,Black NH,36.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Race and Ethnicity,Black NH,36.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Race and Ethnicity,Hispanic,27.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Race and Ethnicity,Hispanic,27.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Race and Ethnicity,White NH,24.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Race and Ethnicity,White NH,24.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Region,NYS Excl NYC,25.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Region,NYS Excl NYC,25.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Region,New York City,25,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Region,New York City,25,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Sex,Female,13.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Sex,Female,13.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Sex,Male,37.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Sex,Male,37.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Total,New York State,25.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2021,Total,New York State,25.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Age Group,0-17 years,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Age Group,0-17 years,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Age Group,18-24 years,12.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Age Group,18-24 years,12.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Age Group,25-44 years,44.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Age Group,25-44 years,44.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Age Group,45-64 years,46.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Age Group,45-64 years,46.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Age Group,65+ years,11.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Age Group,65+ years,11.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,2.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,2.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Race and Ethnicity,Black NH,46.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Race and Ethnicity,Black NH,46.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Race and Ethnicity,Hispanic,31.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Race and Ethnicity,Hispanic,31.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Race and Ethnicity,White NH,24.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Race and Ethnicity,White NH,24.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Region,NYS Excl NYC,26.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Region,NYS Excl NYC,26.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Region,New York City,28.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Region,New York City,28.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Sex,Female,13.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Sex,Female,13.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Sex,Male,42,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Sex,Male,42,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Total,New York State,27.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving any opioid, crude rate per 100,000 population",2022,Total,New York State,27.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2010,Race and Ethnicity,Asian/PI NH,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2010,Race and Ethnicity,Black NH,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2010,Race and Ethnicity,Hispanic,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2010,Race and Ethnicity,White NH,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2010,Region,NYS Excl NYC,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2010,Region,New York City,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2010,Sex,Female,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2010,Sex,Male,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2010,Total,New York State,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2011,Race and Ethnicity,Asian/PI NH,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2011,Race and Ethnicity,Black NH,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2011,Race and Ethnicity,Hispanic,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2011,Race and Ethnicity,White NH,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2011,Region,NYS Excl NYC,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2011,Region,New York City,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2011,Sex,Female,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2011,Sex,Male,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2011,Total,New York State,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2012,Race and Ethnicity,Asian/PI NH,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2012,Race and Ethnicity,Black NH,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2012,Race and Ethnicity,Hispanic,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2012,Race and Ethnicity,White NH,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2012,Region,NYS Excl NYC,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2012,Region,New York City,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2012,Sex,Female,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2012,Sex,Male,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2012,Total,New York State,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2013,Race and Ethnicity,Asian/PI NH,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2013,Race and Ethnicity,Black NH,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2013,Race and Ethnicity,Hispanic,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2013,Race and Ethnicity,White NH,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2013,Region,NYS Excl NYC,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2013,Region,New York City,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2013,Sex,Female,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2013,Sex,Male,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2013,Total,New York State,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2014,Race and Ethnicity,Asian/PI NH,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2014,Race and Ethnicity,Black NH,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2014,Race and Ethnicity,Hispanic,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2014,Race and Ethnicity,White NH,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2014,Region,NYS Excl NYC,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2014,Region,New York City,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2014,Sex,Female,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2014,Sex,Male,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2014,Total,New York State,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2015,Race and Ethnicity,Asian/PI NH,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2015,Race and Ethnicity,Black NH,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2015,Race and Ethnicity,Hispanic,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2015,Race and Ethnicity,White NH,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2015,Region,NYS Excl NYC,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2015,Region,New York City,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2015,Sex,Female,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2015,Sex,Male,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2015,Total,New York State,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Black NH,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Hispanic,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2016,Race and Ethnicity,White NH,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2016,Region,NYS Excl NYC,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2016,Region,New York City,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2016,Sex,Female,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2016,Sex,Male,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2016,Total,New York State,0.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Black NH,0.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Hispanic,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2017,Race and Ethnicity,White NH,1.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2017,Region,NYS Excl NYC,1.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2017,Region,New York City,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2017,Sex,Female,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2017,Sex,Male,1.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2017,Total,New York State,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Black NH,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Hispanic,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2018,Race and Ethnicity,White NH,1.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2018,Region,NYS Excl NYC,1.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2018,Region,New York City,0.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2018,Sex,Female,0.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2018,Sex,Male,1.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2018,Total,New York State,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Black NH,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Hispanic,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2019,Race and Ethnicity,White NH,1.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2019,Region,NYS Excl NYC,1.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2019,Region,New York City,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2019,Sex,Female,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2019,Sex,Male,1.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2019,Total,New York State,1.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Black NH,2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Hispanic,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2020,Race and Ethnicity,White NH,3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2020,Region,NYS Excl NYC,3.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2020,Region,New York City,1.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2020,Sex,Female,1.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2020,Sex,Male,3.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2020,Total,New York State,2.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Black NH,2.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Hispanic,1.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2021,Race and Ethnicity,White NH,4.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2021,Region,NYS Excl NYC,3.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2021,Region,New York City,2.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2021,Sex,Female,1.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2021,Sex,Male,4.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2021,Total,New York State,3.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Black NH,3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Hispanic,2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2022,Race and Ethnicity,White NH,4.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2022,Region,NYS Excl NYC,4.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2022,Region,New York City,2.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2022,Sex,Female,1.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2022,Sex,Male,5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), age-adjusted rate per 100,000 population",2022,Total,New York State,3.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2010,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2010,Age Group,18-24 years,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2010,Age Group,25-44 years,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2010,Age Group,45-64 years,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2010,Age Group,65+ years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2010,Race and Ethnicity,Asian/PI NH,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2010,Race and Ethnicity,Black NH,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2010,Race and Ethnicity,Hispanic,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2010,Race and Ethnicity,White NH,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2010,Region,NYS Excl NYC,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2010,Region,New York City,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2010,Sex,Female,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2010,Sex,Male,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2010,Total,New York State,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2011,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2011,Age Group,18-24 years,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2011,Age Group,25-44 years,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2011,Age Group,45-64 years,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2011,Age Group,65+ years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2011,Race and Ethnicity,Asian/PI NH,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2011,Race and Ethnicity,Black NH,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2011,Race and Ethnicity,Hispanic,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2011,Race and Ethnicity,White NH,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2011,Region,NYS Excl NYC,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2011,Region,New York City,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2011,Sex,Female,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2011,Sex,Male,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2011,Total,New York State,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2012,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2012,Age Group,18-24 years,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2012,Age Group,25-44 years,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2012,Age Group,45-64 years,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2012,Age Group,65+ years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2012,Race and Ethnicity,Asian/PI NH,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2012,Race and Ethnicity,Black NH,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2012,Race and Ethnicity,Hispanic,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2012,Race and Ethnicity,White NH,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2012,Region,NYS Excl NYC,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2012,Region,New York City,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2012,Sex,Female,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2012,Sex,Male,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2012,Total,New York State,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2013,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2013,Age Group,18-24 years,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2013,Age Group,25-44 years,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2013,Age Group,45-64 years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2013,Age Group,65+ years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2013,Race and Ethnicity,Asian/PI NH,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2013,Race and Ethnicity,Black NH,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2013,Race and Ethnicity,Hispanic,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2013,Race and Ethnicity,White NH,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2013,Region,NYS Excl NYC,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2013,Region,New York City,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2013,Sex,Female,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2013,Sex,Male,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2013,Total,New York State,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2014,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2014,Age Group,18-24 years,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2014,Age Group,25-44 years,0.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2014,Age Group,45-64 years,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2014,Age Group,65+ years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2014,Race and Ethnicity,Asian/PI NH,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2014,Race and Ethnicity,Black NH,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2014,Race and Ethnicity,Hispanic,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2014,Race and Ethnicity,White NH,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2014,Region,NYS Excl NYC,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2014,Region,New York City,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2014,Sex,Female,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2014,Sex,Male,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2014,Total,New York State,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2015,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2015,Age Group,18-24 years,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2015,Age Group,25-44 years,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2015,Age Group,45-64 years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2015,Age Group,65+ years,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2015,Race and Ethnicity,Asian/PI NH,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2015,Race and Ethnicity,Black NH,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2015,Race and Ethnicity,Hispanic,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2015,Race and Ethnicity,White NH,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2015,Region,NYS Excl NYC,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2015,Region,New York City,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2015,Sex,Female,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2015,Sex,Male,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2015,Total,New York State,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2016,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2016,Age Group,18-24 years,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2016,Age Group,25-44 years,1.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2016,Age Group,45-64 years,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2016,Age Group,65+ years,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2016,Race and Ethnicity,Black NH,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2016,Race and Ethnicity,Hispanic,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2016,Race and Ethnicity,White NH,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2016,Region,NYS Excl NYC,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2016,Region,New York City,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2016,Sex,Female,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2016,Sex,Male,1.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2016,Total,New York State,0.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2017,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2017,Age Group,18-24 years,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2017,Age Group,25-44 years,2.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2017,Age Group,45-64 years,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2017,Age Group,65+ years,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2017,Race and Ethnicity,Black NH,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2017,Race and Ethnicity,Hispanic,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2017,Race and Ethnicity,White NH,1.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2017,Region,NYS Excl NYC,1.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2017,Region,New York City,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2017,Sex,Female,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2017,Sex,Male,1.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2017,Total,New York State,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2018,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2018,Age Group,18-24 years,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2018,Age Group,25-44 years,2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2018,Age Group,45-64 years,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2018,Age Group,65+ years,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2018,Race and Ethnicity,Black NH,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2018,Race and Ethnicity,Hispanic,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2018,Race and Ethnicity,White NH,1.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2018,Region,NYS Excl NYC,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2018,Region,New York City,0.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2018,Sex,Female,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2018,Sex,Male,1.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2018,Total,New York State,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2019,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2019,Age Group,18-24 years,1.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2019,Age Group,25-44 years,2.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2019,Age Group,45-64 years,1.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2019,Age Group,65+ years,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2019,Race and Ethnicity,Black NH,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2019,Race and Ethnicity,Hispanic,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2019,Race and Ethnicity,White NH,1.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2019,Region,NYS Excl NYC,1.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2019,Region,New York City,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2019,Sex,Female,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2019,Sex,Male,1.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2019,Total,New York State,1.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2020,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2020,Age Group,18-24 years,1.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2020,Age Group,25-44 years,5.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2020,Age Group,45-64 years,2.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2020,Age Group,65+ years,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2020,Race and Ethnicity,Black NH,2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2020,Race and Ethnicity,Hispanic,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2020,Race and Ethnicity,White NH,2.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2020,Region,NYS Excl NYC,2.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2020,Region,New York City,1.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2020,Sex,Female,1.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2020,Sex,Male,3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2020,Total,New York State,2.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2021,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2021,Age Group,18-24 years,2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2021,Age Group,25-44 years,7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2021,Age Group,45-64 years,3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2021,Age Group,65+ years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2021,Race and Ethnicity,Black NH,2.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2021,Race and Ethnicity,Hispanic,1.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2021,Race and Ethnicity,White NH,3.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2021,Region,NYS Excl NYC,3.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2021,Region,New York City,2.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2021,Sex,Female,1.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2021,Sex,Male,4.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2021,Total,New York State,2.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2022,Age Group,0-17 years,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2022,Age Group,18-24 years,1.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2022,Age Group,25-44 years,7.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2022,Age Group,45-64 years,3.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2022,Age Group,65+ years,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2022,Race and Ethnicity,Black NH,3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2022,Race and Ethnicity,Hispanic,1.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2022,Race and Ethnicity,White NH,4.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2022,Region,NYS Excl NYC,4.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2022,Region,New York City,2.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2022,Sex,Female,1.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2022,Sex,Male,4.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving certain psychostimulants (e.g., methamphetamine, MDMA, prescription stimulants), crude rate per 100,000 population",2022,Total,New York State,3.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2010,Race and Ethnicity,Asian/PI NH,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2010,Race and Ethnicity,Black NH,3.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2010,Race and Ethnicity,Hispanic,2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2010,Race and Ethnicity,White NH,1.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2010,Region,NYS Excl NYC,1.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2010,Region,New York City,2.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2010,Sex,Female,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2010,Sex,Male,3.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2010,Total,New York State,1.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2011,Race and Ethnicity,Asian/PI NH,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2011,Race and Ethnicity,Black NH,3.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2011,Race and Ethnicity,Hispanic,2.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2011,Race and Ethnicity,White NH,2.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2011,Region,NYS Excl NYC,1.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2011,Region,New York City,2.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2011,Sex,Female,1.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2011,Sex,Male,3.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2011,Total,New York State,2.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2012,Race and Ethnicity,Asian/PI NH,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2012,Race and Ethnicity,Black NH,3.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2012,Race and Ethnicity,Hispanic,2.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2012,Race and Ethnicity,White NH,2.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2012,Region,NYS Excl NYC,1.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2012,Region,New York City,2.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2012,Sex,Female,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2012,Sex,Male,3.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2012,Total,New York State,1.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2013,Race and Ethnicity,Asian/PI NH,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2013,Race and Ethnicity,Black NH,3.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2013,Race and Ethnicity,Hispanic,2.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2013,Race and Ethnicity,White NH,2.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2013,Region,NYS Excl NYC,2.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2013,Region,New York City,2.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2013,Sex,Female,1.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2013,Sex,Male,3.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2013,Total,New York State,2.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2014,Race and Ethnicity,Asian/PI NH,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2014,Race and Ethnicity,Black NH,3.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2014,Race and Ethnicity,Hispanic,2.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2014,Race and Ethnicity,White NH,2.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2014,Region,NYS Excl NYC,2.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2014,Region,New York City,2.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2014,Sex,Female,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2014,Sex,Male,3.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2014,Total,New York State,2.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2015,Race and Ethnicity,Asian/PI NH,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2015,Race and Ethnicity,Black NH,3.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2015,Race and Ethnicity,Hispanic,3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2015,Race and Ethnicity,White NH,3.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2015,Region,NYS Excl NYC,3.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2015,Region,New York City,2.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2015,Sex,Female,1.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2015,Sex,Male,4.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2015,Total,New York State,3.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Black NH,7.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Hispanic,5.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,White NH,5.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2016,Region,NYS Excl NYC,5.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2016,Region,New York City,5.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2016,Sex,Female,2.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2016,Sex,Male,7.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2016,Total,New York State,5.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Black NH,9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Hispanic,7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,White NH,7.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2017,Region,NYS Excl NYC,7.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2017,Region,New York City,6.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2017,Sex,Female,3.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2017,Sex,Male,10.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2017,Total,New York State,6.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Black NH,9.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Hispanic,7.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,White NH,6.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2018,Region,NYS Excl NYC,6.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2018,Region,New York City,6.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2018,Sex,Female,3.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2018,Sex,Male,9.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2018,Total,New York State,6.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Black NH,10.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Hispanic,7.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,White NH,6.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2019,Region,NYS Excl NYC,6.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2019,Region,New York City,6.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2019,Sex,Female,3.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2019,Sex,Male,9.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2019,Total,New York State,6.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Black NH,15.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Hispanic,9.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,White NH,8.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2020,Region,NYS Excl NYC,9.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2020,Region,New York City,8.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2020,Sex,Female,4.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2020,Sex,Male,13.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2020,Total,New York State,8.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,0.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Black NH,22,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Hispanic,13.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,White NH,9.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2021,Region,NYS Excl NYC,10.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2021,Region,New York City,11.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2021,Sex,Female,6.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2021,Sex,Male,16.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2021,Total,New York State,11,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Black NH,29.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Hispanic,17.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,White NH,10.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2022,Region,NYS Excl NYC,13.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2022,Region,New York City,15.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2022,Sex,Female,7.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2022,Sex,Male,21.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, age-adjusted rate per 100,000 population",2022,Total,New York State,14.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2010,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2010,Age Group,18-24 years,1.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2010,Age Group,25-44 years,2.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2010,Age Group,45-64 years,3.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2010,Age Group,65+ years,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2010,Race and Ethnicity,Asian/PI NH,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2010,Race and Ethnicity,Black NH,3.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2010,Race and Ethnicity,Hispanic,1.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2010,Race and Ethnicity,White NH,1.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2010,Region,NYS Excl NYC,1.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2010,Region,New York City,2.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2010,Sex,Female,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2010,Sex,Male,2.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2010,Total,New York State,1.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2011,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2011,Age Group,18-24 years,1.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2011,Age Group,25-44 years,3.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2011,Age Group,45-64 years,4.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2011,Age Group,65+ years,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2011,Race and Ethnicity,Asian/PI NH,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2011,Race and Ethnicity,Black NH,4.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2011,Race and Ethnicity,Hispanic,2.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2011,Race and Ethnicity,White NH,2.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2011,Region,NYS Excl NYC,1.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2011,Region,New York City,3.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2011,Sex,Female,1.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2011,Sex,Male,3.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2011,Total,New York State,2.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2012,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2012,Age Group,18-24 years,1.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2012,Age Group,25-44 years,3.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2012,Age Group,45-64 years,3.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2012,Age Group,65+ years,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2012,Race and Ethnicity,Asian/PI NH,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2012,Race and Ethnicity,Black NH,3.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2012,Race and Ethnicity,Hispanic,2.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2012,Race and Ethnicity,White NH,2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2012,Region,NYS Excl NYC,1.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2012,Region,New York City,2.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2012,Sex,Female,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2012,Sex,Male,3.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2012,Total,New York State,2.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2013,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2013,Age Group,18-24 years,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2013,Age Group,25-44 years,3.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2013,Age Group,45-64 years,4.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2013,Age Group,65+ years,0.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2013,Race and Ethnicity,Asian/PI NH,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2013,Race and Ethnicity,Black NH,4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2013,Race and Ethnicity,Hispanic,2.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2013,Race and Ethnicity,White NH,2.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2013,Region,NYS Excl NYC,2.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2013,Region,New York City,2.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2013,Sex,Female,1.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2013,Sex,Male,3.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2013,Total,New York State,2.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2014,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2014,Age Group,18-24 years,1.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2014,Age Group,25-44 years,3.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2014,Age Group,45-64 years,4.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2014,Age Group,65+ years,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2014,Race and Ethnicity,Asian/PI NH,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2014,Race and Ethnicity,Black NH,3.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2014,Race and Ethnicity,Hispanic,2.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2014,Race and Ethnicity,White NH,2.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2014,Region,NYS Excl NYC,2.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2014,Region,New York City,2.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2014,Sex,Female,1.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2014,Sex,Male,4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2014,Total,New York State,2.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2015,Age Group,0-17 years,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2015,Age Group,18-24 years,1.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2015,Age Group,25-44 years,5.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2015,Age Group,45-64 years,5.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2015,Age Group,65+ years,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2015,Race and Ethnicity,Asian/PI NH,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2015,Race and Ethnicity,Black NH,4.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2015,Race and Ethnicity,Hispanic,3.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2015,Race and Ethnicity,White NH,3.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2015,Region,NYS Excl NYC,3.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2015,Region,New York City,3.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2015,Sex,Female,1.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2015,Sex,Male,5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2015,Total,New York State,3.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2016,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2016,Age Group,18-24 years,4.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2016,Age Group,25-44 years,8.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2016,Age Group,45-64 years,8.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2016,Age Group,65+ years,1.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2016,Race and Ethnicity,Black NH,8.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2016,Race and Ethnicity,Hispanic,5.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2016,Race and Ethnicity,White NH,4.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2016,Region,NYS Excl NYC,5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2016,Region,New York City,5.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2016,Sex,Female,2.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2016,Sex,Male,8.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2016,Total,New York State,5.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2017,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2017,Age Group,18-24 years,3.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2017,Age Group,25-44 years,11.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2017,Age Group,45-64 years,10.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2017,Age Group,65+ years,1.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2017,Race and Ethnicity,Black NH,9.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2017,Race and Ethnicity,Hispanic,7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2017,Race and Ethnicity,White NH,6.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2017,Region,NYS Excl NYC,6.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2017,Region,New York City,6.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2017,Sex,Female,3.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2017,Sex,Male,10.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2017,Total,New York State,6.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2018,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2018,Age Group,18-24 years,3.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2018,Age Group,25-44 years,10.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2018,Age Group,45-64 years,11,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2018,Age Group,65+ years,2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2018,Race and Ethnicity,Black NH,10.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2018,Race and Ethnicity,Hispanic,7.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2018,Race and Ethnicity,White NH,5.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2018,Region,NYS Excl NYC,6.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2018,Region,New York City,7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2018,Sex,Female,3.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2018,Sex,Male,9.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2018,Total,New York State,6.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2019,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2019,Age Group,18-24 years,3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2019,Age Group,25-44 years,10.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2019,Age Group,45-64 years,12.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2019,Age Group,65+ years,2.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2019,Race and Ethnicity,Black NH,11.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2019,Race and Ethnicity,Hispanic,7.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2019,Race and Ethnicity,White NH,6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2019,Region,NYS Excl NYC,6.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2019,Region,New York City,7.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2019,Sex,Female,3.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2019,Sex,Male,10.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2019,Total,New York State,6.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2020,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2020,Age Group,18-24 years,3.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2020,Age Group,25-44 years,14.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2020,Age Group,45-64 years,16.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2020,Age Group,65+ years,2.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2020,Race and Ethnicity,Black NH,17.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2020,Race and Ethnicity,Hispanic,9.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2020,Race and Ethnicity,White NH,7.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2020,Region,NYS Excl NYC,8.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2020,Region,New York City,9.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2020,Sex,Female,4.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2020,Sex,Male,13.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2020,Total,New York State,9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2021,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2021,Age Group,18-24 years,3.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2021,Age Group,25-44 years,17.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2021,Age Group,45-64 years,22.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2021,Age Group,65+ years,3.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,0.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2021,Race and Ethnicity,Black NH,25.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2021,Race and Ethnicity,Hispanic,13.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2021,Race and Ethnicity,White NH,8.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2021,Region,NYS Excl NYC,10.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2021,Region,New York City,12.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2021,Sex,Female,6.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2021,Sex,Male,17,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2021,Total,New York State,11.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2022,Age Group,0-17 years,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2022,Age Group,18-24 years,4.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2022,Age Group,25-44 years,21.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2022,Age Group,45-64 years,28.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2022,Age Group,65+ years,6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2022,Race and Ethnicity,Black NH,33.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2022,Race and Ethnicity,Hispanic,17.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2022,Race and Ethnicity,White NH,10.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2022,Region,NYS Excl NYC,13.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2022,Region,New York City,16.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2022,Sex,Female,7.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2022,Sex,Male,22.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving cocaine, crude rate per 100,000 population",2022,Total,New York State,14.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2010,Race and Ethnicity,Asian/PI NH,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2010,Race and Ethnicity,Black NH,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2010,Race and Ethnicity,Hispanic,1.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2010,Race and Ethnicity,White NH,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2010,Region,NYS Excl NYC,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2010,Region,New York City,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2010,Sex,Female,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2010,Sex,Male,1.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2010,Total,New York State,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2011,Race and Ethnicity,Asian/PI NH,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2011,Race and Ethnicity,Black NH,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2011,Race and Ethnicity,Hispanic,1.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2011,Race and Ethnicity,White NH,2.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2011,Region,NYS Excl NYC,2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2011,Region,New York City,1.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2011,Sex,Female,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2011,Sex,Male,2.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2011,Total,New York State,1.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2012,Race and Ethnicity,Asian/PI NH,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2012,Race and Ethnicity,Black NH,1.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2012,Race and Ethnicity,Hispanic,2.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2012,Race and Ethnicity,White NH,3.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2012,Region,NYS Excl NYC,2.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2012,Region,New York City,2.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2012,Sex,Female,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2012,Sex,Male,4.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2012,Total,New York State,2.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2013,Race and Ethnicity,Asian/PI NH,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2013,Race and Ethnicity,Black NH,1.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2013,Race and Ethnicity,Hispanic,3.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2013,Race and Ethnicity,White NH,4.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2013,Region,NYS Excl NYC,3.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2013,Region,New York City,2.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2013,Sex,Female,1.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2013,Sex,Male,5.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2013,Total,New York State,3.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2014,Race and Ethnicity,Asian/PI NH,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2014,Race and Ethnicity,Black NH,2.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2014,Race and Ethnicity,Hispanic,3.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2014,Race and Ethnicity,White NH,5.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2014,Region,NYS Excl NYC,5.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2014,Region,New York City,3.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2014,Sex,Female,1.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2014,Sex,Male,6.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2014,Total,New York State,4.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2015,Race and Ethnicity,Asian/PI NH,0.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2015,Race and Ethnicity,Black NH,3.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2015,Race and Ethnicity,Hispanic,5.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2015,Race and Ethnicity,White NH,6.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2015,Region,NYS Excl NYC,6.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2015,Region,New York City,4.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2015,Sex,Female,2.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2015,Sex,Male,8.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2015,Total,New York State,5.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Black NH,4.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Hispanic,6.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2016,Race and Ethnicity,White NH,8.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2016,Region,NYS Excl NYC,8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2016,Region,New York City,5.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2016,Sex,Female,2.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2016,Sex,Male,10.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2016,Total,New York State,6.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Black NH,5.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Hispanic,7.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2017,Race and Ethnicity,White NH,8.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2017,Region,NYS Excl NYC,7.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2017,Region,New York City,6.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2017,Sex,Female,2.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2017,Sex,Male,11.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2017,Total,New York State,7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Black NH,4.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Hispanic,7.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2018,Race and Ethnicity,White NH,7.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2018,Region,NYS Excl NYC,6.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2018,Region,New York City,6.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2018,Sex,Female,2.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2018,Sex,Male,9.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2018,Total,New York State,6.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,0.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Black NH,5.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Hispanic,7.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2019,Race and Ethnicity,White NH,6.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2019,Region,NYS Excl NYC,5.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2019,Region,New York City,6.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2019,Sex,Female,2.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2019,Sex,Male,8.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2019,Total,New York State,5.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Black NH,7.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Hispanic,7.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2020,Race and Ethnicity,White NH,6.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2020,Region,NYS Excl NYC,5.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2020,Region,New York City,8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2020,Sex,Female,2.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2020,Sex,Male,10,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2020,Total,New York State,6.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Black NH,7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Hispanic,7.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2021,Race and Ethnicity,White NH,4.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2021,Region,NYS Excl NYC,3.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2021,Region,New York City,7.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2021,Sex,Female,2.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2021,Sex,Male,7.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2021,Total,New York State,5.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Black NH,8.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Hispanic,7.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2022,Race and Ethnicity,White NH,2.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2022,Region,NYS Excl NYC,2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2022,Region,New York City,7.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2022,Sex,Female,1.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2022,Sex,Male,6.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, age-adjusted rate per 100,000 population",2022,Total,New York State,4.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2010,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2010,Age Group,18-24 years,1.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2010,Age Group,25-44 years,1.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2010,Age Group,45-64 years,1.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2010,Age Group,65+ years,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2010,Race and Ethnicity,Asian/PI NH,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2010,Race and Ethnicity,Black NH,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2010,Race and Ethnicity,Hispanic,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2010,Race and Ethnicity,White NH,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2010,Region,NYS Excl NYC,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2010,Region,New York City,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2010,Sex,Female,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2010,Sex,Male,1.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2010,Total,New York State,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2011,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2011,Age Group,18-24 years,2.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2011,Age Group,25-44 years,3.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2011,Age Group,45-64 years,1.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2011,Age Group,65+ years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2011,Race and Ethnicity,Asian/PI NH,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2011,Race and Ethnicity,Black NH,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2011,Race and Ethnicity,Hispanic,1.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2011,Race and Ethnicity,White NH,2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2011,Region,NYS Excl NYC,1.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2011,Region,New York City,1.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2011,Sex,Female,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2011,Sex,Male,2.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2011,Total,New York State,1.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2012,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2012,Age Group,18-24 years,3.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2012,Age Group,25-44 years,4.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2012,Age Group,45-64 years,3.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2012,Age Group,65+ years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2012,Race and Ethnicity,Asian/PI NH,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2012,Race and Ethnicity,Black NH,1.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2012,Race and Ethnicity,Hispanic,2.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2012,Race and Ethnicity,White NH,3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2012,Region,NYS Excl NYC,2.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2012,Region,New York City,2.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2012,Sex,Female,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2012,Sex,Male,4.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2012,Total,New York State,2.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2013,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2013,Age Group,18-24 years,5.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2013,Age Group,25-44 years,6.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2013,Age Group,45-64 years,3.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2013,Age Group,65+ years,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2013,Race and Ethnicity,Asian/PI NH,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2013,Race and Ethnicity,Black NH,2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2013,Race and Ethnicity,Hispanic,3.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2013,Race and Ethnicity,White NH,4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2013,Region,NYS Excl NYC,3.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2013,Region,New York City,2.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2013,Sex,Female,1.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2013,Sex,Male,5.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2013,Total,New York State,3.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2014,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2014,Age Group,18-24 years,6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2014,Age Group,25-44 years,8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2014,Age Group,45-64 years,4.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2014,Age Group,65+ years,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2014,Race and Ethnicity,Asian/PI NH,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2014,Race and Ethnicity,Black NH,2.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2014,Race and Ethnicity,Hispanic,3.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2014,Race and Ethnicity,White NH,5.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2014,Region,NYS Excl NYC,4.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2014,Region,New York City,3.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2014,Sex,Female,1.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2014,Sex,Male,6.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2014,Total,New York State,4.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2015,Age Group,0-17 years,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2015,Age Group,18-24 years,6.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2015,Age Group,25-44 years,10.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2015,Age Group,45-64 years,6.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2015,Age Group,65+ years,0.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2015,Race and Ethnicity,Asian/PI NH,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2015,Race and Ethnicity,Black NH,3.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2015,Race and Ethnicity,Hispanic,5.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2015,Race and Ethnicity,White NH,6.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2015,Region,NYS Excl NYC,6.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2015,Region,New York City,4.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2015,Sex,Female,2.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2015,Sex,Male,8.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2015,Total,New York State,5.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2016,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2016,Age Group,18-24 years,7.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2016,Age Group,25-44 years,13.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2016,Age Group,45-64 years,8.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2016,Age Group,65+ years,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,0.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2016,Race and Ethnicity,Black NH,5.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2016,Race and Ethnicity,Hispanic,6.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2016,Race and Ethnicity,White NH,7.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2016,Region,NYS Excl NYC,7.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2016,Region,New York City,5.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2016,Sex,Female,2.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2016,Sex,Male,10.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2016,Total,New York State,6.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2017,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2017,Age Group,18-24 years,5.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2017,Age Group,25-44 years,13.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2017,Age Group,45-64 years,9.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2017,Age Group,65+ years,1.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,1.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2017,Race and Ethnicity,Black NH,6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2017,Race and Ethnicity,Hispanic,7.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2017,Race and Ethnicity,White NH,7.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2017,Region,NYS Excl NYC,7.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2017,Region,New York City,6.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2017,Sex,Female,2.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2017,Sex,Male,11.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2017,Total,New York State,7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2018,Age Group,0-17 years,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2018,Age Group,18-24 years,4.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2018,Age Group,25-44 years,11.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2018,Age Group,45-64 years,9.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2018,Age Group,65+ years,1.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2018,Race and Ethnicity,Black NH,5.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2018,Race and Ethnicity,Hispanic,7.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2018,Race and Ethnicity,White NH,6.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2018,Region,NYS Excl NYC,6.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2018,Region,New York City,6.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2018,Sex,Female,2.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2018,Sex,Male,10,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2018,Total,New York State,6.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2019,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2019,Age Group,18-24 years,3.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2019,Age Group,25-44 years,10.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2019,Age Group,45-64 years,9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2019,Age Group,65+ years,2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2019,Race and Ethnicity,Black NH,6.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2019,Race and Ethnicity,Hispanic,7.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2019,Race and Ethnicity,White NH,5.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2019,Region,NYS Excl NYC,4.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2019,Region,New York City,7.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2019,Sex,Female,2.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2019,Sex,Male,9.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2019,Total,New York State,5.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2020,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2020,Age Group,18-24 years,3.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2020,Age Group,25-44 years,10.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2020,Age Group,45-64 years,10.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2020,Age Group,65+ years,2.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2020,Race and Ethnicity,Black NH,8.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2020,Race and Ethnicity,Hispanic,7.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2020,Race and Ethnicity,White NH,6.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2020,Region,NYS Excl NYC,4.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2020,Region,New York City,8.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2020,Sex,Female,2.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2020,Sex,Male,10.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2020,Total,New York State,6.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2021,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2021,Age Group,18-24 years,1.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2021,Age Group,25-44 years,7.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2021,Age Group,45-64 years,10.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2021,Age Group,65+ years,2.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2021,Race and Ethnicity,Black NH,8.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2021,Race and Ethnicity,Hispanic,7.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2021,Race and Ethnicity,White NH,4.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2021,Region,NYS Excl NYC,2.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2021,Region,New York City,8.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2021,Sex,Female,2.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2021,Sex,Male,8.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2021,Total,New York State,5.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2022,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2022,Age Group,18-24 years,1.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2022,Age Group,25-44 years,5.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2022,Age Group,45-64 years,9.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2022,Age Group,65+ years,3.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2022,Race and Ethnicity,Black NH,9.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2022,Race and Ethnicity,Hispanic,7.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2022,Race and Ethnicity,White NH,2.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2022,Region,NYS Excl NYC,1.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2022,Region,New York City,8.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2022,Sex,Female,2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2022,Sex,Male,7.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving heroin, crude rate per 100,000 population",2022,Total,New York State,4.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2010,Race and Ethnicity,Asian/PI NH,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2010,Race and Ethnicity,Black NH,2.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2010,Race and Ethnicity,Hispanic,2.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2010,Race and Ethnicity,White NH,5.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2010,Region,NYS Excl NYC,4.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2010,Region,New York City,3.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2010,Sex,Female,2.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2010,Sex,Male,5.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2010,Total,New York State,3.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2011,Race and Ethnicity,Asian/PI NH,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2011,Race and Ethnicity,Black NH,2.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2011,Race and Ethnicity,Hispanic,2.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2011,Race and Ethnicity,White NH,6.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2011,Region,NYS Excl NYC,5.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2011,Region,New York City,3.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2011,Sex,Female,3.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2011,Sex,Male,5.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2011,Total,New York State,4.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2012,Race and Ethnicity,Asian/PI NH,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2012,Race and Ethnicity,Black NH,2.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2012,Race and Ethnicity,Hispanic,2.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2012,Race and Ethnicity,White NH,5.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2012,Region,NYS Excl NYC,4.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2012,Region,New York City,3.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2012,Sex,Female,2.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2012,Sex,Male,5.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2012,Total,New York State,4.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2013,Race and Ethnicity,Asian/PI NH,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2013,Race and Ethnicity,Black NH,2.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2013,Race and Ethnicity,Hispanic,3.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2013,Race and Ethnicity,White NH,6.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2013,Region,NYS Excl NYC,5.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2013,Region,New York City,3.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2013,Sex,Female,3.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2013,Sex,Male,6.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2013,Total,New York State,4.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2014,Race and Ethnicity,Asian/PI NH,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2014,Race and Ethnicity,Black NH,2.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2014,Race and Ethnicity,Hispanic,2.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2014,Race and Ethnicity,White NH,6.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2014,Region,NYS Excl NYC,6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2014,Region,New York City,3.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2014,Sex,Female,3.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2014,Sex,Male,6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2014,Total,New York State,4.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2015,Race and Ethnicity,Asian/PI NH,0.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2015,Race and Ethnicity,Black NH,3.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2015,Race and Ethnicity,Hispanic,4.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2015,Race and Ethnicity,White NH,9.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2015,Region,NYS Excl NYC,9.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2015,Region,New York City,4.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2015,Sex,Female,4.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2015,Sex,Male,9.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2015,Total,New York State,6.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Black NH,8.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Race and Ethnicity,Hispanic,9.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Race and Ethnicity,White NH,15.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Region,NYS Excl NYC,15.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Region,New York City,8.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Sex,Female,7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Sex,Male,17.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2016,Total,New York State,12.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,1.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Black NH,10.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Race and Ethnicity,Hispanic,11.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Race and Ethnicity,White NH,18.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Region,NYS Excl NYC,18,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Region,New York City,10.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Sex,Female,7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Sex,Male,21.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2017,Total,New York State,14.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Black NH,10.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Race and Ethnicity,Hispanic,12.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Race and Ethnicity,White NH,17.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Region,NYS Excl NYC,16.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Region,New York City,10.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Sex,Female,7.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Sex,Male,19.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2018,Total,New York State,13.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,1.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Black NH,12.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Race and Ethnicity,Hispanic,15.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Race and Ethnicity,White NH,16.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Region,NYS Excl NYC,16.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Region,New York City,11.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Sex,Female,7.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Sex,Male,20.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2019,Total,New York State,13.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,1.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Black NH,23.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Race and Ethnicity,Hispanic,20.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Race and Ethnicity,White NH,23.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Region,NYS Excl NYC,23.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Region,New York City,18,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Sex,Female,10.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Sex,Male,30.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2020,Total,New York State,20.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Black NH,31.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Race and Ethnicity,Hispanic,26.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Race and Ethnicity,White NH,25.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Region,NYS Excl NYC,26.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Region,New York City,22.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Sex,Female,13.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Sex,Male,35.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2021,Total,New York State,24.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,2.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Black NH,40.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Race and Ethnicity,Hispanic,30.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Race and Ethnicity,White NH,25.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Region,NYS Excl NYC,27.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Region,New York City,26.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Sex,Female,13.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Sex,Male,39.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), age-adjusted rate per 100,000 population",2022,Total,New York State,26.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Age Group,0-17 years,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Age Group,18-24 years,3.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Age Group,25-44 years,5.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Age Group,45-64 years,7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Age Group,65+ years,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Race and Ethnicity,Asian/PI NH,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Race and Ethnicity,Black NH,2.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Race and Ethnicity,Hispanic,2.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Race and Ethnicity,White NH,5.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Region,NYS Excl NYC,4.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Region,New York City,3.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Sex,Female,2.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Sex,Male,5.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Total,New York State,3.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Age Group,0-17 years,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Age Group,18-24 years,4.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Age Group,25-44 years,7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Age Group,45-64 years,7.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Age Group,65+ years,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Race and Ethnicity,Asian/PI NH,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Race and Ethnicity,Black NH,2.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Race and Ethnicity,Hispanic,2.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Race and Ethnicity,White NH,6.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Region,NYS Excl NYC,5.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Region,New York City,3.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Sex,Female,3.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Sex,Male,6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Total,New York State,4.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Age Group,0-17 years,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Age Group,18-24 years,3.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Age Group,25-44 years,6.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Age Group,45-64 years,7.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Age Group,65+ years,1.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Race and Ethnicity,Asian/PI NH,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Race and Ethnicity,Black NH,2.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Race and Ethnicity,Hispanic,2.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Race and Ethnicity,White NH,6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Region,NYS Excl NYC,4.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Region,New York City,3.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Sex,Female,3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Sex,Male,6.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Total,New York State,4.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Age Group,0-17 years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Age Group,18-24 years,3.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Age Group,25-44 years,6.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Age Group,45-64 years,8.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Age Group,65+ years,1.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Race and Ethnicity,Asian/PI NH,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Race and Ethnicity,Black NH,2.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Race and Ethnicity,Hispanic,3.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Race and Ethnicity,White NH,6.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Region,NYS Excl NYC,5.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Region,New York City,3.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Sex,Female,3.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Sex,Male,6.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Total,New York State,4.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Age Group,0-17 years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Age Group,18-24 years,4.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Age Group,25-44 years,7.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Age Group,45-64 years,8.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Age Group,65+ years,1.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Race and Ethnicity,Asian/PI NH,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Race and Ethnicity,Black NH,2.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Race and Ethnicity,Hispanic,2.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Race and Ethnicity,White NH,6.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Region,NYS Excl NYC,6.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Region,New York City,3.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Sex,Female,3.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Sex,Male,6.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Total,New York State,5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Age Group,0-17 years,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Age Group,18-24 years,6.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Age Group,25-44 years,12,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Age Group,45-64 years,10.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Age Group,65+ years,1.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Race and Ethnicity,Asian/PI NH,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Race and Ethnicity,Black NH,3.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Race and Ethnicity,Hispanic,4.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Race and Ethnicity,White NH,9.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Region,NYS Excl NYC,8.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Region,New York City,4.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Sex,Female,4.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Sex,Male,9.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Total,New York State,7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Age Group,0-17 years,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Age Group,18-24 years,13,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Age Group,25-44 years,21.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Age Group,45-64 years,17.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Age Group,65+ years,2.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Race and Ethnicity,Black NH,9.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Race and Ethnicity,Hispanic,9.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Race and Ethnicity,White NH,15.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Region,NYS Excl NYC,14.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Region,New York City,9.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Sex,Female,6.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Sex,Male,17.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Total,New York State,12.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Age Group,0-17 years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Age Group,18-24 years,12.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Age Group,25-44 years,26.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Age Group,45-64 years,20.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Age Group,65+ years,3.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,1.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Race and Ethnicity,Black NH,11.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Race and Ethnicity,Hispanic,12.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Race and Ethnicity,White NH,17.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Region,NYS Excl NYC,17.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Region,New York City,11.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Sex,Female,7.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Sex,Male,22.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Total,New York State,14.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Age Group,0-17 years,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Age Group,18-24 years,9.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Age Group,25-44 years,25,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Age Group,45-64 years,20.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Age Group,65+ years,4.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,1.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Race and Ethnicity,Black NH,11.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Race and Ethnicity,Hispanic,12.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Race and Ethnicity,White NH,16.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Region,NYS Excl NYC,15.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Region,New York City,11,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Sex,Female,7.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Sex,Male,20.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Total,New York State,13.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Age Group,0-17 years,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Age Group,18-24 years,9.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Age Group,25-44 years,25.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Age Group,45-64 years,20.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Age Group,65+ years,4.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,1.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Race and Ethnicity,Black NH,13.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Race and Ethnicity,Hispanic,15,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Race and Ethnicity,White NH,15.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Region,NYS Excl NYC,15.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Region,New York City,12.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Sex,Female,7.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Sex,Male,21,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Total,New York State,14.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Age Group,0-17 years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Age Group,18-24 years,14.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Age Group,25-44 years,36.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Age Group,45-64 years,31.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Age Group,65+ years,6.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Race and Ethnicity,Black NH,25.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Race and Ethnicity,Hispanic,20.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Race and Ethnicity,White NH,22.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Region,NYS Excl NYC,22.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Region,New York City,19.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Sex,Female,10.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Sex,Male,31.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Total,New York State,20.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Age Group,0-17 years,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Age Group,18-24 years,12.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Age Group,25-44 years,42.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Age Group,45-64 years,41.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Age Group,65+ years,8.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,2.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Race and Ethnicity,Black NH,35.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Race and Ethnicity,Hispanic,27.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Race and Ethnicity,White NH,24.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Region,NYS Excl NYC,24.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Region,New York City,24.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Sex,Female,13.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Sex,Male,36.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Total,New York State,24.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Age Group,0-17 years,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Age Group,18-24 years,12.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Age Group,25-44 years,43.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Age Group,45-64 years,46.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Age Group,65+ years,11.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,2.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Race and Ethnicity,Black NH,46.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Race and Ethnicity,Hispanic,30.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Race and Ethnicity,White NH,24.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Region,NYS Excl NYC,26,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Region,New York City,28.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Sex,Female,13.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Sex,Male,41.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioid pain relievers (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Total,New York State,27,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2016,Age Group,0-17 years,6.9,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2016,Age Group,18-24 years,451.1,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2016,Age Group,25-44 years,593.3,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2016,Age Group,45-64 years,311.7,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2016,Age Group,65+ years,55.7,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,20.6,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2016,Race and Ethnicity,Black NH,245.4,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2016,Race and Ethnicity,Hispanic,251,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2016,Race and Ethnicity,White NH,313,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2016,Region,NYS Excl NYC,300.2,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2016,Region,New York City,291.5,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2016,Sex,Female,173.2,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2016,Sex,Male,427.1,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2016,Total,New York State,296.5,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2017,Age Group,0-17 years,6.8,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2017,Age Group,18-24 years,362.3,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2017,Age Group,25-44 years,615.5,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2017,Age Group,45-64 years,341.7,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2017,Age Group,65+ years,63.2,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,21.7,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2017,Race and Ethnicity,Black NH,274.5,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2017,Race and Ethnicity,Hispanic,268.2,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2017,Race and Ethnicity,White NH,306,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2017,Region,NYS Excl NYC,293.6,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2017,Region,New York City,314.5,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2017,Sex,Female,176,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2017,Sex,Male,436.7,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2017,Total,New York State,302.6,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2018,Age Group,0-17 years,5.1,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2018,Age Group,18-24 years,270.4,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2018,Age Group,25-44 years,577.2,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2018,Age Group,45-64 years,337.2,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2018,Age Group,65+ years,71.9,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,21.1,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2018,Race and Ethnicity,Black NH,276.7,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2018,Race and Ethnicity,Hispanic,280,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2018,Race and Ethnicity,White NH,272.6,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2018,Region,NYS Excl NYC,258.2,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2018,Region,New York City,316.4,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2018,Sex,Female,161.6,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2018,Sex,Male,412.1,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2018,Total,New York State,283.2,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2019,Age Group,0-17 years,3.9,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2019,Age Group,18-24 years,206.4,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2019,Age Group,25-44 years,536.3,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2019,Age Group,45-64 years,314.8,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2019,Age Group,65+ years,76.9,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,21.5,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2019,Race and Ethnicity,Black NH,263.1,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2019,Race and Ethnicity,Hispanic,266.9,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2019,Race and Ethnicity,White NH,239.6,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2019,Region,NYS Excl NYC,233,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2019,Region,New York City,298,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2019,Sex,Female,144.7,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2019,Sex,Male,384,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2019,Total,New York State,260.9,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2020,Age Group,0-17 years,4,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2020,Age Group,18-24 years,174.1,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2020,Age Group,25-44 years,447.2,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2020,Age Group,45-64 years,257.8,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2020,Age Group,65+ years,71,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,15.5,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2020,Race and Ethnicity,Black NH,228.4,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2020,Race and Ethnicity,Hispanic,212.8,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2020,Race and Ethnicity,White NH,203.6,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2020,Region,NYS Excl NYC,211.7,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2020,Region,New York City,225.8,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2020,Sex,Female,115.1,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2020,Sex,Male,326.5,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2020,Total,New York State,217.8,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2021,Age Group,0-17 years,4.7,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2021,Age Group,18-24 years,154.1,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2021,Age Group,25-44 years,433.9,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2021,Age Group,45-64 years,291,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2021,Age Group,65+ years,90.7,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,15.3,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2021,Race and Ethnicity,Black NH,276.3,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2021,Race and Ethnicity,Hispanic,220.5,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2021,Race and Ethnicity,White NH,193,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2021,Region,NYS Excl NYC,205.3,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2021,Region,New York City,247.4,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2021,Sex,Female,114,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2021,Sex,Male,337.7,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2021,Total,New York State,223.3,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2022,Age Group,0-17 years,5.8,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2022,Age Group,18-24 years,134.5,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2022,Age Group,25-44 years,426.2,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2022,Age Group,45-64 years,329.6,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2022,Age Group,65+ years,102.6,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,15.8,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2022,Race and Ethnicity,Black NH,307.1,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2022,Race and Ethnicity,Hispanic,241.5,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2022,Race and Ethnicity,White NH,173.6,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2022,Region,NYS Excl NYC,187.3,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2022,Region,New York City,290.8,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2022,Sex,Female,118.4,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2022,Sex,Male,349.3,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving opioids and nonfatal opioid related hospital events, crude rate per 100,000 population",2022,Total,New York State,231.2,Data Source: Vital Statistics and SPARCS Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Age Group,18-24 years,0.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Age Group,25-44 years,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Age Group,45-64 years,1.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Age Group,65+ years,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Race and Ethnicity,Asian/PI NH,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Race and Ethnicity,Black NH,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Race and Ethnicity,Hispanic,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Race and Ethnicity,White NH,1.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Region,NYS Excl NYC,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Region,New York City,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Sex,Female,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Sex,Male,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2010,Total,New York State,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Age Group,0-17 years,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Age Group,18-24 years,0.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Age Group,25-44 years,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Age Group,45-64 years,1.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Age Group,65+ years,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Race and Ethnicity,Asian/PI NH,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Race and Ethnicity,Black NH,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Race and Ethnicity,Hispanic,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Race and Ethnicity,White NH,1.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Region,NYS Excl NYC,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Region,New York City,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Sex,Female,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Sex,Male,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2011,Total,New York State,0.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Age Group,18-24 years,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Age Group,25-44 years,1.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Age Group,45-64 years,1.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Age Group,65+ years,0.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Race and Ethnicity,Asian/PI NH,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Race and Ethnicity,Black NH,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Race and Ethnicity,Hispanic,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Race and Ethnicity,White NH,1.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Region,NYS Excl NYC,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Region,New York City,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Sex,Female,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Sex,Male,0.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2012,Total,New York State,0.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Age Group,18-24 years,1.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Age Group,25-44 years,1.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Age Group,45-64 years,1.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Age Group,65+ years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Race and Ethnicity,Asian/PI NH,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Race and Ethnicity,Black NH,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Race and Ethnicity,Hispanic,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Race and Ethnicity,White NH,1.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Region,NYS Excl NYC,1.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Region,New York City,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Sex,Female,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Sex,Male,1.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2013,Total,New York State,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Age Group,0-17 years,0,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Age Group,18-24 years,1.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Age Group,25-44 years,2.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Age Group,45-64 years,2.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Age Group,65+ years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Race and Ethnicity,Asian/PI NH,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Race and Ethnicity,Black NH,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Race and Ethnicity,Hispanic,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Race and Ethnicity,White NH,2.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Region,NYS Excl NYC,2.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Region,New York City,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Sex,Female,1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Sex,Male,2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2014,Total,New York State,1.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Age Group,0-17 years,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Age Group,18-24 years,4.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Age Group,25-44 years,6.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Age Group,45-64 years,4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Age Group,65+ years,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Race and Ethnicity,Asian/PI NH,0.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Race and Ethnicity,Black NH,2.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Race and Ethnicity,Hispanic,2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Race and Ethnicity,White NH,4.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Region,NYS Excl NYC,4.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Region,New York City,1.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Sex,Female,1.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Sex,Male,5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2015,Total,New York State,3.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Age Group,0-17 years,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Age Group,18-24 years,10.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Age Group,25-44 years,17.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Age Group,45-64 years,10.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Age Group,65+ years,1.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Race and Ethnicity,Asian/PI NH,0.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Race and Ethnicity,Black NH,7.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Race and Ethnicity,Hispanic,7.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Race and Ethnicity,White NH,10.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Region,NYS Excl NYC,10.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Region,New York City,6.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Sex,Female,4.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Sex,Male,13.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2016,Total,New York State,8.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Age Group,0-17 years,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Age Group,18-24 years,11.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Age Group,25-44 years,22.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Age Group,45-64 years,15,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Age Group,65+ years,2.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Race and Ethnicity,Asian/PI NH,1.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Race and Ethnicity,Black NH,9.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Race and Ethnicity,Hispanic,10.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Race and Ethnicity,White NH,14,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Region,NYS Excl NYC,13.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Region,New York City,8.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Sex,Female,5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Sex,Male,18.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2017,Total,New York State,11.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Age Group,0-17 years,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Age Group,18-24 years,8.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Age Group,25-44 years,21.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Age Group,45-64 years,15.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Age Group,65+ years,2.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Race and Ethnicity,Asian/PI NH,0.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Race and Ethnicity,Black NH,9.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Race and Ethnicity,Hispanic,10.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Race and Ethnicity,White NH,12.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Region,NYS Excl NYC,12.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Region,New York City,9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Sex,Female,5.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Sex,Male,17.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2018,Total,New York State,11.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Age Group,0-17 years,0.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Age Group,18-24 years,8.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Age Group,25-44 years,22.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Age Group,45-64 years,17.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Age Group,65+ years,3.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Race and Ethnicity,Asian/PI NH,1.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Race and Ethnicity,Black NH,12.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Race and Ethnicity,Hispanic,13.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Race and Ethnicity,White NH,12.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Region,NYS Excl NYC,12.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Region,New York City,11,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Sex,Female,5.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Sex,Male,18.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2019,Total,New York State,12,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Age Group,0-17 years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Age Group,18-24 years,13.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Age Group,25-44 years,33.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Age Group,45-64 years,28.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Age Group,65+ years,5.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Race and Ethnicity,Asian/PI NH,1.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Race and Ethnicity,Black NH,24.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Race and Ethnicity,Hispanic,19.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Race and Ethnicity,White NH,19.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Region,NYS Excl NYC,19.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Region,New York City,17.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Sex,Female,8.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Sex,Male,29.4,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2020,Total,New York State,18.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Age Group,0-17 years,0.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Age Group,18-24 years,12.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Age Group,25-44 years,40,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Age Group,45-64 years,37.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Age Group,65+ years,7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Race and Ethnicity,Asian/PI NH,1.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Race and Ethnicity,Black NH,34.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Race and Ethnicity,Hispanic,26.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Race and Ethnicity,White NH,22,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Region,NYS Excl NYC,22.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Region,New York City,23.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Sex,Female,11.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Sex,Male,34.9,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2021,Total,New York State,23,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Age Group,0-17 years,0.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Age Group,18-24 years,11.5,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Age Group,25-44 years,41.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Age Group,45-64 years,43.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Age Group,65+ years,10.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Race and Ethnicity,Asian/PI NH,2.3,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Race and Ethnicity,Black NH,44.8,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Race and Ethnicity,Hispanic,29.2,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Race and Ethnicity,White NH,22,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Region,NYS Excl NYC,24,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Region,New York City,27.1,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Sex,Female,11.6,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Sex,Male,39.7,Data Source: Vital Statistics Data as of March 2025
"Overdose deaths involving synthetic opioids other than methadone (incl. illicitly produced opioids such as fentanyl), crude rate per 100,000 population",2022,Total,New York State,25.3,Data Source: Vital Statistics Data as of March 2025
"Pain reliever dependence in the past year, among persons aged 12 years or older",2015-2016,Sex,Female,0.2 (0.1 - 0.5),Data Source: National Survey on Drug Use and Health
"Pain reliever dependence in the past year, among persons aged 12 years or older",2015-2016,Sex,Male,0.5 (0.3 - 0.9),Data Source: National Survey on Drug Use and Health
"Pain reliever dependence in the past year, among persons aged 12 years or older",2015-2016,Total,New York State,0.4 (0.2 - 0.6),Data Source: National Survey on Drug Use and Health
"Pain reliever dependence in the past year, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Black NH,0.5 (0.1 - 1.9),Data Source: National Survey on Drug Use and Health
"Pain reliever dependence in the past year, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Hispanic,0.3 (0.1 - 0.9),Data Source: National Survey on Drug Use and Health
"Pain reliever dependence in the past year, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Other NH,0.6 (0.2 - 2.0),Data Source: National Survey on Drug Use and Health
"Pain reliever dependence in the past year, among persons aged 12 years or older",2016-2017,Race and Ethnicity,White NH,0.3 (0.2 - 0.6),Data Source: National Survey on Drug Use and Health
"Pain reliever dependence in the past year, among persons aged 12 years or older",2016-2017,Sex,Female,0.2 (0.1 - 0.5),Data Source: National Survey on Drug Use and Health
"Pain reliever dependence in the past year, among persons aged 12 years or older",2016-2017,Sex,Male,0.5 (0.3 - 0.9),Data Source: National Survey on Drug Use and Health
"Pain reliever dependence in the past year, among persons aged 12 years or older",2016-2017,Total,New York State,0.4 (0.2 - 0.6),Data Source: National Survey on Drug Use and Health
"Pain reliever dependence in the past year, among persons aged 12 years or older",2017-2018,Sex,Female,0.2 (0.1 - 0.5),Data Source: National Survey on Drug Use and Health
"Pain reliever dependence in the past year, among persons aged 12 years or older",2017-2018,Sex,Male,0.5 (0.3 - 1.0),Data Source: National Survey on Drug Use and Health
"Pain reliever dependence in the past year, among persons aged 12 years or older",2017-2018,Total,New York State,0.4 (0.2 - 0.6),Data Source: National Survey on Drug Use and Health
"Pain reliever dependence in the past year, among persons aged 12 years or older",2018-2019,Sex,Female,0.3 (0.1 - 0.5),Data Source: National Survey on Drug Use and Health
"Pain reliever dependence in the past year, among persons aged 12 years or older",2018-2019,Sex,Male,0.2 (0.1 - 0.6),Data Source: National Survey on Drug Use and Health
"Pain reliever dependence in the past year, among persons aged 12 years or older",2018-2019,Total,New York State,0.2 (0.1 - 0.4),Data Source: National Survey on Drug Use and Health
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group,18 - 24 years,168.6,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group,18 - 24 years,168.6,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group,25 - 34 years,907.5,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group,25 - 34 years,907.5,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group,35 - 44 years,965.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group,35 - 44 years,965.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group,45 - 54 years,525.7,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group,45 - 54 years,525.7,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group,55 - 64 years,370.9,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group,55 - 64 years,370.9,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group,65+ years,93.7,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group,65+ years,93.7,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group by Sex,Female & 18 - 24 years,143.6,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group by Sex,Female & 18 - 24 years,143.6,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group by Sex,Female & 25 - 34 years,681.9,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group by Sex,Female & 25 - 34 years,681.9,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group by Sex,Female & 35 - 44 years,708.1,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group by Sex,Female & 35 - 44 years,708.1,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group by Sex,Female & 45 - 54 years,351.3,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group by Sex,Female & 45 - 54 years,351.3,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group by Sex,Female & 55 - 64 years,242.4,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group by Sex,Female & 55 - 64 years,242.4,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group by Sex,Female & 65+ years,57.7,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group by Sex,Female & 65+ years,57.7,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group by Sex,Male & 18 - 24 years,193.4,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group by Sex,Male & 18 - 24 years,193.4,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group by Sex,Male & 25 - 34 years,"1,132.30",Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group by Sex,Male & 25 - 34 years,"1,132.30",Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group by Sex,Male & 35 - 44 years,"1,230.90",Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group by Sex,Male & 35 - 44 years,"1,230.90",Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group by Sex,Male & 45 - 54 years,710.1,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group by Sex,Male & 45 - 54 years,710.1,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group by Sex,Male & 55 - 64 years,510.7,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group by Sex,Male & 55 - 64 years,510.7,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group by Sex,Male & 65+ years,141.4,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Age Group by Sex,Male & 65+ years,141.4,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Region,NYS Excl NYC,555.4,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Region,NYS Excl NYC,555.4,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Region,New York City,199.2,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Region,New York City,199.2,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Sex,Female,285.9,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Sex,Female,285.9,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Sex,Male,525.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Sex,Male,525.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Total,New York State,402.4,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2019,Total,New York State,402.4,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group,18 - 24 years,139,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group,18 - 24 years,139,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group,25 - 34 years,868.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group,25 - 34 years,868.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group,35 - 44 years,"1,037.20",Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group,35 - 44 years,"1,037.20",Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group,45 - 54 years,533.4,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group,45 - 54 years,533.4,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group,55 - 64 years,385,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group,55 - 64 years,385,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group,65+ years,108.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group,65+ years,108.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group by Sex,Female & 18 - 24 years,114,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group by Sex,Female & 18 - 24 years,114,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group by Sex,Female & 25 - 34 years,655.1,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group by Sex,Female & 25 - 34 years,655.1,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group by Sex,Female & 35 - 44 years,767.3,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group by Sex,Female & 35 - 44 years,767.3,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group by Sex,Female & 45 - 54 years,363.2,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group by Sex,Female & 45 - 54 years,363.2,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group by Sex,Female & 55 - 64 years,249.9,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group by Sex,Female & 55 - 64 years,249.9,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group by Sex,Female & 65+ years,65.9,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group by Sex,Female & 65+ years,65.9,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group by Sex,Male & 18 - 24 years,163.4,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group by Sex,Male & 18 - 24 years,163.4,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group by Sex,Male & 25 - 34 years,"1,081.70",Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group by Sex,Male & 25 - 34 years,"1,081.70",Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group by Sex,Male & 35 - 44 years,"1,314.70",Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group by Sex,Male & 35 - 44 years,"1,314.70",Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group by Sex,Male & 45 - 54 years,713.3,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group by Sex,Male & 45 - 54 years,713.3,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group by Sex,Male & 55 - 64 years,531.9,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group by Sex,Male & 55 - 64 years,531.9,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group by Sex,Male & 65+ years,165.4,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Age Group by Sex,Male & 65+ years,165.4,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Region,NYS Excl NYC,570.2,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Region,NYS Excl NYC,570.2,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Region,New York City,193.2,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Region,New York City,193.2,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Sex,Female,290.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Sex,Female,290.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Sex,Male,532.5,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Sex,Male,532.5,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Total,New York State,408.3,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2020,Total,New York State,408.3,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group,18 - 24 years,114.4,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group,18 - 24 years,114.4,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group,25 - 34 years,831.6,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group,25 - 34 years,831.6,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group,35 - 44 years,"1,052.50",Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group,35 - 44 years,"1,052.50",Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group,45 - 54 years,568,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group,45 - 54 years,568,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group,55 - 64 years,392.9,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group,55 - 64 years,392.9,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group,65+ years,116.6,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group,65+ years,116.6,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group by Sex,Female & 18 - 24 years,85.9,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group by Sex,Female & 18 - 24 years,85.9,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group by Sex,Female & 25 - 34 years,625.7,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group by Sex,Female & 25 - 34 years,625.7,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group by Sex,Female & 35 - 44 years,794.3,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group by Sex,Female & 35 - 44 years,794.3,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group by Sex,Female & 45 - 54 years,392.5,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group by Sex,Female & 45 - 54 years,392.5,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group by Sex,Female & 55 - 64 years,266.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group by Sex,Female & 55 - 64 years,266.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group by Sex,Female & 65+ years,74.5,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group by Sex,Female & 65+ years,74.5,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group by Sex,Male & 18 - 24 years,142.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group by Sex,Male & 18 - 24 years,142.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group by Sex,Male & 25 - 34 years,"1,038.40",Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group by Sex,Male & 25 - 34 years,"1,038.40",Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group by Sex,Male & 35 - 44 years,"1,312.10",Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group by Sex,Male & 35 - 44 years,"1,312.10",Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group by Sex,Male & 45 - 54 years,749.3,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group by Sex,Male & 45 - 54 years,749.3,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group by Sex,Male & 55 - 64 years,526.4,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group by Sex,Male & 55 - 64 years,526.4,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group by Sex,Male & 65+ years,170.3,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Age Group by Sex,Male & 65+ years,170.3,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Region,NYS Excl NYC,574.7,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Region,NYS Excl NYC,574.7,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Region,New York City,182.4,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Region,New York City,182.4,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Sex,Female,293.7,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Sex,Female,293.7,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Sex,Male,526.5,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Sex,Male,526.5,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Total,New York State,407.5,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2021,Total,New York State,407.5,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group,18 - 24 years,107.1,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group,18 - 24 years,107.1,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group,25 - 34 years,780.3,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group,25 - 34 years,780.3,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group,35 - 44 years,"1,123.70",Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group,35 - 44 years,"1,123.70",Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group,45 - 54 years,618.6,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group,45 - 54 years,618.6,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group,55 - 64 years,412.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group,55 - 64 years,412.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group,65+ years,127.9,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group,65+ years,127.9,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group by Sex,Female & 18 - 24 years,76.4,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group by Sex,Female & 18 - 24 years,76.4,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group by Sex,Female & 25 - 34 years,570.9,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group by Sex,Female & 25 - 34 years,570.9,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group by Sex,Female & 35 - 44 years,847,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group by Sex,Female & 35 - 44 years,847,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group by Sex,Female & 45 - 54 years,429.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group by Sex,Female & 45 - 54 years,429.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group by Sex,Female & 55 - 64 years,282.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group by Sex,Female & 55 - 64 years,282.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group by Sex,Female & 65+ years,82.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group by Sex,Female & 65+ years,82.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group by Sex,Male & 18 - 24 years,137.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group by Sex,Male & 18 - 24 years,137.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group by Sex,Male & 25 - 34 years,991,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group by Sex,Male & 25 - 34 years,991,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group by Sex,Male & 35 - 44 years,"1,401.50",Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group by Sex,Male & 35 - 44 years,"1,401.50",Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group by Sex,Male & 45 - 54 years,813.9,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group by Sex,Male & 45 - 54 years,813.9,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group by Sex,Male & 55 - 64 years,550.7,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group by Sex,Male & 55 - 64 years,550.7,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group by Sex,Male & 65+ years,185.3,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Age Group by Sex,Male & 65+ years,185.3,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Region,NYS Excl NYC,592,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Region,NYS Excl NYC,592,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Region,New York City,183.3,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Region,New York City,183.3,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Sex,Female,299.6,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Sex,Female,299.6,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Sex,Male,543.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Sex,Male,543.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Total,New York State,418.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2022,Total,New York State,418.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group,18 - 24 years,106.5,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group,18 - 24 years,106.5,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group,25 - 34 years,759,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group,25 - 34 years,759,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group,35 - 44 years,"1,233.10",Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group,35 - 44 years,"1,233.10",Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group,45 - 54 years,695.3,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group,45 - 54 years,695.3,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group,55 - 64 years,446.7,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group,55 - 64 years,446.7,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group,65+ years,143.7,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group,65+ years,143.7,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group by Sex,Female & 18 - 24 years,70.7,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group by Sex,Female & 18 - 24 years,70.7,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group by Sex,Female & 25 - 34 years,519.4,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group by Sex,Female & 25 - 34 years,519.4,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group by Sex,Female & 35 - 44 years,880.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group by Sex,Female & 35 - 44 years,880.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group by Sex,Female & 45 - 54 years,466.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group by Sex,Female & 45 - 54 years,466.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group by Sex,Female & 55 - 64 years,304.2,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group by Sex,Female & 55 - 64 years,304.2,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group by Sex,Female & 65+ years,92.1,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group by Sex,Female & 65+ years,92.1,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group by Sex,Male & 18 - 24 years,142.1,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group by Sex,Male & 18 - 24 years,142.1,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group by Sex,Male & 25 - 34 years,999.6,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group by Sex,Male & 25 - 34 years,999.6,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group by Sex,Male & 35 - 44 years,"1,584.50",Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group by Sex,Male & 35 - 44 years,"1,584.50",Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group by Sex,Male & 45 - 54 years,931.6,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group by Sex,Male & 45 - 54 years,931.6,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group by Sex,Male & 55 - 64 years,597.3,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group by Sex,Male & 55 - 64 years,597.3,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group by Sex,Male & 65+ years,208.6,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Age Group by Sex,Male & 65+ years,208.6,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Region,NYS Excl NYC,634.6,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Region,NYS Excl NYC,634.6,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Region,New York City,187.5,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Region,New York City,187.5,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Sex,Female,304.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Sex,Female,304.8,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Sex,Male,593.3,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Sex,Male,593.3,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Total,New York State,446,Data Source: NYS PMP Data as of April 2024
"Patients who received at least one buprenorphine prescription for opioid use disorder, crude rate per 100,000 population",2023,Total,New York State,446,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2012,Age Group,18 - 24 years,10.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2012,Age Group,25 - 34 years,47.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2012,Age Group,35 - 44 years,52.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2012,Age Group,45 - 54 years,52.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2012,Age Group,55 - 64 years,29.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2012,Age Group,65+ years,8.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2012,Age Group by Sex,Female & 18 - 24 years,11.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2012,Age Group by Sex,Female & 25 - 34 years,56.5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2012,Age Group by Sex,Female & 35 - 44 years,55.2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2012,Age Group by Sex,Female & 45 - 54 years,51.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2012,Age Group by Sex,Female & 55 - 64 years,25.5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2012,Age Group by Sex,Female & 65+ years,8.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2012,Age Group by Sex,Male & 18 - 24 years,8.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2012,Age Group by Sex,Male & 25 - 34 years,39,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2012,Age Group by Sex,Male & 35 - 44 years,50.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2012,Age Group by Sex,Male & 45 - 54 years,53,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2012,Age Group by Sex,Male & 55 - 64 years,33,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2012,Age Group by Sex,Male & 65+ years,9.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2012,Region,NYS Excl NYC,32.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2012,Region,New York City,20.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2012,Sex,Female,27.9,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2012,Sex,Male,26,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2012,Total,New York State,27,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2013,Age Group,18 - 24 years,6.6,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2013,Age Group,25 - 34 years,34.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2013,Age Group,35 - 44 years,41.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2013,Age Group,45 - 54 years,37.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2013,Age Group,55 - 64 years,23.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2013,Age Group,65+ years,7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2013,Age Group by Sex,Female & 18 - 24 years,8.9,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2013,Age Group by Sex,Female & 25 - 34 years,42.2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2013,Age Group by Sex,Female & 35 - 44 years,46.5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2013,Age Group by Sex,Female & 45 - 54 years,39.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2013,Age Group by Sex,Female & 55 - 64 years,23.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2013,Age Group by Sex,Female & 65+ years,6.9,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2013,Age Group by Sex,Male & 18 - 24 years,4.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2013,Age Group by Sex,Male & 25 - 34 years,26.6,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2013,Age Group by Sex,Male & 35 - 44 years,36.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2013,Age Group by Sex,Male & 45 - 54 years,35.9,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2013,Age Group by Sex,Male & 55 - 64 years,23.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2013,Age Group by Sex,Male & 65+ years,7.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2013,Region,NYS Excl NYC,25.2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2013,Region,New York City,13.5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2013,Sex,Female,22.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2013,Sex,Male,18,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2013,Total,New York State,20.2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2014,Age Group,18 - 24 years,4.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2014,Age Group,25 - 34 years,19,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2014,Age Group,35 - 44 years,21,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2014,Age Group,45 - 54 years,18.5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2014,Age Group,55 - 64 years,13.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2014,Age Group,65+ years,5.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2014,Age Group by Sex,Female & 18 - 24 years,5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2014,Age Group by Sex,Female & 25 - 34 years,24.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2014,Age Group by Sex,Female & 35 - 44 years,25,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2014,Age Group by Sex,Female & 45 - 54 years,19.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2014,Age Group by Sex,Female & 55 - 64 years,13.2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2014,Age Group by Sex,Female & 65+ years,5.5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2014,Age Group by Sex,Male & 18 - 24 years,3.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2014,Age Group by Sex,Male & 25 - 34 years,13.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2014,Age Group by Sex,Male & 35 - 44 years,16.9,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2014,Age Group by Sex,Male & 45 - 54 years,17.5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2014,Age Group by Sex,Male & 55 - 64 years,13.5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2014,Age Group by Sex,Male & 65+ years,5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2014,Region,NYS Excl NYC,13.6,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2014,Region,New York City,7.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2014,Sex,Female,12.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2014,Sex,Male,9.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2014,Total,New York State,10.9,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2015,Age Group,18 - 24 years,2.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2015,Age Group,25 - 34 years,14.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2015,Age Group,35 - 44 years,16.2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2015,Age Group,45 - 54 years,14.6,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2015,Age Group,55 - 64 years,11.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2015,Age Group,65+ years,5.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2015,Age Group by Sex,Female & 18 - 24 years,3.6,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2015,Age Group by Sex,Female & 25 - 34 years,18.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2015,Age Group by Sex,Female & 35 - 44 years,19.6,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2015,Age Group by Sex,Female & 45 - 54 years,15.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2015,Age Group by Sex,Female & 55 - 64 years,11.5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2015,Age Group by Sex,Female & 65+ years,5.6,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2015,Age Group by Sex,Male & 18 - 24 years,2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2015,Age Group by Sex,Male & 25 - 34 years,10.9,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2015,Age Group by Sex,Male & 35 - 44 years,12.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2015,Age Group by Sex,Male & 45 - 54 years,13.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2015,Age Group by Sex,Male & 55 - 64 years,10.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2015,Age Group by Sex,Male & 65+ years,4.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2015,Region,NYS Excl NYC,10.6,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2015,Region,New York City,6.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2015,Sex,Female,10,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2015,Sex,Male,7.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2015,Total,New York State,8.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2016,Age Group,18 - 24 years,0.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2016,Age Group,25 - 34 years,4.5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2016,Age Group,35 - 44 years,5.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2016,Age Group,45 - 54 years,4.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2016,Age Group,55 - 64 years,4.2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2016,Age Group,65+ years,2.5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2016,Age Group by Sex,Female & 18 - 24 years,0.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2016,Age Group by Sex,Female & 25 - 34 years,5.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2016,Age Group by Sex,Female & 35 - 44 years,6.6,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2016,Age Group by Sex,Female & 45 - 54 years,4.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2016,Age Group by Sex,Female & 55 - 64 years,3.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2016,Age Group by Sex,Female & 65+ years,2.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2016,Age Group by Sex,Male & 18 - 24 years,0.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2016,Age Group by Sex,Male & 25 - 34 years,3.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2016,Age Group by Sex,Male & 35 - 44 years,4.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2016,Age Group by Sex,Male & 45 - 54 years,4.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2016,Age Group by Sex,Male & 55 - 64 years,4.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2016,Age Group by Sex,Male & 65+ years,2.6,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2016,Region,NYS Excl NYC,3.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2016,Region,New York City,2.5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2016,Sex,Female,3.2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2016,Sex,Male,2.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2016,Total,New York State,2.9,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2017,Age Group,18 - 24 years,0.5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2017,Age Group,25 - 34 years,1.6,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2017,Age Group,35 - 44 years,2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2017,Age Group,45 - 54 years,2.6,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2017,Age Group,55 - 64 years,2.5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2017,Age Group,65+ years,2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2017,Age Group by Sex,Female & 18 - 24 years,0.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2017,Age Group by Sex,Female & 25 - 34 years,2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2017,Age Group by Sex,Female & 35 - 44 years,2.6,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2017,Age Group by Sex,Female & 45 - 54 years,2.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2017,Age Group by Sex,Female & 55 - 64 years,2.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2017,Age Group by Sex,Female & 65+ years,1.6,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2017,Age Group by Sex,Male & 18 - 24 years,0.6,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2017,Age Group by Sex,Male & 25 - 34 years,1.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2017,Age Group by Sex,Male & 35 - 44 years,1.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2017,Age Group by Sex,Male & 45 - 54 years,2.5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2017,Age Group by Sex,Male & 55 - 64 years,2.6,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2017,Age Group by Sex,Male & 65+ years,2.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2017,Region,NYS Excl NYC,1.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2017,Region,New York City,1.2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2017,Sex,Female,1.6,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2017,Sex,Male,1.5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2017,Total,New York State,1.5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2018,Age Group,18 - 24 years,0.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2018,Age Group,25 - 34 years,1.6,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2018,Age Group,35 - 44 years,3.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2018,Age Group,45 - 54 years,4.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2018,Age Group,55 - 64 years,4.9,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2018,Age Group,65+ years,4.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2018,Age Group by Sex,Female & 18 - 24 years,0.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2018,Age Group by Sex,Female & 25 - 34 years,2.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2018,Age Group by Sex,Female & 35 - 44 years,3.9,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2018,Age Group by Sex,Female & 45 - 54 years,4.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2018,Age Group by Sex,Female & 55 - 64 years,4.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2018,Age Group by Sex,Female & 65+ years,4.6,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2018,Age Group by Sex,Male & 18 - 24 years,1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2018,Age Group by Sex,Male & 25 - 34 years,1.2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2018,Age Group by Sex,Male & 35 - 44 years,3.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2018,Age Group by Sex,Male & 45 - 54 years,3.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2018,Age Group by Sex,Male & 55 - 64 years,5.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2018,Age Group by Sex,Male & 65+ years,4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2018,Region,NYS Excl NYC,3.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2018,Region,New York City,1.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2018,Sex,Female,2.9,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2018,Sex,Male,2.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2018,Total,New York State,2.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2019,Age Group,18 - 24 years,0.6,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2019,Age Group,25 - 34 years,1.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2019,Age Group,35 - 44 years,2.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2019,Age Group,45 - 54 years,3.2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2019,Age Group,55 - 64 years,4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2019,Age Group,65+ years,5.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2019,Age Group by Sex,Female & 18 - 24 years,0.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2019,Age Group by Sex,Female & 25 - 34 years,1.9,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2019,Age Group by Sex,Female & 35 - 44 years,3.2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2019,Age Group by Sex,Female & 45 - 54 years,3.2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2019,Age Group by Sex,Female & 55 - 64 years,4.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2019,Age Group by Sex,Female & 65+ years,5.2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2019,Age Group by Sex,Male & 18 - 24 years,0.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2019,Age Group by Sex,Male & 25 - 34 years,0.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2019,Age Group by Sex,Male & 35 - 44 years,2.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2019,Age Group by Sex,Male & 45 - 54 years,3.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2019,Age Group by Sex,Male & 55 - 64 years,3.6,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2019,Age Group by Sex,Male & 65+ years,4.9,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2019,Region,NYS Excl NYC,2.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2019,Region,New York City,1.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2019,Sex,Female,2.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2019,Sex,Male,2.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2019,Total,New York State,2.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2020,Age Group,18 - 24 years,0.2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2020,Age Group,25 - 34 years,0.9,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2020,Age Group,35 - 44 years,2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2020,Age Group,45 - 54 years,2.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2020,Age Group,55 - 64 years,3.5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2020,Age Group,65+ years,3.5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2020,Age Group by Sex,Female & 18 - 24 years,0.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2020,Age Group by Sex,Female & 25 - 34 years,1.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2020,Age Group by Sex,Female & 35 - 44 years,2.5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2020,Age Group by Sex,Female & 45 - 54 years,3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2020,Age Group by Sex,Female & 55 - 64 years,2.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2020,Age Group by Sex,Female & 65+ years,3.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2020,Age Group by Sex,Male & 18 - 24 years,0.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2020,Age Group by Sex,Male & 25 - 34 years,0.5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2020,Age Group by Sex,Male & 35 - 44 years,1.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2020,Age Group by Sex,Male & 45 - 54 years,1.5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2020,Age Group by Sex,Male & 55 - 64 years,4.9,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2020,Age Group by Sex,Male & 65+ years,3.6,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2020,Region,NYS Excl NYC,2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2020,Region,New York City,1.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2020,Sex,Female,1.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2020,Sex,Male,1.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2020,Total,New York State,1.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2021,Age Group,18 - 24 years,0.2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2021,Age Group,25 - 34 years,1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2021,Age Group,35 - 44 years,2.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2021,Age Group,45 - 54 years,2.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2021,Age Group,55 - 64 years,3.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2021,Age Group,65+ years,3.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2021,Age Group by Sex,Female & 18 - 24 years,0.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2021,Age Group by Sex,Female & 25 - 34 years,1.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2021,Age Group by Sex,Female & 35 - 44 years,2.5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2021,Age Group by Sex,Female & 45 - 54 years,2.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2021,Age Group by Sex,Female & 55 - 64 years,3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2021,Age Group by Sex,Female & 65+ years,3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2021,Age Group by Sex,Male & 18 - 24 years,0.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2021,Age Group by Sex,Male & 25 - 34 years,0.5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2021,Age Group by Sex,Male & 35 - 44 years,1.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2021,Age Group by Sex,Male & 45 - 54 years,2.5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2021,Age Group by Sex,Male & 55 - 64 years,4.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2021,Age Group by Sex,Male & 65+ years,3.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2021,Region,NYS Excl NYC,2.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2021,Region,New York City,1.2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2021,Sex,Female,1.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2021,Sex,Male,1.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2021,Total,New York State,1.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2022,Age Group,18 - 24 years,0.2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2022,Age Group,25 - 34 years,0.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2022,Age Group,35 - 44 years,1.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2022,Age Group,45 - 54 years,2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2022,Age Group,55 - 64 years,3.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2022,Age Group,65+ years,3.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2022,Age Group by Sex,Female & 18 - 24 years,0.2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2022,Age Group by Sex,Female & 25 - 34 years,0.9,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2022,Age Group by Sex,Female & 35 - 44 years,0.9,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2022,Age Group by Sex,Female & 45 - 54 years,2.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2022,Age Group by Sex,Female & 55 - 64 years,3.2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2022,Age Group by Sex,Female & 65+ years,3.5,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2022,Age Group by Sex,Male & 18 - 24 years,0.2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2022,Age Group by Sex,Male & 25 - 34 years,0.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2022,Age Group by Sex,Male & 35 - 44 years,1.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2022,Age Group by Sex,Male & 45 - 54 years,1.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2022,Age Group by Sex,Male & 55 - 64 years,3.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2022,Age Group by Sex,Male & 65+ years,4.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2022,Region,NYS Excl NYC,2.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2022,Region,New York City,1.2,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2022,Sex,Female,1.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2022,Sex,Male,1.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2022,Total,New York State,1.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2023,Age Group,18 - 24 years,0.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2023,Age Group,25 - 34 years,1.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2023,Age Group,35 - 44 years,2.6,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2023,Age Group,45 - 54 years,2.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2023,Age Group,55 - 64 years,3.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2023,Age Group,65+ years,5.6,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2023,Age Group by Sex,Female & 18 - 24 years,0.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2023,Age Group by Sex,Female & 25 - 34 years,1.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2023,Age Group by Sex,Female & 35 - 44 years,3.3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2023,Age Group by Sex,Female & 45 - 54 years,3,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2023,Age Group by Sex,Female & 55 - 64 years,3.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2023,Age Group by Sex,Female & 65+ years,5.4,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2023,Age Group by Sex,Male & 25 - 34 years,0.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2023,Age Group by Sex,Male & 35 - 44 years,1.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2023,Age Group by Sex,Male & 45 - 54 years,1.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2023,Age Group by Sex,Male & 55 - 64 years,3.7,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2023,Age Group by Sex,Male & 65+ years,5.8,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2023,Region,NYS Excl NYC,2.9,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2023,Region,New York City,1.6,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2023,Sex,Female,2.6,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2023,Sex,Male,2.1,Data Source: NYS PMP Data as of April 2024
"Patients who were prescribed opioid analgesics from five or more prescribers and dispensed at five or more pharmacies, crude rate per 100,000 population",2023,Total,New York State,2.4,Data Source: NYS PMP Data as of April 2024
Percentage of adults who have self-reported heroin use in the past 12 months,2018,Age Group,18-24 years,0.2* (0.0 - 0.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported heroin use in the past 12 months,2018,Age Group,25-34 years,0.2* (0.1 - 0.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported heroin use in the past 12 months,2018,Age Group,35-44 years,0.4* (0.0 - 0.7),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported heroin use in the past 12 months,2018,Age Group,45-54 years,0.6* (0.1 - 1.1),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported heroin use in the past 12 months,2018,Age Group,55-64 years,0.1* (0.0 - 0.3),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported heroin use in the past 12 months,2018,Age Group,65+ years,s,Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported heroin use in the past 12 months,2018,Race and Ethnicity,Black NH,s,Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported heroin use in the past 12 months,2018,Race and Ethnicity,Hispanic,0.2* (0.0 - 0.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported heroin use in the past 12 months,2018,Race and Ethnicity,Other NH,0.4* (0.0 - 0.9),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported heroin use in the past 12 months,2018,Race and Ethnicity,White NH,0.3 (0.1 - 0.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported heroin use in the past 12 months,2018,Region,NYS Excl NYC,0.3 (0.2 - 0.5),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported heroin use in the past 12 months,2018,Region,New York City,0.2 (0.1 - 0.3),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported heroin use in the past 12 months,2018,Sex,Female,0.1* (0.0 - 0.2),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported heroin use in the past 12 months,2018,Sex,Male,0.4 (0.2 - 0.6),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported heroin use in the past 12 months,2018,Total,New York State,0.3 (0.2 - 0.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2017,Age Group,18-24 years,8.3 (5.4 - 11.3),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2017,Age Group,25-34 years,5.7 (4.1 - 7.3),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2017,Age Group,35-44 years,6.4 (4.6 - 8.2),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2017,Age Group,45-54 years,3.5 (2.4 - 4.7),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2017,Age Group,55-64 years,3.9 (2.7 - 5.0),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2017,Age Group,65+ years,4.0 (3.1 - 4.9),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2017,Race and Ethnicity,Black NH,4.5 (2.8 - 6.1),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2017,Race and Ethnicity,Hispanic,11.2 (8.9 - 13.5),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2017,Race and Ethnicity,Other NH,4.1 (2.3 - 5.8),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2017,Race and Ethnicity,White NH,3.6 (3.0 - 4.3),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2017,Region,NYS Excl NYC,4.5 (3.7 - 5.2),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2017,Region,New York City,5.8 (4.8 - 6.9),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2017,Sex,Female,4.9 (4.1 - 5.7),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2017,Sex,Male,5.2 (4.2 - 6.1),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2017,Total,New York State,5.0 (4.4 - 5.7),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2018,Age Group,18-24 years,4.1 (2.8 - 5.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2018,Age Group,25-34 years,4.6 (3.4 - 5.8),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2018,Age Group,35-44 years,3.5 (2.6 - 4.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2018,Age Group,45-54 years,4.3 (3.2 - 5.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2018,Age Group,55-64 years,3.4 (2.4 - 4.3),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2018,Age Group,65+ years,3.9 (3.0 - 4.8),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2018,Race and Ethnicity,Black NH,4.0 (2.8 - 5.3),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2018,Race and Ethnicity,Hispanic,8.1 (6.5 - 9.7),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2018,Race and Ethnicity,Other NH,3.5 (2.3 - 4.6),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2018,Race and Ethnicity,White NH,2.8 (2.4 - 3.2),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2018,Region,NYS Excl NYC,3.2 (2.8 - 3.7),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2018,Region,New York City,5.0 (4.2 - 5.8),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2018,Sex,Female,3.7 (3.1 - 4.3),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2018,Sex,Male,4.2 (3.6 - 4.9),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2018,Total,New York State,4.0 (3.5 - 4.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2019,Age Group,18-24 years,8.0 (5.1 - 10.9),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2019,Age Group,25-34 years,8.5 (6.4 - 10.7),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2019,Age Group,35-44 years,5.4 (3.6 - 7.1),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2019,Age Group,45-54 years,4.5 (3.2 - 5.8),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2019,Age Group,55-64 years,5.8 (4.0 - 7.6),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2019,Age Group,65+ years,4.5 (3.5 - 5.5),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2019,Race and Ethnicity,Black NH,7.0 (4.8 - 9.3),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2019,Race and Ethnicity,Hispanic,12.9 (10.5 - 15.3),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2019,Race and Ethnicity,Other NH,4.9 (2.3 - 7.5),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2019,Race and Ethnicity,White NH,3.7 (3.0 - 4.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2019,Region,NYS Excl NYC,4.4 (3.7 - 5.1),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2019,Region,New York City,8.1 (6.7 - 9.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2019,Sex,Female,5.9 (4.9 - 6.9),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2019,Sex,Male,5.9 (4.9 - 6.9),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2019,Total,New York State,5.9 (5.2 - 6.6),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2020,Age Group,18-24 years,3.2 (1.7 - 4.7),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2020,Age Group,25-34 years,3.5 (2.1 - 4.8),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2020,Age Group,35-44 years,3.9 (2.5 - 5.2),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2020,Age Group,45-54 years,3.7 (2.4 - 4.9),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2020,Age Group,55-64 years,3.6 (2.5 - 4.6),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2020,Age Group,65+ years,3.8 (2.8 - 4.7),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2020,Race and Ethnicity,Black NH,5.1 (3.4 - 6.9),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2020,Race and Ethnicity,Hispanic,6.1 (4.6 - 7.6),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2020,Race and Ethnicity,Other NH,4.8 (2.8 - 6.8),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2020,Race and Ethnicity,White NH,2.3 (1.8 - 2.7),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2020,Region,NYS Excl NYC,2.7 (2.1 - 3.2),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2020,Region,New York City,5.0 (4.1 - 6.0),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2020,Sex,Female,3.6 (2.9 - 4.3),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2020,Sex,Male,3.6 (2.9 - 4.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2020,Total,New York State,3.6 (3.1 - 4.1),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2021,Age Group,18-24 years,3.4* (0.9 - 5.9),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2021,Age Group,25-34 years,5.2 (3.0 - 7.3),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2021,Age Group,35-44 years,2.9 (1.6 - 4.2),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2021,Age Group,45-54 years,4.5 (2.9 - 6.2),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2021,Age Group,55-64 years,4.0 (2.5 - 5.6),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2021,Age Group,65+ years,3.6 (2.4 - 4.8),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2021,Race and Ethnicity,Black NH,3.3 (2.0 - 4.7),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2021,Race and Ethnicity,Hispanic,9.3 (6.5 - 12.1),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2021,Race and Ethnicity,Other NH,4.2 (2.2 - 6.2),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2021,Race and Ethnicity,White NH,2.4 (1.8 - 3.0),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2021,Region,NYS Excl NYC,3.5 (2.7 - 4.2),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2021,Region,New York City,4.9 (3.5 - 6.2),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2021,Sex,Female,2.8 (2.1 - 3.6),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2021,Sex,Male,5.2 (4.0 - 6.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2021,Total,New York State,3.9 (3.3 - 4.6),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2022,Age Group,18-24 years,5.6* (1.9 - 9.2),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2022,Age Group,25-34 years,5.6 (3.0 - 8.1),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2022,Age Group,35-44 years,4.2 (2.4 - 6.0),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2022,Age Group,45-54 years,3.4 (1.8 - 5.1),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2022,Age Group,55-64 years,4.5 (2.5 - 6.5),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2022,Age Group,65+ years,3.7 (2.2 - 5.2),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2022,Race and Ethnicity,Black NH,4.2 (1.8 - 6.5),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2022,Race and Ethnicity,Hispanic,9.7 (6.9 - 12.5),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2022,Race and Ethnicity,Other NH,5.5 (2.8 - 8.1),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2022,Race and Ethnicity,White NH,2.5 (1.6 - 3.5),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2022,Region,NYS Excl NYC,2.8 (1.9 - 3.7),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2022,Region,New York City,7.0 (5.3 - 8.7),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2022,Sex,Female,4.3 (3.1 - 5.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2022,Sex,Male,4.6 (3.2 - 5.9),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2022,Total,New York State,4.4 (3.5 - 5.3),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2023,Age Group,18-24 years,4.3 (2.3 - 6.3),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2023,Age Group,25-34 years,4.6 (2.7 - 6.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2023,Age Group,35-44 years,5.5 (3.5 - 7.5),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2023,Age Group,45-54 years,8.0 (5.3 - 10.8),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2023,Age Group,55-64 years,7.7 (5.0 - 10.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2023,Age Group,65+ years,6.9 (4.9 - 8.9),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2023,Race and Ethnicity,Black NH,7.8 (4.7 - 10.9),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2023,Race and Ethnicity,Hispanic,15.0 (12.0 - 18.0),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2023,Race and Ethnicity,Other NH,7.8 (4.6 - 11.0),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2023,Race and Ethnicity,White NH,2.4 (1.8 - 3.1),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2023,Region,NYS Excl NYC,4.4 (3.3 - 5.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2023,Region,New York City,9.0 (7.3 - 10.6),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2023,Sex,Female,7.2 (5.8 - 8.6),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2023,Sex,Male,5.3 (4.1 - 6.4),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of adults who have self-reported prescription pain medication misuse in the past 12 months,2023,Total,New York State,6.3 (5.3 - 7.2),Data Source: The Behavioral Risk Factor Surveillance System as of September 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group,18 - 24 years,9.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group,18 - 24 years,9.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group,25 - 34 years,15.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group,25 - 34 years,15.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group,35 - 44 years,24.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group,35 - 44 years,24.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group,45 - 54 years,34,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group,45 - 54 years,34,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group,55 - 64 years,41.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group,55 - 64 years,41.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group,65+ years,51.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group,65+ years,51.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group by Sex,Female & 18 - 24 years,9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group by Sex,Female & 18 - 24 years,9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group by Sex,Female & 25 - 34 years,14.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group by Sex,Female & 25 - 34 years,14.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group by Sex,Female & 35 - 44 years,23.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group by Sex,Female & 35 - 44 years,23.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group by Sex,Female & 45 - 54 years,33.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group by Sex,Female & 45 - 54 years,33.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group by Sex,Female & 55 - 64 years,42,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group by Sex,Female & 55 - 64 years,42,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group by Sex,Female & 65+ years,54,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group by Sex,Female & 65+ years,54,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group by Sex,Male & 18 - 24 years,10.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group by Sex,Male & 18 - 24 years,10.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group by Sex,Male & 25 - 34 years,17.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group by Sex,Male & 25 - 34 years,17.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group by Sex,Male & 35 - 44 years,26.1,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group by Sex,Male & 35 - 44 years,26.1,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group by Sex,Male & 45 - 54 years,34.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group by Sex,Male & 45 - 54 years,34.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group by Sex,Male & 55 - 64 years,40.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group by Sex,Male & 55 - 64 years,40.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group by Sex,Male & 65+ years,47.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Age Group by Sex,Male & 65+ years,47.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Region,NYS Excl NYC,33.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Region,NYS Excl NYC,33.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Region,New York City,35.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Region,New York City,35.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Sex,Female,34.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Sex,Female,34.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Sex,Male,34.1,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Sex,Male,34.1,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Total,New York State,34.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2016,Total,New York State,34.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group,18 - 24 years,6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group,18 - 24 years,6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group,25 - 34 years,10.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group,25 - 34 years,10.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group,35 - 44 years,17.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group,35 - 44 years,17.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group,45 - 54 years,26.2,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group,45 - 54 years,26.2,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group,55 - 64 years,33.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group,55 - 64 years,33.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group,65+ years,46.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group,65+ years,46.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group by Sex,Female & 18 - 24 years,5.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group by Sex,Female & 18 - 24 years,5.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group by Sex,Female & 25 - 34 years,9.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group by Sex,Female & 25 - 34 years,9.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group by Sex,Female & 35 - 44 years,16.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group by Sex,Female & 35 - 44 years,16.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group by Sex,Female & 45 - 54 years,25.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group by Sex,Female & 45 - 54 years,25.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group by Sex,Female & 55 - 64 years,33.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group by Sex,Female & 55 - 64 years,33.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group by Sex,Female & 65+ years,49.2,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group by Sex,Female & 65+ years,49.2,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group by Sex,Male & 18 - 24 years,6.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group by Sex,Male & 18 - 24 years,6.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group by Sex,Male & 25 - 34 years,12.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group by Sex,Male & 25 - 34 years,12.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group by Sex,Male & 35 - 44 years,19.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group by Sex,Male & 35 - 44 years,19.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group by Sex,Male & 45 - 54 years,26.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group by Sex,Male & 45 - 54 years,26.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group by Sex,Male & 55 - 64 years,32.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group by Sex,Male & 55 - 64 years,32.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group by Sex,Male & 65+ years,42.1,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Age Group by Sex,Male & 65+ years,42.1,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Region,NYS Excl NYC,28.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Region,NYS Excl NYC,28.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Region,New York City,28.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Region,New York City,28.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Sex,Female,29,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Sex,Female,29,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Sex,Male,28.1,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Sex,Male,28.1,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Total,New York State,28.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2017,Total,New York State,28.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group,18 - 24 years,3.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group,18 - 24 years,3.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group,25 - 34 years,7.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group,25 - 34 years,7.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group,35 - 44 years,13.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group,35 - 44 years,13.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group,45 - 54 years,20.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group,45 - 54 years,20.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group,55 - 64 years,27.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group,55 - 64 years,27.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group,65+ years,41.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group,65+ years,41.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group by Sex,Female & 18 - 24 years,3.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group by Sex,Female & 18 - 24 years,3.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group by Sex,Female & 25 - 34 years,6.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group by Sex,Female & 25 - 34 years,6.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group by Sex,Female & 35 - 44 years,12.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group by Sex,Female & 35 - 44 years,12.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group by Sex,Female & 45 - 54 years,20.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group by Sex,Female & 45 - 54 years,20.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group by Sex,Female & 55 - 64 years,28,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group by Sex,Female & 55 - 64 years,28,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group by Sex,Female & 65+ years,44.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group by Sex,Female & 65+ years,44.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group by Sex,Male & 18 - 24 years,4.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group by Sex,Male & 18 - 24 years,4.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group by Sex,Male & 25 - 34 years,9.1,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group by Sex,Male & 25 - 34 years,9.1,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group by Sex,Male & 35 - 44 years,14.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group by Sex,Male & 35 - 44 years,14.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group by Sex,Male & 45 - 54 years,20.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group by Sex,Male & 45 - 54 years,20.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group by Sex,Male & 55 - 64 years,26.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group by Sex,Male & 55 - 64 years,26.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group by Sex,Male & 65+ years,37.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Age Group by Sex,Male & 65+ years,37.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Region,NYS Excl NYC,24.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Region,NYS Excl NYC,24.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Region,New York City,24.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Region,New York City,24.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Sex,Female,25,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Sex,Female,25,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Sex,Male,23.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Sex,Male,23.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Total,New York State,24.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2018,Total,New York State,24.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group,18 - 24 years,2.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group,18 - 24 years,2.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group,25 - 34 years,4.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group,25 - 34 years,4.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group,35 - 44 years,9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group,35 - 44 years,9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group,45 - 54 years,14.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group,45 - 54 years,14.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group,55 - 64 years,19.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group,55 - 64 years,19.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group,65+ years,28.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group,65+ years,28.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group by Sex,Female & 18 - 24 years,2.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group by Sex,Female & 18 - 24 years,2.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group by Sex,Female & 25 - 34 years,4.2,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group by Sex,Female & 25 - 34 years,4.2,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group by Sex,Female & 35 - 44 years,8.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group by Sex,Female & 35 - 44 years,8.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group by Sex,Female & 45 - 54 years,14.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group by Sex,Female & 45 - 54 years,14.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group by Sex,Female & 55 - 64 years,19.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group by Sex,Female & 55 - 64 years,19.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group by Sex,Female & 65+ years,30,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group by Sex,Female & 65+ years,30,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group by Sex,Male & 18 - 24 years,2.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group by Sex,Male & 18 - 24 years,2.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group by Sex,Male & 25 - 34 years,5.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group by Sex,Male & 25 - 34 years,5.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group by Sex,Male & 35 - 44 years,10,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group by Sex,Male & 35 - 44 years,10,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group by Sex,Male & 45 - 54 years,14.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group by Sex,Male & 45 - 54 years,14.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group by Sex,Male & 55 - 64 years,18.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group by Sex,Male & 55 - 64 years,18.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group by Sex,Male & 65+ years,26,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Age Group by Sex,Male & 65+ years,26,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Region,NYS Excl NYC,17.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Region,NYS Excl NYC,17.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Region,New York City,16.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Region,New York City,16.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Sex,Female,17.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Sex,Female,17.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Sex,Male,16.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Sex,Male,16.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Total,New York State,17.2,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2019,Total,New York State,17.2,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group,18 - 24 years,1.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group,18 - 24 years,1.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group,25 - 34 years,4.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group,25 - 34 years,4.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group,35 - 44 years,8.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group,35 - 44 years,8.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group,45 - 54 years,13.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group,45 - 54 years,13.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group,55 - 64 years,18.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group,55 - 64 years,18.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group,65+ years,28.2,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group,65+ years,28.2,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group by Sex,Female & 18 - 24 years,1.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group by Sex,Female & 18 - 24 years,1.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group by Sex,Female & 25 - 34 years,3.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group by Sex,Female & 25 - 34 years,3.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group by Sex,Female & 35 - 44 years,7.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group by Sex,Female & 35 - 44 years,7.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group by Sex,Female & 45 - 54 years,13.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group by Sex,Female & 45 - 54 years,13.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group by Sex,Female & 55 - 64 years,19,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group by Sex,Female & 55 - 64 years,19,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group by Sex,Female & 65+ years,30,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group by Sex,Female & 65+ years,30,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group by Sex,Male & 18 - 24 years,2.1,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group by Sex,Male & 18 - 24 years,2.1,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group by Sex,Male & 25 - 34 years,5.2,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group by Sex,Male & 25 - 34 years,5.2,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group by Sex,Male & 35 - 44 years,9.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group by Sex,Male & 35 - 44 years,9.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group by Sex,Male & 45 - 54 years,13.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group by Sex,Male & 45 - 54 years,13.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group by Sex,Male & 55 - 64 years,18,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group by Sex,Male & 55 - 64 years,18,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group by Sex,Male & 65+ years,25.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Age Group by Sex,Male & 65+ years,25.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Region,NYS Excl NYC,16.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Region,NYS Excl NYC,16.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Region,New York City,16.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Region,New York City,16.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Sex,Female,17,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Sex,Female,17,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Sex,Male,16.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Sex,Male,16.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Total,New York State,16.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2020,Total,New York State,16.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group,18 - 24 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group,18 - 24 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group,25 - 34 years,3.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group,25 - 34 years,3.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group,35 - 44 years,6.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group,35 - 44 years,6.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group,45 - 54 years,11.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group,45 - 54 years,11.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group,55 - 64 years,15.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group,55 - 64 years,15.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group,65+ years,25.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group,65+ years,25.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group by Sex,Female & 18 - 24 years,1.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group by Sex,Female & 18 - 24 years,1.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group by Sex,Female & 25 - 34 years,3.1,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group by Sex,Female & 25 - 34 years,3.1,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group by Sex,Female & 35 - 44 years,6.1,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group by Sex,Female & 35 - 44 years,6.1,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group by Sex,Female & 45 - 54 years,11,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group by Sex,Female & 45 - 54 years,11,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group by Sex,Female & 55 - 64 years,16,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group by Sex,Female & 55 - 64 years,16,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group by Sex,Female & 65+ years,26.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group by Sex,Female & 65+ years,26.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group by Sex,Male & 18 - 24 years,1.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group by Sex,Male & 18 - 24 years,1.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group by Sex,Male & 25 - 34 years,4.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group by Sex,Male & 25 - 34 years,4.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group by Sex,Male & 35 - 44 years,7.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group by Sex,Male & 35 - 44 years,7.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group by Sex,Male & 45 - 54 years,11.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group by Sex,Male & 45 - 54 years,11.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group by Sex,Male & 55 - 64 years,15.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group by Sex,Male & 55 - 64 years,15.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group by Sex,Male & 65+ years,23.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Age Group by Sex,Male & 65+ years,23.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Region,NYS Excl NYC,14.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Region,NYS Excl NYC,14.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Region,New York City,13.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Region,New York City,13.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Sex,Female,14.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Sex,Female,14.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Sex,Male,14.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Sex,Male,14.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Total,New York State,14.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2021,Total,New York State,14.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group,18 - 24 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group,18 - 24 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group,25 - 34 years,3.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group,25 - 34 years,3.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group,35 - 44 years,6.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group,35 - 44 years,6.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group,45 - 54 years,11,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group,45 - 54 years,11,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group,55 - 64 years,15.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group,55 - 64 years,15.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group,65+ years,24.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group,65+ years,24.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group by Sex,Female & 18 - 24 years,1.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group by Sex,Female & 18 - 24 years,1.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group by Sex,Female & 25 - 34 years,3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group by Sex,Female & 25 - 34 years,3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group by Sex,Female & 35 - 44 years,6.1,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group by Sex,Female & 35 - 44 years,6.1,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group by Sex,Female & 45 - 54 years,10.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group by Sex,Female & 45 - 54 years,10.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group by Sex,Female & 55 - 64 years,16,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group by Sex,Female & 55 - 64 years,16,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group by Sex,Female & 65+ years,26.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group by Sex,Female & 65+ years,26.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group by Sex,Male & 18 - 24 years,1.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group by Sex,Male & 18 - 24 years,1.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group by Sex,Male & 25 - 34 years,4.1,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group by Sex,Male & 25 - 34 years,4.1,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group by Sex,Male & 35 - 44 years,7.2,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group by Sex,Male & 35 - 44 years,7.2,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group by Sex,Male & 45 - 54 years,11.1,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group by Sex,Male & 45 - 54 years,11.1,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group by Sex,Male & 55 - 64 years,15.2,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group by Sex,Male & 55 - 64 years,15.2,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group by Sex,Male & 65+ years,22.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Age Group by Sex,Male & 65+ years,22.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Region,NYS Excl NYC,15.1,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Region,NYS Excl NYC,15.1,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Region,New York City,13.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Region,New York City,13.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Sex,Female,14.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Sex,Female,14.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Sex,Male,14.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Sex,Male,14.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Total,New York State,14.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2022,Total,New York State,14.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group,18 - 24 years,1.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group,18 - 24 years,1.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group,25 - 34 years,3.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group,25 - 34 years,3.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group,35 - 44 years,7.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group,35 - 44 years,7.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group,45 - 54 years,11.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group,45 - 54 years,11.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group,55 - 64 years,16.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group,55 - 64 years,16.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group,65+ years,24.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group,65+ years,24.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group by Sex,Female & 18 - 24 years,1.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group by Sex,Female & 18 - 24 years,1.6,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group by Sex,Female & 25 - 34 years,3.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group by Sex,Female & 25 - 34 years,3.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group by Sex,Female & 35 - 44 years,6.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group by Sex,Female & 35 - 44 years,6.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group by Sex,Female & 45 - 54 years,11.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group by Sex,Female & 45 - 54 years,11.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group by Sex,Female & 55 - 64 years,16.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group by Sex,Female & 55 - 64 years,16.9,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group by Sex,Female & 65+ years,25.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group by Sex,Female & 65+ years,25.8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group by Sex,Male & 18 - 24 years,2,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group by Sex,Male & 18 - 24 years,2,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group by Sex,Male & 25 - 34 years,4.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group by Sex,Male & 25 - 34 years,4.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group by Sex,Male & 35 - 44 years,8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group by Sex,Male & 35 - 44 years,8,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group by Sex,Male & 45 - 54 years,11.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group by Sex,Male & 45 - 54 years,11.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group by Sex,Male & 55 - 64 years,16,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group by Sex,Male & 55 - 64 years,16,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group by Sex,Male & 65+ years,22.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Age Group by Sex,Male & 65+ years,22.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Region,NYS Excl NYC,15.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Region,NYS Excl NYC,15.5,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Region,New York City,14.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Region,New York City,14.3,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Sex,Female,15.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Sex,Female,15.4,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Sex,Male,14.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Sex,Male,14.7,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Total,New York State,15.1,Data Source: NYS PMP Data as of April 2024
Percentage of episodes when patients were opioid naïve and received an opioid prescription of more than seven days,2023,Total,New York State,15.1,Data Source: NYS PMP Data as of April 2024
Percentage of high school students reporting ever injecting an illegal drug,2003,Education,10th grade,1.4 (0.8 - 2.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2003,Education,11th grade,1.0 (0.3 - 1.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2003,Education,12th grade,1.5 (0.7 - 2.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2003,Education,9th grade,1.5 (0.9 - 2.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2003,Race and Ethnicity,Black NH,0.9 (0.3 - 1.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2003,Race and Ethnicity,Hispanic,1.1 (0.5 - 1.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2003,Race and Ethnicity,Other NH,2.1 (1.0 - 3.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2003,Race and Ethnicity,White NH,1.6 (1.0 - 2.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2003,Sex,Female,0.8 (0.4 - 1.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2003,Sex,Male,2.1 (1.4 - 2.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2003,Total,New York State,1.4 (1.1 - 1.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2005,Education,10th grade,1.8 (1.0 - 2.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2005,Education,11th grade,1.3 (0.3 - 2.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2005,Education,12th grade,1.0 (0.1 - 1.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2005,Education,9th grade,2.0 (1.0 - 3.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2005,Race and Ethnicity,Black NH,2.0 (0.9 - 3.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2005,Race and Ethnicity,Hispanic,2.3 (1.3 - 3.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2005,Race and Ethnicity,Other NH,3.6 (1.1 - 6.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2005,Race and Ethnicity,White NH,1.0 (0.5 - 1.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2005,Sex,Female,0.7 (0.4 - 1.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2005,Sex,Male,2.5 (1.8 - 3.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2005,Total,New York State,1.6 (1.2 - 2.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2007,Education,10th grade,2.9 (1.8 - 4.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2007,Education,11th grade,2.8 (1.4 - 4.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2007,Education,12th grade,1.4 (0.6 - 2.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2007,Education,9th grade,3.1 (1.5 - 4.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2007,Race and Ethnicity,Black NH,2.5 (1.0 - 4.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2007,Race and Ethnicity,Hispanic,6.3 (3.1 - 9.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2007,Race and Ethnicity,Other NH,4.1 (1.4 - 6.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2007,Race and Ethnicity,White NH,1.8 (1.3 - 2.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2007,Sex,Female,1.6 (1.0 - 2.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2007,Sex,Male,4.0 (2.6 - 5.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2007,Total,New York State,2.9 (2.0 - 3.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2009,Education,10th grade,3.7 (2.2 - 5.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2009,Education,11th grade,2.9 (1.2 - 4.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2009,Education,12th grade,4.0 (2.1 - 5.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2009,Education,9th grade,4.7 (2.8 - 6.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2009,Race and Ethnicity,Black NH,3.8 (1.2 - 6.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2009,Race and Ethnicity,Hispanic,8.3 (5.2 - 11.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2009,Race and Ethnicity,Other NH,2.5 (1.1 - 3.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2009,Race and Ethnicity,White NH,2.5 (1.5 - 3.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2009,Sex,Female,2.4 (1.3 - 3.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2009,Sex,Male,5.0 (3.3 - 6.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2009,Total,New York State,4.0 (2.8 - 5.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2011,Education,10th grade,1.6 (1.0 - 2.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2011,Education,11th grade,2.1 (1.1 - 3.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2011,Education,12th grade,4.6 (2.9 - 6.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2011,Education,9th grade,4.0 (2.3 - 5.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2011,Race and Ethnicity,Black NH,3.1 (1.3 - 4.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2011,Race and Ethnicity,Hispanic,6.6 (4.3 - 8.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2011,Race and Ethnicity,Other NH,4.9 (2.0 - 7.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2011,Race and Ethnicity,White NH,2.4 (1.5 - 3.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2011,Sex,Female,2.1 (1.3 - 2.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2011,Sex,Male,4.8 (3.5 - 6.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2011,Total,New York State,3.5 (2.7 - 4.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2013,Education,10th grade,2.8 (1.7 - 3.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2013,Education,11th grade,2.6 (1.4 - 3.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2013,Education,12th grade,4.1 (2.3 - 5.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2013,Education,9th grade,3.5 (1.1 - 5.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2013,Race and Ethnicity,Black NH,2.8 (1.2 - 4.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2013,Race and Ethnicity,Hispanic,5.3 (2.8 - 7.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2013,Race and Ethnicity,Other NH,3.3 (1.6 - 5.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2013,Race and Ethnicity,White NH,2.9 (1.7 - 4.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2013,Sex,Female,2.2 (1.3 - 3.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2013,Sex,Male,4.5 (3.0 - 6.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2013,Total,New York State,3.4 (2.5 - 4.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2015,Education,10th grade,3.1 (1.5 - 4.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2015,Education,11th grade,3.8 (2.0 - 5.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2015,Education,12th grade,3.5 (1.1 - 5.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2015,Education,9th grade,2.5 (1.5 - 3.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2015,Race and Ethnicity,Black NH,3.8 (1.5 - 6.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2015,Race and Ethnicity,Hispanic,3.5 (2.2 - 4.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2015,Race and Ethnicity,Other NH,3.5 (1.8 - 5.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2015,Race and Ethnicity,White NH,2.7 (1.4 - 3.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2015,Sex,Female,2.2 (1.5 - 3.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2015,Sex,Male,4.4 (2.9 - 5.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2015,Total,New York State,3.4 (2.5 - 4.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2017,Education,10th grade,2.2 (1.3 - 3.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2017,Education,11th grade,2.9 (1.5 - 4.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2017,Education,12th grade,3.9 (2.2 - 5.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2017,Education,9th grade,3.3 (0.8 - 5.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2017,Race and Ethnicity,Black NH,4.0 (1.5 - 6.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2017,Race and Ethnicity,Hispanic,4.6 (2.6 - 6.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2017,Race and Ethnicity,Other NH,3.4 (1.4 - 5.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2017,Race and Ethnicity,White NH,1.6 (0.8 - 2.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2017,Sex,Female,1.7 (0.9 - 2.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2017,Sex,Male,4.3 (2.5 - 6.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2017,Total,New York State,3.4 (2.2 - 4.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2019,Education,10th grade,2.4 (1.4 - 3.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2019,Education,11th grade,3.1 (2.0 - 4.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2019,Education,12th grade,4.9 (2.8 - 6.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2019,Education,9th grade,3.7 (2.2 - 5.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2019,Race and Ethnicity,Black NH,3.3 (2.1 - 4.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2019,Race and Ethnicity,Hispanic,5.0 (3.5 - 6.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2019,Race and Ethnicity,Other NH,3.1 (1.7 - 4.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2019,Race and Ethnicity,White NH,2.6 (1.5 - 3.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2019,Sex,Female,2.6 (1.8 - 3.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2019,Sex,Male,4.4 (3.2 - 5.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2019,Total,New York State,3.8 (2.9 - 4.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2021,Education,10th grade,2.5 (0.0 - 5.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2021,Education,11th grade,2.5 (1.0 - 4.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2021,Education,12th grade,4.6 (1.1 - 8.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2021,Education,9th grade,2.4 (0.6 - 4.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2021,Race and Ethnicity,Black NH,4.2 (1.5 - 6.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2021,Race and Ethnicity,Hispanic,3.2 (0.9 - 5.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2021,Race and Ethnicity,Other NH,2.8 (1.3 - 4.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2021,Race and Ethnicity,White NH,1.8 (0.5 - 3.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2021,Sex,Female,0.8 (0.2 - 1.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2021,Sex,Male,4.4 (2.3 - 6.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever injecting an illegal drug,2021,Total,New York State,3.1 (1.8 - 4.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2003,Education,10th grade,5.8 (4.2 - 7.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2003,Education,11th grade,6.3 (3.9 - 8.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2003,Education,12th grade,8.5 (6.3 - 10.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2003,Education,9th grade,4.5 (3.3 - 5.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2003,Race and Ethnicity,Black NH,2.0 (0.9 - 3.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2003,Race and Ethnicity,Hispanic,4.0 (2.8 - 5.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2003,Race and Ethnicity,Other NH,6.3 (4.5 - 8.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2003,Race and Ethnicity,White NH,8.0 (6.7 - 9.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2003,Sex,Female,5.7 (4.4 - 6.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2003,Sex,Male,6.6 (5.3 - 7.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2003,Total,New York State,6.1 (5.2 - 7.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2005,Education,10th grade,4.4 (2.8 - 6.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2005,Education,11th grade,5.9 (3.3 - 8.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2005,Education,12th grade,6.4 (4.0 - 8.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2005,Education,9th grade,4.2 (2.8 - 5.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2005,Race and Ethnicity,Black NH,2.1 (0.8 - 3.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2005,Race and Ethnicity,Hispanic,4.8 (3.4 - 6.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2005,Race and Ethnicity,Other NH,3.6 (2.3 - 5.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2005,Race and Ethnicity,White NH,6.5 (5.0 - 8.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2005,Sex,Female,3.9 (2.8 - 5.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2005,Sex,Male,6.2 (4.8 - 7.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2005,Total,New York State,5.1 (4.1 - 6.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2007,Education,10th grade,5.4 (4.2 - 6.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2007,Education,11th grade,7.5 (5.3 - 9.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2007,Education,12th grade,10.0 (6.8 - 13.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2007,Education,9th grade,4.6 (2.6 - 6.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2007,Race and Ethnicity,Black NH,4.3 (2.5 - 6.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2007,Race and Ethnicity,Hispanic,9.9 (5.3 - 14.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2007,Race and Ethnicity,Other NH,7.3 (3.8 - 10.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2007,Race and Ethnicity,White NH,6.8 (5.3 - 8.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2007,Sex,Female,5.1 (3.8 - 6.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2007,Sex,Male,8.8 (6.8 - 10.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2007,Total,New York State,7.0 (5.5 - 8.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2009,Education,10th grade,6.5 (4.3 - 8.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2009,Education,11th grade,8.4 (4.4 - 12.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2009,Education,12th grade,6.6 (3.8 - 9.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2009,Education,9th grade,6.7 (4.2 - 9.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2009,Race and Ethnicity,Black NH,6.5 (2.7 - 10.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2009,Race and Ethnicity,Hispanic,10.9 (7.1 - 14.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2009,Race and Ethnicity,Other NH,4.3 (2.4 - 6.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2009,Race and Ethnicity,White NH,6.3 (3.8 - 8.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2009,Sex,Female,5.4 (3.6 - 7.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2009,Sex,Male,8.4 (5.5 - 11.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2009,Total,New York State,7.2 (5.3 - 9.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2011,Education,10th grade,4.1 (2.8 - 5.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2011,Education,11th grade,6.4 (4.5 - 8.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2011,Education,12th grade,7.8 (5.4 - 10.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2011,Education,9th grade,5.0 (3.5 - 6.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2011,Race and Ethnicity,Black NH,5.0 (2.1 - 8.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2011,Race and Ethnicity,Hispanic,10.1 (7.6 - 12.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2011,Race and Ethnicity,Other NH,5.4 (2.2 - 8.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2011,Race and Ethnicity,White NH,5.4 (4.2 - 6.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2011,Sex,Female,5.1 (3.8 - 6.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2011,Sex,Male,7.2 (5.6 - 8.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2011,Total,New York State,6.2 (5.2 - 7.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2013,Education,10th grade,4.5 (2.6 - 6.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2013,Education,11th grade,4.4 (2.8 - 5.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2013,Education,12th grade,7.1 (5.0 - 9.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2013,Education,9th grade,4.7 (2.0 - 7.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2013,Race and Ethnicity,Black NH,3.9 (1.7 - 6.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2013,Race and Ethnicity,Hispanic,7.7 (5.2 - 10.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2013,Race and Ethnicity,Other NH,4.4 (2.3 - 6.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2013,Race and Ethnicity,White NH,4.9 (3.2 - 6.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2013,Sex,Female,3.7 (2.3 - 5.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2013,Sex,Male,6.8 (5.1 - 8.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2013,Total,New York State,5.3 (4.1 - 6.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2015,Education,10th grade,6.7 (4.3 - 9.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2015,Education,11th grade,7.6 (5.0 - 10.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2015,Education,12th grade,10.4 (7.3 - 13.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2015,Education,9th grade,4.9 (3.5 - 6.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2015,Race and Ethnicity,Black NH,4.6 (2.0 - 7.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2015,Race and Ethnicity,Hispanic,6.7 (4.7 - 8.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2015,Race and Ethnicity,Other NH,5.9 (3.5 - 8.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2015,Race and Ethnicity,White NH,7.8 (5.3 - 10.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2015,Sex,Female,5.4 (3.6 - 7.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2015,Sex,Male,9.2 (7.2 - 11.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2015,Total,New York State,7.6 (5.9 - 9.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2017,Education,10th grade,2.6 (1.7 - 3.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2017,Education,11th grade,5.9 (3.6 - 8.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2017,Education,12th grade,5.7 (3.7 - 7.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2017,Education,9th grade,4.1 (1.2 - 6.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2017,Race and Ethnicity,Black NH,4.1 (2.5 - 5.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2017,Race and Ethnicity,Hispanic,6.8 (4.3 - 9.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2017,Race and Ethnicity,Other NH,3.8 (1.8 - 5.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2017,Race and Ethnicity,White NH,3.3 (2.0 - 4.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2017,Sex,Female,3.2 (2.2 - 4.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2017,Sex,Male,5.8 (4.2 - 7.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2017,Total,New York State,4.9 (3.7 - 6.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2019,Education,10th grade,4.2 (2.2 - 6.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2019,Education,11th grade,6.3 (4.2 - 8.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2019,Education,12th grade,7.3 (3.9 - 10.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2019,Education,9th grade,5.8 (3.8 - 7.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2019,Race and Ethnicity,Black NH,4.4 (2.9 - 6.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2019,Race and Ethnicity,Hispanic,7.0 (4.8 - 9.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2019,Race and Ethnicity,Other NH,3.7 (2.3 - 5.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2019,Race and Ethnicity,White NH,6.0 (3.9 - 8.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2019,Sex,Female,4.3 (2.9 - 5.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2019,Sex,Male,7.5 (5.6 - 9.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2019,Total,New York State,6.3 (5.0 - 7.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2021,Education,10th grade,2.5 (1.1 - 3.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2021,Education,11th grade,1.6 (0.3 - 2.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2021,Education,12th grade,6.4 (2.0 - 10.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2021,Education,9th grade,2.8 (1.6 - 4.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2021,Race and Ethnicity,Black NH,5.3 (1.1 - 9.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2021,Race and Ethnicity,Hispanic,3.9 (1.3 - 6.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2021,Race and Ethnicity,Other NH,2.1 (0.6 - 3.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2021,Race and Ethnicity,White NH,2.0 (0.6 - 3.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2021,Sex,Female,1.5 (0.6 - 2.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2021,Sex,Male,4.2 (2.1 - 6.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using cocaine,2021,Total,New York State,3.6 (2.3 - 4.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2003,Education,10th grade,1.7 (1.0 - 2.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2003,Education,11th grade,0.8 (0.2 - 1.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2003,Education,12th grade,2.0 (0.9 - 3.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2003,Education,9th grade,2.2 (1.5 - 3.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2003,Race and Ethnicity,Black NH,1.0 (0.4 - 1.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2003,Race and Ethnicity,Hispanic,1.6 (0.9 - 2.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2003,Race and Ethnicity,Other NH,2.7 (1.5 - 3.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2003,Race and Ethnicity,White NH,2.0 (1.4 - 2.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2003,Sex,Female,1.3 (0.8 - 1.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2003,Sex,Male,2.4 (1.7 - 3.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2003,Total,New York State,1.8 (1.4 - 2.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2005,Education,10th grade,1.9 (1.1 - 2.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2005,Education,11th grade,1.5 (0.5 - 2.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2005,Education,12th grade,1.6 (0.6 - 2.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2005,Education,9th grade,1.9 (0.9 - 2.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2005,Race and Ethnicity,Black NH,2.0 (0.9 - 3.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2005,Race and Ethnicity,Hispanic,2.2 (1.2 - 3.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2005,Race and Ethnicity,Other NH,2.3 (1.3 - 3.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2005,Race and Ethnicity,White NH,1.5 (0.8 - 2.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2005,Sex,Female,0.8 (0.4 - 1.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2005,Sex,Male,2.7 (1.8 - 3.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2005,Total,New York State,1.8 (1.3 - 2.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2007,Education,10th grade,3.4 (2.1 - 4.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2007,Education,11th grade,3.2 (1.6 - 4.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2007,Education,12th grade,2.6 (1.1 - 4.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2007,Education,9th grade,2.7 (1.2 - 4.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2007,Race and Ethnicity,Black NH,3.4 (1.8 - 5.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2007,Race and Ethnicity,Hispanic,7.7 (3.9 - 11.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2007,Race and Ethnicity,Other NH,4.5 (1.7 - 7.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2007,Race and Ethnicity,White NH,1.8 (1.1 - 2.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2007,Sex,Female,1.6 (0.9 - 2.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2007,Sex,Male,5.1 (3.4 - 6.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2007,Total,New York State,3.4 (2.4 - 4.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2009,Education,10th grade,2.8 (1.6 - 4.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2009,Education,11th grade,3.7 (1.4 - 6.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2009,Education,12th grade,4.3 (2.2 - 6.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2009,Education,9th grade,4.6 (2.6 - 6.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2009,Race and Ethnicity,Black NH,3.6 (1.1 - 6.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2009,Race and Ethnicity,Hispanic,8.6 (5.3 - 11.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2009,Race and Ethnicity,Other NH,3.4 (1.5 - 5.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2009,Race and Ethnicity,White NH,2.3 (1.2 - 3.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2009,Sex,Female,2.3 (1.1 - 3.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2009,Sex,Male,5.1 (3.6 - 6.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2009,Total,New York State,3.9 (2.7 - 5.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2011,Education,10th grade,2.3 (1.2 - 3.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2011,Education,11th grade,2.6 (1.6 - 3.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2011,Education,12th grade,4.8 (3.5 - 6.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2011,Education,9th grade,4.8 (2.7 - 6.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2011,Race and Ethnicity,Black NH,4.3 (1.8 - 6.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2011,Race and Ethnicity,Hispanic,7.9 (5.4 - 10.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2011,Race and Ethnicity,Other NH,5.7 (1.4 - 10.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2011,Race and Ethnicity,White NH,2.3 (1.4 - 3.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2011,Sex,Female,2.7 (1.8 - 3.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2011,Sex,Male,5.2 (3.6 - 6.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2011,Total,New York State,4.0 (3.0 - 5.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2013,Education,10th grade,2.7 (1.3 - 4.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2013,Education,11th grade,2.6 (1.4 - 3.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2013,Education,12th grade,5.5 (3.5 - 7.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2013,Education,9th grade,3.3 (1.0 - 5.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2013,Race and Ethnicity,Black NH,3.7 (1.5 - 6.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2013,Race and Ethnicity,Hispanic,5.3 (2.9 - 7.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2013,Race and Ethnicity,Other NH,2.9 (1.4 - 4.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2013,Race and Ethnicity,White NH,3.1 (1.9 - 4.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2013,Sex,Female,2.7 (1.6 - 3.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2013,Sex,Male,4.5 (3.1 - 6.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2013,Total,New York State,3.7 (2.6 - 4.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2015,Education,10th grade,5.4 (3.1 - 7.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2015,Education,11th grade,4.2 (2.7 - 5.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2015,Education,12th grade,5.0 (2.7 - 7.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2015,Education,9th grade,3.1 (2.0 - 4.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2015,Race and Ethnicity,Black NH,3.2 (1.3 - 5.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2015,Race and Ethnicity,Hispanic,5.5 (3.7 - 7.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2015,Race and Ethnicity,Other NH,3.4 (1.9 - 4.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2015,Race and Ethnicity,White NH,3.5 (2.4 - 4.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2015,Sex,Female,2.6 (1.5 - 3.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2015,Sex,Male,6.5 (5.0 - 8.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2015,Total,New York State,4.8 (3.7 - 5.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2017,Education,10th grade,2.3 (1.6 - 3.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2017,Education,11th grade,3.8 (2.2 - 5.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2017,Education,12th grade,4.5 (2.8 - 6.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2017,Education,9th grade,3.6 (0.5 - 6.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2017,Race and Ethnicity,Black NH,4.3 (1.9 - 6.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2017,Race and Ethnicity,Hispanic,5.2 (3.1 - 7.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2017,Race and Ethnicity,Other NH,3.7 (1.8 - 5.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2017,Race and Ethnicity,White NH,1.8 (1.1 - 2.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2017,Sex,Female,2.1 (1.0 - 3.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2017,Sex,Male,4.8 (3.1 - 6.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2017,Total,New York State,3.9 (2.5 - 5.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2019,Education,10th grade,3.5 (2.1 - 5.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2019,Education,11th grade,5.6 (3.7 - 7.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2019,Education,12th grade,5.9 (3.9 - 7.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2019,Education,9th grade,6.5 (4.1 - 8.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2019,Race and Ethnicity,Black NH,5.2 (3.4 - 6.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2019,Race and Ethnicity,Hispanic,6.8 (4.9 - 8.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2019,Race and Ethnicity,Other NH,5.5 (3.1 - 8.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2019,Race and Ethnicity,White NH,3.9 (2.5 - 5.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2019,Sex,Female,3.2 (2.2 - 4.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2019,Sex,Male,7.2 (5.3 - 9.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2019,Total,New York State,5.8 (4.5 - 7.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2021,Education,10th grade,1.8 (0.7 - 3.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2021,Education,11th grade,2.2 (0.5 - 3.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2021,Education,12th grade,5.9 (1.8 - 10.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2021,Education,9th grade,1.8 (0.7 - 2.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2021,Race and Ethnicity,Black NH,4.6 (0.6 - 8.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2021,Race and Ethnicity,Hispanic,2.5 (0.2 - 4.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2021,Race and Ethnicity,Other NH,3.3 (1.3 - 5.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2021,Race and Ethnicity,White NH,1.4 (0.4 - 2.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2021,Sex,Female,1.3 (0.2 - 2.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2021,Sex,Male,3.9 (1.1 - 6.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using heroin,2021,Total,New York State,3.4 (1.9 - 4.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,,Education,10th grade,,Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,,Education,10th grade,,Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,,Education,11th grade,,Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,,Education,11th grade,,Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,,Education,12th grade,,Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,,Education,12th grade,,Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,,Education,9th grade,,Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,,Education,9th grade,,Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,,Race and Ethnicity,Black NH,,Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,,Race and Ethnicity,Black NH,,Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,,Race and Ethnicity,Hispanic,,Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,,Race and Ethnicity,Hispanic,,Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,,Race and Ethnicity,Other NH,,Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,,Race and Ethnicity,Other NH,,Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,,Race and Ethnicity,White NH,,Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,,Race and Ethnicity,White NH,,Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,,Sex,Female,,Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,,Sex,Female,,Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,,Sex,Male,,Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,,Sex,Male,,Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,,Total,New York State,,Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,,Total,New York State,,Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2003,Education,10th grade,5.0 (3.1 - 6.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2003,Education,11th grade,3.1 (1.6 - 4.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2003,Education,12th grade,6.6 (4.4 - 8.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2003,Education,9th grade,4.2 (2.9 - 5.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2003,Race and Ethnicity,Black NH,1.5 (0.3 - 2.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2003,Race and Ethnicity,Hispanic,2.1 (1.2 - 3.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2003,Race and Ethnicity,Other NH,4.7 (2.8 - 6.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2003,Race and Ethnicity,White NH,6.3 (5.1 - 7.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2003,Sex,Female,4.0 (2.9 - 5.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2003,Sex,Male,5.4 (4.0 - 6.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2003,Total,New York State,4.7 (3.8 - 5.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2005,Education,10th grade,4.2 (2.2 - 6.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2005,Education,11th grade,3.6 (2.0 - 5.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2005,Education,12th grade,2.6 (1.5 - 3.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2005,Education,9th grade,2.8 (1.8 - 3.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2005,Race and Ethnicity,Black NH,2.4 (1.2 - 3.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2005,Race and Ethnicity,Hispanic,2.8 (1.6 - 4.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2005,Race and Ethnicity,Other NH,3.4 (1.6 - 5.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2005,Race and Ethnicity,White NH,3.8 (2.6 - 5.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2005,Sex,Female,2.2 (1.4 - 3.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2005,Sex,Male,4.3 (3.2 - 5.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2005,Total,New York State,3.3 (2.6 - 4.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2007,Education,10th grade,4.5 (3.1 - 5.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2007,Education,11th grade,4.4 (2.6 - 6.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2007,Education,12th grade,3.7 (2.4 - 5.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2007,Education,9th grade,3.3 (1.8 - 4.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2007,Race and Ethnicity,Black NH,2.9 (1.3 - 4.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2007,Race and Ethnicity,Hispanic,7.4 (3.3 - 11.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2007,Race and Ethnicity,Other NH,3.6 (1.6 - 5.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2007,Race and Ethnicity,White NH,3.6 (2.7 - 4.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2007,Sex,Female,2.5 (1.7 - 3.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2007,Sex,Male,6.0 (4.4 - 7.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2007,Total,New York State,4.4 (3.5 - 5.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2009,Education,10th grade,3.9 (2.6 - 5.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2009,Education,11th grade,3.9 (1.5 - 6.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2009,Education,12th grade,5.2 (2.4 - 8.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2009,Education,9th grade,5.1 (3.0 - 7.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2009,Race and Ethnicity,Black NH,3.8 (1.2 - 6.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2009,Race and Ethnicity,Hispanic,10.1 (6.3 - 13.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2009,Race and Ethnicity,Other NH,3.8 (1.9 - 5.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2009,Race and Ethnicity,White NH,2.8 (1.5 - 4.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2009,Sex,Female,2.8 (1.6 - 4.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2009,Sex,Male,5.9 (3.9 - 8.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2009,Total,New York State,4.8 (3.3 - 6.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2011,Education,10th grade,2.5 (1.2 - 3.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2011,Education,11th grade,3.1 (1.9 - 4.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2011,Education,12th grade,5.7 (4.2 - 7.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2011,Education,9th grade,5.4 (3.0 - 7.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2011,Race and Ethnicity,Black NH,5.2 (2.6 - 7.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2011,Race and Ethnicity,Hispanic,7.1 (4.5 - 9.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2011,Race and Ethnicity,Other NH,5.2 (0.7 - 9.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2011,Race and Ethnicity,White NH,3.5 (2.6 - 4.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2011,Sex,Female,3.3 (2.1 - 4.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2011,Sex,Male,5.8 (3.9 - 7.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2011,Total,New York State,4.6 (3.6 - 5.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2013,Education,10th grade,3.7 (2.3 - 5.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2013,Education,11th grade,3.8 (2.2 - 5.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2013,Education,12th grade,5.7 (3.3 - 8.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2013,Education,9th grade,4.0 (1.5 - 6.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2013,Race and Ethnicity,Black NH,5.3 (1.8 - 8.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2013,Race and Ethnicity,Hispanic,6.8 (3.6 - 10.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2013,Race and Ethnicity,Other NH,3.7 (2.0 - 5.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2013,Race and Ethnicity,White NH,3.4 (2.3 - 4.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2013,Sex,Female,3.1 (1.9 - 4.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2013,Sex,Male,5.8 (4.1 - 7.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2013,Total,New York State,4.5 (3.4 - 5.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2019,Education,10th grade,3.5 (1.9 - 5.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2019,Education,11th grade,4.8 (2.7 - 6.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2019,Education,12th grade,4.5 (2.8 - 6.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2019,Education,9th grade,5.1 (3.1 - 7.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2019,Race and Ethnicity,Black NH,4.3 (2.6 - 6.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2019,Race and Ethnicity,Hispanic,6.4 (4.7 - 8.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2019,Race and Ethnicity,Other NH,4.2 (2.5 - 6.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2019,Race and Ethnicity,White NH,2.9 (1.6 - 4.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2019,Sex,Female,2.8 (1.7 - 4.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2019,Sex,Male,6.0 (4.6 - 7.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2019,Total,New York State,4.9 (3.7 - 6.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2021,Education,10th grade,1.6 (0.5 - 2.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2021,Education,11th grade,2.1 (0.5 - 3.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2021,Education,12th grade,7.0 (3.1 - 11.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2021,Education,9th grade,1.9 (0.7 - 3.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2021,Race and Ethnicity,Black NH,5.7 (1.2 - 10.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2021,Race and Ethnicity,Hispanic,3.1 (0.9 - 5.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2021,Race and Ethnicity,Other NH,3.8 (1.7 - 6.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2021,Race and Ethnicity,White NH,1.2 (0.2 - 2.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2021,Sex,Female,1.1 (0.4 - 1.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2021,Sex,Male,4.6 (2.4 - 6.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using methamphetamines,2021,Total,New York State,3.5 (2.1 - 4.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2015,Education,10th grade,9.6 (6.2 - 13.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2015,Education,11th grade,9.5 (6.9 - 12.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2015,Education,12th grade,12.3 (8.1 - 16.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2015,Education,9th grade,7.5 (5.5 - 9.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2015,Race and Ethnicity,Black NH,6.7 (3.7 - 9.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2015,Race and Ethnicity,Hispanic,9.3 (6.9 - 11.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2015,Race and Ethnicity,Other NH,6.6 (4.1 - 9.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2015,Race and Ethnicity,White NH,10.7 (7.5 - 13.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2015,Sex,Female,8.5 (6.3 - 10.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2015,Sex,Male,10.8 (8.1 - 13.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2015,Total,New York State,10.0 (7.8 - 12.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2017,Education,10th grade,5.7 (4.5 - 6.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2017,Education,11th grade,5.8 (3.8 - 7.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2017,Education,12th grade,6.5 (5.0 - 8.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2017,Education,9th grade,5.7 (2.6 - 8.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2017,Race and Ethnicity,Black NH,6.1 (4.0 - 8.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2017,Race and Ethnicity,Hispanic,8.6 (5.9 - 11.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2017,Race and Ethnicity,Other NH,4.9 (2.7 - 7.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2017,Race and Ethnicity,White NH,3.9 (2.9 - 4.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2017,Sex,Female,5.1 (4.1 - 6.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2017,Sex,Male,6.4 (4.8 - 8.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2017,Total,New York State,6.2 (5.2 - 7.3),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2019,Education,10th grade,8.7 (6.3 - 11.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2019,Education,11th grade,11.8 (8.5 - 15.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2019,Education,12th grade,10.7 (8.4 - 13.0),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2019,Education,9th grade,8.5 (6.9 - 10.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2019,Race and Ethnicity,Black NH,8.3 (6.0 - 10.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2019,Race and Ethnicity,Hispanic,13.1 (10.7 - 15.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2019,Race and Ethnicity,Other NH,5.5 (3.8 - 7.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2019,Race and Ethnicity,White NH,9.6 (7.6 - 11.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2019,Sex,Female,8.7 (7.3 - 10.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2019,Sex,Male,11.0 (8.9 - 13.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2019,Total,New York State,10.3 (8.8 - 11.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2021,Education,10th grade,5.8 (3.2 - 8.4),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2021,Education,11th grade,8.8 (5.6 - 12.1),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2021,Education,12th grade,9.5 (5.2 - 13.8),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2021,Education,9th grade,3.9 (1.6 - 6.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2021,Race and Ethnicity,Black NH,6.9 (3.4 - 10.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2021,Race and Ethnicity,Hispanic,8.9 (4.4 - 13.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2021,Race and Ethnicity,Other NH,3.7 (1.6 - 5.7),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2021,Race and Ethnicity,White NH,6.8 (4.5 - 9.2),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2021,Sex,Female,6.3 (4.1 - 8.5),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2021,Sex,Male,7.2 (4.8 - 9.6),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of high school students reporting ever using synthetic cannabis,2021,Total,New York State,7.1 (5.3 - 8.9),Data Source: CDC Youth Risk Behavior Surveillance System Data as of October 2023
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group,18 - 24 years,4.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group,18 - 24 years,4.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group,25 - 34 years,8.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group,25 - 34 years,8.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group,35 - 44 years,12.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group,35 - 44 years,12.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group,45 - 54 years,15.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group,45 - 54 years,15.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group,55 - 64 years,16.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group,55 - 64 years,16.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group,65+ years,14.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group,65+ years,14.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group by Sex,Female & 18 - 24 years,3.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group by Sex,Female & 18 - 24 years,3.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group by Sex,Female & 25 - 34 years,7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group by Sex,Female & 25 - 34 years,7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group by Sex,Female & 35 - 44 years,10.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group by Sex,Female & 35 - 44 years,10.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group by Sex,Female & 45 - 54 years,14.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group by Sex,Female & 45 - 54 years,14.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group by Sex,Female & 55 - 64 years,15.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group by Sex,Female & 55 - 64 years,15.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group by Sex,Female & 65+ years,13.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group by Sex,Female & 65+ years,13.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group by Sex,Male & 18 - 24 years,5.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group by Sex,Male & 18 - 24 years,5.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group by Sex,Male & 25 - 34 years,10.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group by Sex,Male & 25 - 34 years,10.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group by Sex,Male & 35 - 44 years,14.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group by Sex,Male & 35 - 44 years,14.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group by Sex,Male & 45 - 54 years,17.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group by Sex,Male & 45 - 54 years,17.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group by Sex,Male & 55 - 64 years,18.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group by Sex,Male & 55 - 64 years,18.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group by Sex,Male & 65+ years,14.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Age Group by Sex,Male & 65+ years,14.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Region,NYS Excl NYC,13.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Region,NYS Excl NYC,13.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Region,New York City,11.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Region,New York City,11.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Sex,Female,11.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Sex,Female,11.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Sex,Male,14.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Sex,Male,14.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Total,New York State,12.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2015,Total,New York State,12.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group,18 - 24 years,4.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group,18 - 24 years,4.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group,25 - 34 years,8.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group,25 - 34 years,8.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group,35 - 44 years,12.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group,35 - 44 years,12.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group,45 - 54 years,16,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group,45 - 54 years,16,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group,55 - 64 years,17.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group,55 - 64 years,17.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group,65+ years,14.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group,65+ years,14.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group by Sex,Female & 18 - 24 years,3.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group by Sex,Female & 18 - 24 years,3.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group by Sex,Female & 25 - 34 years,6.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group by Sex,Female & 25 - 34 years,6.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group by Sex,Female & 35 - 44 years,10.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group by Sex,Female & 35 - 44 years,10.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group by Sex,Female & 45 - 54 years,14.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group by Sex,Female & 45 - 54 years,14.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group by Sex,Female & 55 - 64 years,15.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group by Sex,Female & 55 - 64 years,15.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group by Sex,Female & 65+ years,14,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group by Sex,Female & 65+ years,14,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group by Sex,Male & 18 - 24 years,5.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group by Sex,Male & 18 - 24 years,5.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group by Sex,Male & 25 - 34 years,10,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group by Sex,Male & 25 - 34 years,10,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group by Sex,Male & 35 - 44 years,14.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group by Sex,Male & 35 - 44 years,14.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group by Sex,Male & 45 - 54 years,17.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group by Sex,Male & 45 - 54 years,17.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group by Sex,Male & 55 - 64 years,18.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group by Sex,Male & 55 - 64 years,18.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group by Sex,Male & 65+ years,15,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Age Group by Sex,Male & 65+ years,15,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Region,NYS Excl NYC,13.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Region,NYS Excl NYC,13.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Region,New York City,12.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Region,New York City,12.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Sex,Female,12,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Sex,Female,12,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Sex,Male,14.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Sex,Male,14.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Total,New York State,13.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2016,Total,New York State,13.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group,18 - 24 years,3.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group,18 - 24 years,3.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group,25 - 34 years,7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group,25 - 34 years,7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group,35 - 44 years,11.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group,35 - 44 years,11.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group,45 - 54 years,15.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group,45 - 54 years,15.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group,55 - 64 years,16.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group,55 - 64 years,16.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group,65+ years,14.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group,65+ years,14.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group by Sex,Female & 18 - 24 years,2.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group by Sex,Female & 18 - 24 years,2.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group by Sex,Female & 25 - 34 years,5.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group by Sex,Female & 25 - 34 years,5.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group by Sex,Female & 35 - 44 years,9.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group by Sex,Female & 35 - 44 years,9.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group by Sex,Female & 45 - 54 years,13.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group by Sex,Female & 45 - 54 years,13.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group by Sex,Female & 55 - 64 years,15.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group by Sex,Female & 55 - 64 years,15.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group by Sex,Female & 65+ years,13.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group by Sex,Female & 65+ years,13.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group by Sex,Male & 18 - 24 years,4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group by Sex,Male & 18 - 24 years,4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group by Sex,Male & 25 - 34 years,9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group by Sex,Male & 25 - 34 years,9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group by Sex,Male & 35 - 44 years,13.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group by Sex,Male & 35 - 44 years,13.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group by Sex,Male & 45 - 54 years,16.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group by Sex,Male & 45 - 54 years,16.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group by Sex,Male & 55 - 64 years,18,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group by Sex,Male & 55 - 64 years,18,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group by Sex,Male & 65+ years,14.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Age Group by Sex,Male & 65+ years,14.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Region,NYS Excl NYC,12.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Region,NYS Excl NYC,12.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Region,New York City,11.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Region,New York City,11.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Sex,Female,11.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Sex,Female,11.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Sex,Male,14,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Sex,Male,14,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Total,New York State,12.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2017,Total,New York State,12.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group,18 - 24 years,2.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group,18 - 24 years,2.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group,25 - 34 years,5.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group,25 - 34 years,5.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group,35 - 44 years,9.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group,35 - 44 years,9.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group,45 - 54 years,13.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group,45 - 54 years,13.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group,55 - 64 years,15.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group,55 - 64 years,15.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group,65+ years,13.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group,65+ years,13.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group by Sex,Female & 18 - 24 years,1.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group by Sex,Female & 18 - 24 years,1.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group by Sex,Female & 25 - 34 years,4.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group by Sex,Female & 25 - 34 years,4.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group by Sex,Female & 35 - 44 years,8.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group by Sex,Female & 35 - 44 years,8.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group by Sex,Female & 45 - 54 years,12,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group by Sex,Female & 45 - 54 years,12,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group by Sex,Female & 55 - 64 years,14.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group by Sex,Female & 55 - 64 years,14.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group by Sex,Female & 65+ years,12.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group by Sex,Female & 65+ years,12.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group by Sex,Male & 18 - 24 years,2.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group by Sex,Male & 18 - 24 years,2.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group by Sex,Male & 25 - 34 years,7.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group by Sex,Male & 25 - 34 years,7.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group by Sex,Male & 35 - 44 years,11.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group by Sex,Male & 35 - 44 years,11.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group by Sex,Male & 45 - 54 years,15,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group by Sex,Male & 45 - 54 years,15,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group by Sex,Male & 55 - 64 years,16.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group by Sex,Male & 55 - 64 years,16.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group by Sex,Male & 65+ years,14.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Age Group by Sex,Male & 65+ years,14.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Region,NYS Excl NYC,11.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Region,NYS Excl NYC,11.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Region,New York City,10.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Region,New York City,10.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Sex,Female,10.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Sex,Female,10.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Sex,Male,12.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Sex,Male,12.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Total,New York State,11.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2018,Total,New York State,11.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group,18 - 24 years,1.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group,18 - 24 years,1.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group,25 - 34 years,4.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group,25 - 34 years,4.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group,35 - 44 years,8.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group,35 - 44 years,8.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group,45 - 54 years,12.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group,45 - 54 years,12.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group,55 - 64 years,14.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group,55 - 64 years,14.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group,65+ years,12.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group,65+ years,12.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group,< 18 years,0.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group,< 18 years,0.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Female & 18 - 24 years,1.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Female & 18 - 24 years,1.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Female & 25 - 34 years,3.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Female & 25 - 34 years,3.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Female & 35 - 44 years,7.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Female & 35 - 44 years,7.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Female & 45 - 54 years,11.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Female & 45 - 54 years,11.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Female & 55 - 64 years,13.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Female & 55 - 64 years,13.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Female & 65+ years,12.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Female & 65+ years,12.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Female & < 18 years,1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Female & < 18 years,1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Male & 18 - 24 years,2.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Male & 18 - 24 years,2.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Male & 25 - 34 years,6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Male & 25 - 34 years,6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Male & 35 - 44 years,10.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Male & 35 - 44 years,10.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Male & 45 - 54 years,13.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Male & 45 - 54 years,13.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Male & 55 - 64 years,15.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Male & 55 - 64 years,15.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Male & 65+ years,13.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Male & 65+ years,13.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Male & < 18 years,0.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Age Group by Sex,Male & < 18 years,0.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Region,NYS Excl NYC,10.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Region,NYS Excl NYC,10.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Region,New York City,10.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Region,New York City,10.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Sex,Female,9.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Sex,Female,9.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Sex,Male,12,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Sex,Male,12,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Total,New York State,10.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2019,Total,New York State,10.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group,18 - 24 years,1.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group,18 - 24 years,1.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group,25 - 34 years,4.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group,25 - 34 years,4.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group,35 - 44 years,8.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group,35 - 44 years,8.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group,45 - 54 years,12,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group,45 - 54 years,12,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group,55 - 64 years,14.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group,55 - 64 years,14.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group,65+ years,13,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group,65+ years,13,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group,< 18 years,0.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group,< 18 years,0.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Female & 18 - 24 years,1.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Female & 18 - 24 years,1.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Female & 25 - 34 years,3.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Female & 25 - 34 years,3.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Female & 35 - 44 years,7.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Female & 35 - 44 years,7.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Female & 45 - 54 years,10.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Female & 45 - 54 years,10.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Female & 55 - 64 years,13.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Female & 55 - 64 years,13.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Female & 65+ years,12.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Female & 65+ years,12.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Female & < 18 years,0.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Female & < 18 years,0.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Male & 18 - 24 years,2.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Male & 18 - 24 years,2.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Male & 25 - 34 years,5.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Male & 25 - 34 years,5.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Male & 35 - 44 years,10.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Male & 35 - 44 years,10.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Male & 45 - 54 years,13.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Male & 45 - 54 years,13.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Male & 55 - 64 years,15.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Male & 55 - 64 years,15.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Male & 65+ years,14,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Male & 65+ years,14,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Male & < 18 years,1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Age Group by Sex,Male & < 18 years,1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Region,NYS Excl NYC,10.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Region,NYS Excl NYC,10.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Region,New York City,10.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Region,New York City,10.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Sex,Female,9.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Sex,Female,9.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Sex,Male,12.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Sex,Male,12.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Total,New York State,10.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2020,Total,New York State,10.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group,18 - 24 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group,18 - 24 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group,25 - 34 years,3.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group,25 - 34 years,3.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group,35 - 44 years,7.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group,35 - 44 years,7.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group,45 - 54 years,10.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group,45 - 54 years,10.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group,55 - 64 years,13.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group,55 - 64 years,13.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group,65+ years,12.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group,65+ years,12.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group,< 18 years,0.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group,< 18 years,0.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Female & 18 - 24 years,1.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Female & 18 - 24 years,1.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Female & 25 - 34 years,2.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Female & 25 - 34 years,2.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Female & 35 - 44 years,6.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Female & 35 - 44 years,6.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Female & 45 - 54 years,9.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Female & 45 - 54 years,9.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Female & 55 - 64 years,12.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Female & 55 - 64 years,12.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Female & 65+ years,11.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Female & 65+ years,11.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Female & < 18 years,1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Female & < 18 years,1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Male & 18 - 24 years,1.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Male & 18 - 24 years,1.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Male & 25 - 34 years,4.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Male & 25 - 34 years,4.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Male & 35 - 44 years,8.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Male & 35 - 44 years,8.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Male & 45 - 54 years,12,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Male & 45 - 54 years,12,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Male & 55 - 64 years,14.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Male & 55 - 64 years,14.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Male & 65+ years,13.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Male & 65+ years,13.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Male & < 18 years,0.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Age Group by Sex,Male & < 18 years,0.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Region,NYS Excl NYC,10.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Region,NYS Excl NYC,10.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Region,New York City,9.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Region,New York City,9.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Sex,Female,8.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Sex,Female,8.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Sex,Male,11,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Sex,Male,11,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Total,New York State,9.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2021,Total,New York State,9.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group,18 - 24 years,1.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group,18 - 24 years,1.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group,25 - 34 years,3.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group,25 - 34 years,3.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group,35 - 44 years,6.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group,35 - 44 years,6.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group,45 - 54 years,10,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group,45 - 54 years,10,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group,55 - 64 years,12.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group,55 - 64 years,12.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group,65+ years,11.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group,65+ years,11.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group,< 18 years,0.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group,< 18 years,0.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Female & 18 - 24 years,1.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Female & 18 - 24 years,1.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Female & 25 - 34 years,2.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Female & 25 - 34 years,2.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Female & 35 - 44 years,5.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Female & 35 - 44 years,5.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Female & 45 - 54 years,8.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Female & 45 - 54 years,8.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Female & 55 - 64 years,11.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Female & 55 - 64 years,11.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Female & 65+ years,11,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Female & 65+ years,11,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Female & < 18 years,0.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Female & < 18 years,0.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Male & 18 - 24 years,1.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Male & 18 - 24 years,1.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Male & 25 - 34 years,4.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Male & 25 - 34 years,4.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Male & 35 - 44 years,8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Male & 35 - 44 years,8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Male & 45 - 54 years,11.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Male & 45 - 54 years,11.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Male & 55 - 64 years,13.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Male & 55 - 64 years,13.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Male & 65+ years,12.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Male & 65+ years,12.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Male & < 18 years,0.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Age Group by Sex,Male & < 18 years,0.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Region,NYS Excl NYC,9.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Region,NYS Excl NYC,9.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Region,New York City,8.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Region,New York City,8.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Sex,Female,8.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Sex,Female,8.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Sex,Male,10.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Sex,Male,10.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Total,New York State,9.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2022,Total,New York State,9.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group,18 - 24 years,1.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group,18 - 24 years,1.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group,25 - 34 years,3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group,25 - 34 years,3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group,35 - 44 years,6.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group,35 - 44 years,6.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group,45 - 54 years,9.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group,45 - 54 years,9.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group,55 - 64 years,12.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group,55 - 64 years,12.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group,65+ years,11.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group,65+ years,11.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group,< 18 years,0.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group,< 18 years,0.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Female & 18 - 24 years,1.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Female & 18 - 24 years,1.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Female & 25 - 34 years,2.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Female & 25 - 34 years,2.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Female & 35 - 44 years,5.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Female & 35 - 44 years,5.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Female & 45 - 54 years,8.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Female & 45 - 54 years,8.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Female & 55 - 64 years,11.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Female & 55 - 64 years,11.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Female & 65+ years,10.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Female & 65+ years,10.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Female & < 18 years,0.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Female & < 18 years,0.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Male & 18 - 24 years,1.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Male & 18 - 24 years,1.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Male & 25 - 34 years,3.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Male & 25 - 34 years,3.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Male & 35 - 44 years,7.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Male & 35 - 44 years,7.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Male & 45 - 54 years,10.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Male & 45 - 54 years,10.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Male & 55 - 64 years,13.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Male & 55 - 64 years,13.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Male & 65+ years,12.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Male & 65+ years,12.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Male & < 18 years,0.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Age Group by Sex,Male & < 18 years,0.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Region,NYS Excl NYC,9.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Region,NYS Excl NYC,9.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Region,New York City,8.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Region,New York City,8.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Sex,Female,8.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Sex,Female,8.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Sex,Male,10,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Sex,Male,10,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Total,New York State,9,Data Source: NYS PMP Data as of April 2024
Percentage of patients prescribed one or more opioid analgesics with a total daily dose of 90 MME or more on at least one day,2023,Total,New York State,9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group,18 - 24 years,2.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group,18 - 24 years,2.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group,25 - 34 years,5.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group,25 - 34 years,5.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group,35 - 44 years,8.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group,35 - 44 years,8.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group,45 - 54 years,11.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group,45 - 54 years,11.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group,55 - 64 years,12,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group,55 - 64 years,12,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group,65+ years,12.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group,65+ years,12.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group by Sex,Female & 18 - 24 years,2.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group by Sex,Female & 18 - 24 years,2.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group by Sex,Female & 25 - 34 years,6.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group by Sex,Female & 25 - 34 years,6.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group by Sex,Female & 35 - 44 years,9.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group by Sex,Female & 35 - 44 years,9.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group by Sex,Female & 45 - 54 years,12.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group by Sex,Female & 45 - 54 years,12.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group by Sex,Female & 55 - 64 years,13.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group by Sex,Female & 55 - 64 years,13.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group by Sex,Female & 65+ years,13.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group by Sex,Female & 65+ years,13.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group by Sex,Male & 18 - 24 years,2.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group by Sex,Male & 18 - 24 years,2.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group by Sex,Male & 25 - 34 years,5.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group by Sex,Male & 25 - 34 years,5.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group by Sex,Male & 35 - 44 years,7.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group by Sex,Male & 35 - 44 years,7.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group by Sex,Male & 45 - 54 years,9.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group by Sex,Male & 45 - 54 years,9.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group by Sex,Male & 55 - 64 years,10.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group by Sex,Male & 55 - 64 years,10.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group by Sex,Male & 65+ years,10.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Age Group by Sex,Male & 65+ years,10.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Region,NYS Excl NYC,10.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Region,NYS Excl NYC,10.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Region,New York City,7.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Region,New York City,7.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Sex,Female,10.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Sex,Female,10.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Sex,Male,8.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Sex,Male,8.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Total,New York State,9.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2015,Total,New York State,9.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group,18 - 24 years,2.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group,18 - 24 years,2.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group,25 - 34 years,5.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group,25 - 34 years,5.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group,35 - 44 years,8.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group,35 - 44 years,8.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group,45 - 54 years,11.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group,45 - 54 years,11.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group,55 - 64 years,12.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group,55 - 64 years,12.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group,65+ years,12.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group,65+ years,12.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group by Sex,Female & 18 - 24 years,2.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group by Sex,Female & 18 - 24 years,2.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group by Sex,Female & 25 - 34 years,5.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group by Sex,Female & 25 - 34 years,5.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group by Sex,Female & 35 - 44 years,9.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group by Sex,Female & 35 - 44 years,9.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group by Sex,Female & 45 - 54 years,12.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group by Sex,Female & 45 - 54 years,12.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group by Sex,Female & 55 - 64 years,13.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group by Sex,Female & 55 - 64 years,13.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group by Sex,Female & 65+ years,13.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group by Sex,Female & 65+ years,13.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group by Sex,Male & 18 - 24 years,1.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group by Sex,Male & 18 - 24 years,1.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group by Sex,Male & 25 - 34 years,5.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group by Sex,Male & 25 - 34 years,5.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group by Sex,Male & 35 - 44 years,7.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group by Sex,Male & 35 - 44 years,7.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group by Sex,Male & 45 - 54 years,9.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group by Sex,Male & 45 - 54 years,9.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group by Sex,Male & 55 - 64 years,10.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group by Sex,Male & 55 - 64 years,10.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group by Sex,Male & 65+ years,10.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Age Group by Sex,Male & 65+ years,10.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Region,NYS Excl NYC,10.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Region,NYS Excl NYC,10.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Region,New York City,7.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Region,New York City,7.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Sex,Female,10.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Sex,Female,10.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Sex,Male,8.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Sex,Male,8.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Total,New York State,9.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2016,Total,New York State,9.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group,18 - 24 years,1.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group,18 - 24 years,1.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group,25 - 34 years,4.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group,25 - 34 years,4.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group,35 - 44 years,7.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group,35 - 44 years,7.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group,45 - 54 years,10.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group,45 - 54 years,10.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group,55 - 64 years,11.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group,55 - 64 years,11.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group,65+ years,12,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group,65+ years,12,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group by Sex,Female & 18 - 24 years,1.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group by Sex,Female & 18 - 24 years,1.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group by Sex,Female & 25 - 34 years,5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group by Sex,Female & 25 - 34 years,5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group by Sex,Female & 35 - 44 years,8.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group by Sex,Female & 35 - 44 years,8.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group by Sex,Female & 45 - 54 years,11.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group by Sex,Female & 45 - 54 years,11.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group by Sex,Female & 55 - 64 years,12.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group by Sex,Female & 55 - 64 years,12.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group by Sex,Female & 65+ years,12.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group by Sex,Female & 65+ years,12.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group by Sex,Male & 18 - 24 years,1.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group by Sex,Male & 18 - 24 years,1.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group by Sex,Male & 25 - 34 years,4.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group by Sex,Male & 25 - 34 years,4.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group by Sex,Male & 35 - 44 years,6.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group by Sex,Male & 35 - 44 years,6.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group by Sex,Male & 45 - 54 years,8.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group by Sex,Male & 45 - 54 years,8.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group by Sex,Male & 55 - 64 years,10.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group by Sex,Male & 55 - 64 years,10.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group by Sex,Male & 65+ years,10.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Age Group by Sex,Male & 65+ years,10.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Region,NYS Excl NYC,10.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Region,NYS Excl NYC,10.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Region,New York City,7.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Region,New York City,7.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Sex,Female,10.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Sex,Female,10.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Sex,Male,8.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Sex,Male,8.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Total,New York State,9.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2017,Total,New York State,9.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group,18 - 24 years,1.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group,18 - 24 years,1.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group,25 - 34 years,4.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group,25 - 34 years,4.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group,35 - 44 years,7.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group,35 - 44 years,7.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group,45 - 54 years,9.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group,45 - 54 years,9.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group,55 - 64 years,10.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group,55 - 64 years,10.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group,65+ years,11.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group,65+ years,11.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group by Sex,Female & 18 - 24 years,1.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group by Sex,Female & 18 - 24 years,1.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group by Sex,Female & 25 - 34 years,4.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group by Sex,Female & 25 - 34 years,4.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group by Sex,Female & 35 - 44 years,7.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group by Sex,Female & 35 - 44 years,7.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group by Sex,Female & 45 - 54 years,10.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group by Sex,Female & 45 - 54 years,10.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group by Sex,Female & 55 - 64 years,11.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group by Sex,Female & 55 - 64 years,11.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group by Sex,Female & 65+ years,12.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group by Sex,Female & 65+ years,12.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group by Sex,Male & 18 - 24 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group by Sex,Male & 18 - 24 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group by Sex,Male & 25 - 34 years,3.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group by Sex,Male & 25 - 34 years,3.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group by Sex,Male & 35 - 44 years,6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group by Sex,Male & 35 - 44 years,6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group by Sex,Male & 45 - 54 years,7.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group by Sex,Male & 45 - 54 years,7.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group by Sex,Male & 55 - 64 years,9.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group by Sex,Male & 55 - 64 years,9.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group by Sex,Male & 65+ years,10.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Age Group by Sex,Male & 65+ years,10.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Region,NYS Excl NYC,9.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Region,NYS Excl NYC,9.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Region,New York City,6.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Region,New York City,6.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Sex,Female,9.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Sex,Female,9.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Sex,Male,7.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Sex,Male,7.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Total,New York State,8.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2018,Total,New York State,8.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group,18 - 24 years,1.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group,18 - 24 years,1.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group,25 - 34 years,3.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group,25 - 34 years,3.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group,35 - 44 years,6.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group,35 - 44 years,6.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group,45 - 54 years,8.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group,45 - 54 years,8.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group,55 - 64 years,10,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group,55 - 64 years,10,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group,65+ years,11.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group,65+ years,11.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group,< 18 years,1.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group,< 18 years,1.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Female & 18 - 24 years,1.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Female & 18 - 24 years,1.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Female & 25 - 34 years,4.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Female & 25 - 34 years,4.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Female & 35 - 44 years,7.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Female & 35 - 44 years,7.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Female & 45 - 54 years,9.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Female & 45 - 54 years,9.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Female & 55 - 64 years,11,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Female & 55 - 64 years,11,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Female & 65+ years,12,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Female & 65+ years,12,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Female & < 18 years,1.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Female & < 18 years,1.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Male & 18 - 24 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Male & 18 - 24 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Male & 25 - 34 years,3.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Male & 25 - 34 years,3.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Male & 35 - 44 years,5.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Male & 35 - 44 years,5.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Male & 45 - 54 years,7.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Male & 45 - 54 years,7.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Male & 55 - 64 years,8.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Male & 55 - 64 years,8.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Male & 65+ years,10,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Male & 65+ years,10,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Male & < 18 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Age Group by Sex,Male & < 18 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Region,NYS Excl NYC,9.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Region,NYS Excl NYC,9.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Region,New York City,6.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Region,New York City,6.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Sex,Female,9.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Sex,Female,9.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Sex,Male,7.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Sex,Male,7.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Total,New York State,8.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2019,Total,New York State,8.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group,18 - 24 years,1.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group,18 - 24 years,1.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group,25 - 34 years,3.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group,25 - 34 years,3.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group,35 - 44 years,6.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group,35 - 44 years,6.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group,45 - 54 years,8.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group,45 - 54 years,8.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group,55 - 64 years,9.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group,55 - 64 years,9.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group,65+ years,11.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group,65+ years,11.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group,< 18 years,1.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group,< 18 years,1.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Female & 18 - 24 years,2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Female & 18 - 24 years,2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Female & 25 - 34 years,4.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Female & 25 - 34 years,4.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Female & 35 - 44 years,7.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Female & 35 - 44 years,7.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Female & 45 - 54 years,9.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Female & 45 - 54 years,9.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Female & 55 - 64 years,11,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Female & 55 - 64 years,11,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Female & 65+ years,12.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Female & 65+ years,12.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Female & < 18 years,2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Female & < 18 years,2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Male & 18 - 24 years,1.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Male & 18 - 24 years,1.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Male & 25 - 34 years,3.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Male & 25 - 34 years,3.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Male & 35 - 44 years,5.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Male & 35 - 44 years,5.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Male & 45 - 54 years,7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Male & 45 - 54 years,7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Male & 55 - 64 years,8.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Male & 55 - 64 years,8.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Male & 65+ years,10.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Male & 65+ years,10.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Male & < 18 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Age Group by Sex,Male & < 18 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Region,NYS Excl NYC,9.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Region,NYS Excl NYC,9.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Region,New York City,6.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Region,New York City,6.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Sex,Female,9.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Sex,Female,9.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Sex,Male,7.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Sex,Male,7.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Total,New York State,8.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2020,Total,New York State,8.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group,18 - 24 years,1.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group,18 - 24 years,1.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group,25 - 34 years,3.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group,25 - 34 years,3.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group,35 - 44 years,6.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group,35 - 44 years,6.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group,45 - 54 years,8.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group,45 - 54 years,8.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group,55 - 64 years,9.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group,55 - 64 years,9.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group,65+ years,11.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group,65+ years,11.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group,< 18 years,2.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group,< 18 years,2.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Female & 18 - 24 years,1.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Female & 18 - 24 years,1.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Female & 25 - 34 years,3.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Female & 25 - 34 years,3.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Female & 35 - 44 years,6.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Female & 35 - 44 years,6.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Female & 45 - 54 years,9.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Female & 45 - 54 years,9.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Female & 55 - 64 years,10.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Female & 55 - 64 years,10.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Female & 65+ years,12,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Female & 65+ years,12,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Female & < 18 years,2.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Female & < 18 years,2.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Male & 18 - 24 years,1.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Male & 18 - 24 years,1.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Male & 25 - 34 years,2.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Male & 25 - 34 years,2.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Male & 35 - 44 years,4.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Male & 35 - 44 years,4.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Male & 45 - 54 years,6.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Male & 45 - 54 years,6.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Male & 55 - 64 years,8.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Male & 55 - 64 years,8.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Male & 65+ years,10.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Male & 65+ years,10.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Male & < 18 years,1.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Age Group by Sex,Male & < 18 years,1.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Region,NYS Excl NYC,8.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Region,NYS Excl NYC,8.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Region,New York City,6.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Region,New York City,6.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Sex,Female,8.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Sex,Female,8.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Sex,Male,7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Sex,Male,7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Total,New York State,8.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2021,Total,New York State,8.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group,18 - 24 years,1.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group,18 - 24 years,1.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group,25 - 34 years,3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group,25 - 34 years,3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group,35 - 44 years,5.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group,35 - 44 years,5.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group,45 - 54 years,7.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group,45 - 54 years,7.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group,55 - 64 years,9.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group,55 - 64 years,9.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group,65+ years,10.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group,65+ years,10.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group,< 18 years,1.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group,< 18 years,1.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Female & 18 - 24 years,1.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Female & 18 - 24 years,1.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Female & 25 - 34 years,3.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Female & 25 - 34 years,3.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Female & 35 - 44 years,6.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Female & 35 - 44 years,6.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Female & 45 - 54 years,8.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Female & 45 - 54 years,8.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Female & 55 - 64 years,10.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Female & 55 - 64 years,10.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Female & 65+ years,11.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Female & 65+ years,11.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Female & < 18 years,2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Female & < 18 years,2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Male & 18 - 24 years,1.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Male & 18 - 24 years,1.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Male & 25 - 34 years,2.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Male & 25 - 34 years,2.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Male & 35 - 44 years,4.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Male & 35 - 44 years,4.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Male & 45 - 54 years,6.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Male & 45 - 54 years,6.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Male & 55 - 64 years,7.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Male & 55 - 64 years,7.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Male & 65+ years,9.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Male & 65+ years,9.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Male & < 18 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Age Group by Sex,Male & < 18 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Region,NYS Excl NYC,8.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Region,NYS Excl NYC,8.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Region,New York City,6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Region,New York City,6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Sex,Female,8.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Sex,Female,8.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Sex,Male,6.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Sex,Male,6.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Total,New York State,7.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2022,Total,New York State,7.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group,18 - 24 years,1.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group,18 - 24 years,1.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group,25 - 34 years,2.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group,25 - 34 years,2.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group,35 - 44 years,5.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group,35 - 44 years,5.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group,45 - 54 years,7.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group,45 - 54 years,7.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group,55 - 64 years,8.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group,55 - 64 years,8.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group,65+ years,10.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group,65+ years,10.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group,< 18 years,1.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group,< 18 years,1.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Female & 18 - 24 years,1.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Female & 18 - 24 years,1.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Female & 25 - 34 years,2.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Female & 25 - 34 years,2.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Female & 35 - 44 years,5.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Female & 35 - 44 years,5.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Female & 45 - 54 years,8.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Female & 45 - 54 years,8.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Female & 55 - 64 years,9.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Female & 55 - 64 years,9.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Female & 65+ years,11.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Female & 65+ years,11.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Female & < 18 years,2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Female & < 18 years,2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Male & 18 - 24 years,1.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Male & 18 - 24 years,1.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Male & 25 - 34 years,2.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Male & 25 - 34 years,2.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Male & 35 - 44 years,4.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Male & 35 - 44 years,4.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Male & 45 - 54 years,5.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Male & 45 - 54 years,5.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Male & 55 - 64 years,7.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Male & 55 - 64 years,7.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Male & 65+ years,9.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Male & 65+ years,9.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Male & < 18 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Age Group by Sex,Male & < 18 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Region,NYS Excl NYC,8.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Region,NYS Excl NYC,8.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Region,New York City,5.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Region,New York City,5.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Sex,Female,8.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Sex,Female,8.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Sex,Male,6.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Sex,Male,6.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Total,New York State,7.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic and benzodiazepine prescriptions,2023,Total,New York State,7.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2015,Age Group,18 - 24 years,3.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2015,Age Group,25 - 34 years,9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2015,Age Group,35 - 44 years,14.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2015,Age Group,45 - 54 years,19.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2015,Age Group,55 - 64 years,21.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2015,Age Group,65+ years,21.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2015,Age Group by Sex,Female & 18 - 24 years,3.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2015,Age Group by Sex,Female & 25 - 34 years,8.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2015,Age Group by Sex,Female & 35 - 44 years,13.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2015,Age Group by Sex,Female & 45 - 54 years,19,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2015,Age Group by Sex,Female & 55 - 64 years,21.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2015,Age Group by Sex,Female & 65+ years,22.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2015,Age Group by Sex,Male & 18 - 24 years,4.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2015,Age Group by Sex,Male & 25 - 34 years,10.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2015,Age Group by Sex,Male & 35 - 44 years,15.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2015,Age Group by Sex,Male & 45 - 54 years,20.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2015,Age Group by Sex,Male & 55 - 64 years,22.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2015,Age Group by Sex,Male & 65+ years,19.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2015,Region,NYS Excl NYC,17.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2015,Region,New York City,14.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2015,Sex,Female,16.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2015,Sex,Male,16.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2015,Total,New York State,16.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2016,Age Group,18 - 24 years,3.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2016,Age Group,25 - 34 years,8.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2016,Age Group,35 - 44 years,14.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2016,Age Group,45 - 54 years,20.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2016,Age Group,55 - 64 years,22.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2016,Age Group,65+ years,22.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2016,Age Group by Sex,Female & 18 - 24 years,3.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2016,Age Group by Sex,Female & 25 - 34 years,7.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2016,Age Group by Sex,Female & 35 - 44 years,13.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2016,Age Group by Sex,Female & 45 - 54 years,19.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2016,Age Group by Sex,Female & 55 - 64 years,21.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2016,Age Group by Sex,Female & 65+ years,23.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2016,Age Group by Sex,Male & 18 - 24 years,3.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2016,Age Group by Sex,Male & 25 - 34 years,10.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2016,Age Group by Sex,Male & 35 - 44 years,16.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2016,Age Group by Sex,Male & 45 - 54 years,21,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2016,Age Group by Sex,Male & 55 - 64 years,23.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2016,Age Group by Sex,Male & 65+ years,20.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2016,Region,NYS Excl NYC,18.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2016,Region,New York City,15.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2016,Sex,Female,16.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2016,Sex,Male,17.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2016,Total,New York State,17.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2017,Age Group,18 - 24 years,2.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2017,Age Group,25 - 34 years,7.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2017,Age Group,35 - 44 years,13.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2017,Age Group,45 - 54 years,19.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2017,Age Group,55 - 64 years,21.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2017,Age Group,65+ years,21.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2017,Age Group by Sex,Female & 18 - 24 years,2.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2017,Age Group by Sex,Female & 25 - 34 years,6.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2017,Age Group by Sex,Female & 35 - 44 years,12.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2017,Age Group by Sex,Female & 45 - 54 years,18.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2017,Age Group by Sex,Female & 55 - 64 years,21.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2017,Age Group by Sex,Female & 65+ years,22.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2017,Age Group by Sex,Male & 18 - 24 years,3.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2017,Age Group by Sex,Male & 25 - 34 years,9.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2017,Age Group by Sex,Male & 35 - 44 years,15.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2017,Age Group by Sex,Male & 45 - 54 years,20,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2017,Age Group by Sex,Male & 55 - 64 years,22.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2017,Age Group by Sex,Male & 65+ years,20.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2017,Region,NYS Excl NYC,17.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2017,Region,New York City,15.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2017,Sex,Female,16.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2017,Sex,Male,17.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2017,Total,New York State,16.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2018,Age Group,18 - 24 years,2.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2018,Age Group,25 - 34 years,6.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2018,Age Group,35 - 44 years,12.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2018,Age Group,45 - 54 years,17.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2018,Age Group,55 - 64 years,20.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2018,Age Group,65+ years,21,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2018,Age Group by Sex,Female & 18 - 24 years,2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2018,Age Group by Sex,Female & 25 - 34 years,5.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2018,Age Group by Sex,Female & 35 - 44 years,11.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2018,Age Group by Sex,Female & 45 - 54 years,17,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2018,Age Group by Sex,Female & 55 - 64 years,20.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2018,Age Group by Sex,Female & 65+ years,21.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2018,Age Group by Sex,Male & 18 - 24 years,2.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2018,Age Group by Sex,Male & 25 - 34 years,7.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2018,Age Group by Sex,Male & 35 - 44 years,13.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2018,Age Group by Sex,Male & 45 - 54 years,18.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2018,Age Group by Sex,Male & 55 - 64 years,21.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2018,Age Group by Sex,Male & 65+ years,19.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2018,Region,NYS Excl NYC,16.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2018,Region,New York City,14.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2018,Sex,Female,15.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2018,Sex,Male,16.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2018,Total,New York State,15.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2019,Age Group,18 - 24 years,2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2019,Age Group,25 - 34 years,5.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2019,Age Group,35 - 44 years,11.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2019,Age Group,45 - 54 years,16.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2019,Age Group,55 - 64 years,20.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2019,Age Group,65+ years,20.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2019,Age Group,< 18 years,1.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2019,Age Group by Sex,Female & 18 - 24 years,1.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2019,Age Group by Sex,Female & 25 - 34 years,5.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2019,Age Group by Sex,Female & 35 - 44 years,10.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2019,Age Group by Sex,Female & 45 - 54 years,16.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2019,Age Group by Sex,Female & 55 - 64 years,20.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2019,Age Group by Sex,Female & 65+ years,21.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2019,Age Group by Sex,Female & < 18 years,1.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2019,Age Group by Sex,Male & 18 - 24 years,2.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2019,Age Group by Sex,Male & 25 - 34 years,7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2019,Age Group by Sex,Male & 35 - 44 years,12.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2019,Age Group by Sex,Male & 45 - 54 years,17.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2019,Age Group by Sex,Male & 55 - 64 years,20.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2019,Age Group by Sex,Male & 65+ years,19.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2019,Age Group by Sex,Male & < 18 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2019,Region,NYS Excl NYC,16.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2019,Region,New York City,14.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2019,Sex,Female,15.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2019,Sex,Male,16.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2019,Total,New York State,15.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2020,Age Group,18 - 24 years,2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2020,Age Group,25 - 34 years,5.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2020,Age Group,35 - 44 years,11.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2020,Age Group,45 - 54 years,16.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2020,Age Group,55 - 64 years,21,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2020,Age Group,65+ years,21.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2020,Age Group,< 18 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2020,Age Group by Sex,Female & 18 - 24 years,1.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2020,Age Group by Sex,Female & 25 - 34 years,4.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2020,Age Group by Sex,Female & 35 - 44 years,11,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2020,Age Group by Sex,Female & 45 - 54 years,16.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2020,Age Group by Sex,Female & 55 - 64 years,20.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2020,Age Group by Sex,Female & 65+ years,22.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2020,Age Group by Sex,Female & < 18 years,1.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2020,Age Group by Sex,Male & 18 - 24 years,2.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2020,Age Group by Sex,Male & 25 - 34 years,6.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2020,Age Group by Sex,Male & 35 - 44 years,12.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2020,Age Group by Sex,Male & 45 - 54 years,17.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2020,Age Group by Sex,Male & 55 - 64 years,21.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2020,Age Group by Sex,Male & 65+ years,20.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2020,Age Group by Sex,Male & < 18 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2020,Region,NYS Excl NYC,16.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2020,Region,New York City,15,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2020,Sex,Female,16.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2020,Sex,Male,16.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2020,Total,New York State,16.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2021,Age Group,18 - 24 years,1.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2021,Age Group,25 - 34 years,4.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2021,Age Group,35 - 44 years,10.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2021,Age Group,45 - 54 years,15.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2021,Age Group,55 - 64 years,19.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2021,Age Group,65+ years,20.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2021,Age Group,< 18 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2021,Age Group by Sex,Female & 18 - 24 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2021,Age Group by Sex,Female & 25 - 34 years,4.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2021,Age Group by Sex,Female & 35 - 44 years,9.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2021,Age Group by Sex,Female & 45 - 54 years,14.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2021,Age Group by Sex,Female & 55 - 64 years,19.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2021,Age Group by Sex,Female & 65+ years,21.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2021,Age Group by Sex,Female & < 18 years,1.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2021,Age Group by Sex,Male & 18 - 24 years,2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2021,Age Group by Sex,Male & 25 - 34 years,5.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2021,Age Group by Sex,Male & 35 - 44 years,11.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2021,Age Group by Sex,Male & 45 - 54 years,15.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2021,Age Group by Sex,Male & 55 - 64 years,19.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2021,Age Group by Sex,Male & 65+ years,19.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2021,Age Group by Sex,Male & < 18 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2021,Region,NYS Excl NYC,15.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2021,Region,New York City,13.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2021,Sex,Female,14.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2021,Sex,Male,15.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2021,Total,New York State,15.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2022,Age Group,18 - 24 years,1.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2022,Age Group,25 - 34 years,4.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2022,Age Group,35 - 44 years,9.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2022,Age Group,45 - 54 years,14.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2022,Age Group,55 - 64 years,19.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2022,Age Group,65+ years,20.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2022,Age Group,< 18 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2022,Age Group by Sex,Female & 18 - 24 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2022,Age Group by Sex,Female & 25 - 34 years,3.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2022,Age Group by Sex,Female & 35 - 44 years,8.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2022,Age Group by Sex,Female & 45 - 54 years,14.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2022,Age Group by Sex,Female & 55 - 64 years,19.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2022,Age Group by Sex,Female & 65+ years,21.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2022,Age Group by Sex,Female & < 18 years,1.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2022,Age Group by Sex,Male & 18 - 24 years,2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2022,Age Group by Sex,Male & 25 - 34 years,5.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2022,Age Group by Sex,Male & 35 - 44 years,10.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2022,Age Group by Sex,Male & 45 - 54 years,15.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2022,Age Group by Sex,Male & 55 - 64 years,19.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2022,Age Group by Sex,Male & 65+ years,19.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2022,Age Group by Sex,Male & < 18 years,1.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2022,Region,NYS Excl NYC,15.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2022,Region,New York City,13.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2022,Sex,Female,14.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2022,Sex,Male,15.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2022,Total,New York State,15,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2023,Age Group,18 - 24 years,1.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2023,Age Group,25 - 34 years,4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2023,Age Group,35 - 44 years,8.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2023,Age Group,45 - 54 years,14.1,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2023,Age Group,55 - 64 years,18.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2023,Age Group,65+ years,20.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2023,Age Group,< 18 years,1.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2023,Age Group by Sex,Female & 18 - 24 years,1.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2023,Age Group by Sex,Female & 25 - 34 years,3.5,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2023,Age Group by Sex,Female & 35 - 44 years,8.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2023,Age Group by Sex,Female & 45 - 54 years,13.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2023,Age Group by Sex,Female & 55 - 64 years,18.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2023,Age Group by Sex,Female & 65+ years,21,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2023,Age Group by Sex,Female & < 18 years,1.2,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2023,Age Group by Sex,Male & 18 - 24 years,1.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2023,Age Group by Sex,Male & 25 - 34 years,4.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2023,Age Group by Sex,Male & 35 - 44 years,9.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2023,Age Group by Sex,Male & 45 - 54 years,14.3,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2023,Age Group by Sex,Male & 55 - 64 years,18.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2023,Age Group by Sex,Male & 65+ years,19.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2023,Age Group by Sex,Male & < 18 years,1.4,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2023,Region,NYS Excl NYC,15.6,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2023,Region,New York City,12.8,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2023,Sex,Female,14.7,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2023,Sex,Male,14.9,Data Source: NYS PMP Data as of April 2024
Percentage of patients* with two or more calendar days of overlapping opioid analgesic prescriptions,2023,Total,New York State,14.8,Data Source: NYS PMP Data as of April 2024
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2015-2016,Age Group,12-17 years,66.0 (63.5 - 68.5),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2015-2016,Age Group,18-25 years,83.0 (80.9 - 84.9),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2015-2016,Age Group,26-34 years,82.5 (79.4 - 85.2),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2015-2016,Age Group,35+ years,87.4 (85.4 - 89.1),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Black NH,86.1 (83.0 - 88.8),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Hispanic,84.9 (81.2 - 88.0),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Other NH,78.9 (73.8 - 83.3),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2015-2016,Race and Ethnicity,White NH,84.5 (82.8 - 86.2),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2015-2016,Sex,Female,86.6 (84.8 - 88.3),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2015-2016,Sex,Male,81.7 (79.8 - 83.4),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2015-2016,Total,New York State,84.3 (83.0 - 85.5),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2016-2017,Age Group,12-17 years,66.3 (63.3 - 69.2),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2016-2017,Age Group,18-25 years,82.4 (80.0 - 84.6),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2016-2017,Age Group,26-34 years,84.0 (81.5 - 86.3),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2016-2017,Age Group,35+ years,88.5 (86.4 - 90.4),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Black NH,84.5 (80.9 - 87.5),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Hispanic,85.9 (81.9 - 89.2),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Other NH,83.0 (79.2 - 86.2),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2016-2017,Race and Ethnicity,White NH,85.6 (83.7 - 87.3),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2016-2017,Sex,Female,86.7 (84.8 - 88.4),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2016-2017,Sex,Male,83.6 (81.8 - 85.3),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2016-2017,Total,New York State,85.2 (83.8 - 86.5),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2017-2018,Age Group,12-17 years,67.9 (64.9 - 70.8),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2017-2018,Age Group,18-25 years,81.0 (78.7 - 83.1),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2017-2018,Age Group,26-34 years,81.5 (78.6 - 84.1),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2017-2018,Age Group,35+ years,89.0 (87.1 - 90.7),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Black NH,86.1 (83.0 - 88.8),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Hispanic,86.5 (83.3 - 89.1),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Other NH,80.9 (75.1 - 85.7),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2017-2018,Race and Ethnicity,White NH,85.3 (83.5 - 86.9),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2017-2018,Sex,Female,87.4 (85.7 - 89.0),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2017-2018,Sex,Male,82.7 (80.6 - 84.7),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2017-2018,Total,New York State,85.2 (83.7 - 86.5),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2018-2019,Age Group,12-17 years,66.5 (63.7 - 69.2),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2018-2019,Age Group,18-25 years,80.8 (78.5 - 83.0),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2018-2019,Age Group,26-34 years,82.0 (78.9 - 84.7),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2018-2019,Age Group,35+ years,87.4 (85.5 - 89.1),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Black NH,85.2 (81.7 - 88.1),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Hispanic,85.5 (82.8 - 87.8),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Other NH,74.1 (67.6 - 79.6),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2018-2019,Race and Ethnicity,White NH,85.3 (83.5 - 86.9),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2018-2019,Sex,Female,86.6 (84.8 - 88.3),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2018-2019,Sex,Male,81.4 (79.1 - 83.5),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2018-2019,Total,New York State,84.1 (82.6 - 85.5),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2019-2020,Age Group,12-17 years,.,Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2019-2020,Age Group,18-25 years,.,Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2019-2020,Age Group,26-34 years,.,Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2019-2020,Age Group,35+ years,.,Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2019-2020,Race and Ethnicity,Black NH,.,Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2019-2020,Race and Ethnicity,Hispanic,.,Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2019-2020,Race and Ethnicity,Other NH,.,Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2019-2020,Race and Ethnicity,White NH,.,Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2019-2020,Sex,Female,.,Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2019-2020,Sex,Male,.,Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2019-2020,Total,New York State,.,Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2021-2022,Age Group,12-17 years,56.2 (51.1 - 61.2),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2021-2022,Age Group,18-25 years,75.8 (71.1 - 80.0),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2021-2022,Age Group,26-34 years,81.2 (77.6 - 84.3),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2021-2022,Age Group,35+ years,85.7 (83.2 - 88.0),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2021-2022,Race and Ethnicity,Black NH,85.3 (81.3 - 88.6),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2021-2022,Race and Ethnicity,Hispanic,79.8 (75.8 - 83.3),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2021-2022,Race and Ethnicity,Other NH,72.9 (64.1 - 80.1),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2021-2022,Race and Ethnicity,White NH,82.8 (80.4 - 84.9),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2021-2022,Sex,Female,82.3 (80.1 - 84.4),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2021-2022,Sex,Male,80.6 (78.1 - 82.8),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from trying heroin once or twice, among persons aged 12 years or older",2021-2022,Total,New York State,81.5 (79.7 - 83.1),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2015-2016,Age Group,12-17 years,56.0 (53.4 - 58.5),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2015-2016,Age Group,18-25 years,62.6 (59.5 - 65.6),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2015-2016,Age Group,26-34 years,64.5 (61.0 - 67.9),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2015-2016,Age Group,35+ years,73.6 (71.1 - 76.0),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Black NH,74.7 (70.5 - 78.5),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Hispanic,73.4 (69.5 - 76.9),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Other NH,71.7 (67.7 - 75.3),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2015-2016,Race and Ethnicity,White NH,66.3 (63.9 - 68.6),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2015-2016,Sex,Female,74.0 (71.8 - 76.0),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2015-2016,Sex,Male,64.3 (61.8 - 66.7),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2015-2016,Total,New York State,69.3 (67.6 - 71.0),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2016-2017,Age Group,12-17 years,55.6 (52.7 - 58.5),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2016-2017,Age Group,18-25 years,61.8 (58.8 - 64.7),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2016-2017,Age Group,26-34 years,63.4 (59.7 - 67.0),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2016-2017,Age Group,35+ years,73.3 (70.6 - 75.8),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Black NH,74.3 (70.4 - 77.8),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Hispanic,72.5 (67.7 - 76.7),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Other NH,71.9 (66.5 - 76.7),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2016-2017,Race and Ethnicity,White NH,65.8 (63.4 - 68.1),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2016-2017,Sex,Female,73.0 (70.5 - 75.4),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2016-2017,Sex,Male,64.3 (62.0 - 66.6),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2016-2017,Total,New York State,68.8 (66.9 - 70.7),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2017-2018,Age Group,12-17 years,56.6 (53.4 - 59.8),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2017-2018,Age Group,18-25 years,59.2 (55.8 - 62.5),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2017-2018,Age Group,26-34 years,62.7 (58.6 - 66.6),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2017-2018,Age Group,35+ years,74.5 (71.9 - 77.0),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Black NH,77.2 (73.7 - 80.4),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Hispanic,72.6 (67.7 - 77.1),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Other NH,70.1 (61.7 - 77.3),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2017-2018,Race and Ethnicity,White NH,66.2 (64.0 - 68.3),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2017-2018,Sex,Female,74.3 (71.8 - 76.7),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2017-2018,Sex,Male,64.0 (61.2 - 66.7),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2017-2018,Total,New York State,69.3 (67.4 - 71.2),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2018-2019,Age Group,12-17 years,54.9 (51.6 - 58.0),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2018-2019,Age Group,18-25 years,58.2 (55.3 - 61.1),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2018-2019,Age Group,26-34 years,61.6 (57.7 - 65.4),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2018-2019,Age Group,35+ years,73.4 (70.8 - 75.8),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Black NH,77.1 (73.1 - 80.6),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Hispanic,72.4 (68.4 - 76.1),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Other NH,65.2 (59.2 - 70.8),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2018-2019,Race and Ethnicity,White NH,65.2 (62.8 - 67.5),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2018-2019,Sex,Female,73.5 (71.1 - 75.7),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2018-2019,Sex,Male,62.5 (59.5 - 65.4),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2018-2019,Total,New York State,68.2 (66.2 - 70.2),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2019-2020,Age Group,12-17 years,.,Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2019-2020,Age Group,18-25 years,.,Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2019-2020,Age Group,26-34 years,.,Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2019-2020,Age Group,35+ years,.,Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2019-2020,Race and Ethnicity,Black NH,.,Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2019-2020,Race and Ethnicity,Hispanic,.,Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2019-2020,Race and Ethnicity,Other NH,.,Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2019-2020,Race and Ethnicity,White NH,.,Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2019-2020,Sex,Female,.,Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2019-2020,Sex,Male,.,Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2019-2020,Total,New York State,.,Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2021-2022,Age Group,12-17 years,46.8 (42.3 - 51.3),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2021-2022,Age Group,18-25 years,56.7 (51.7 - 61.5),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2021-2022,Age Group,26-34 years,60.9 (55.1 - 66.4),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2021-2022,Age Group,35+ years,67.2 (63.5 - 70.7),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2021-2022,Race and Ethnicity,Black NH,71.1 (63.9 - 77.4),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2021-2022,Race and Ethnicity,Hispanic,67.9 (62.8 - 72.7),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2021-2022,Race and Ethnicity,Other NH,65.5 (57.0 - 73.1),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2021-2022,Race and Ethnicity,White NH,59.5 (55.5 - 63.3),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2021-2022,Sex,Female,66.8 (63.2 - 70.1),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2021-2022,Sex,Male,59.7 (56.2 - 63.2),Data Source: National Survey on Drug Use and Health
"Perceptions of great risk from using cocaine once a month, among persons aged 12 years or older",2021-2022,Total,New York State,63.4 (60.5 - 66.1),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2015-2016,Age Group,12-17 years,2.3 (1.6 - 3.3),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2015-2016,Age Group,18-25 years,7.1 (5.7 - 8.7),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2015-2016,Age Group,26-34 years,4.9 (3.6 - 6.6),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2015-2016,Age Group,35+ years,2.9 (2.2 - 3.9),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Black NH,2.6 (1.5 - 4.5),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Hispanic,3.9 (2.8 - 5.4),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2015-2016,Race and Ethnicity,Other NH,2.6 (1.6 - 4.4),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2015-2016,Race and Ethnicity,White NH,4.1 (3.3 - 5.1),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2015-2016,Sex,Female,3.2 (2.6 - 4.0),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2015-2016,Sex,Male,4.3 (3.3 - 5.4),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2015-2016,Total,New York State,3.7 (3.1 - 4.4),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2016-2017,Age Group,12-17 years,2.1 (1.5 - 2.9),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2016-2017,Age Group,18-25 years,5.9 (4.7 - 7.5),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2016-2017,Age Group,26-34 years,3.7 (2.8 - 5.1),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2016-2017,Age Group,35+ years,2.7 (2.0 - 3.6),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Black NH,2.6 (1.6 - 4.2),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Hispanic,3.0 (1.9 - 4.9),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2016-2017,Race and Ethnicity,Other NH,2.4 (1.3 - 4.4),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2016-2017,Race and Ethnicity,White NH,3.6 (2.9 - 4.4),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2016-2017,Sex,Female,2.8 (2.2 - 3.5),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2016-2017,Sex,Male,3.7 (2.9 - 4.8),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2016-2017,Total,New York State,3.2 (2.7 - 3.9),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2017-2018,Age Group,12-17 years,1.4 (0.9 - 2.2),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2017-2018,Age Group,18-25 years,5.4 (4.3 - 6.8),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2017-2018,Age Group,26-34 years,4.1 (2.9 - 5.8),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2017-2018,Age Group,35+ years,2.1 (1.5 - 2.9),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Black NH,2.2 (1.3 - 3.7),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Hispanic,3.2 (1.9 - 5.2),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2017-2018,Race and Ethnicity,Other NH,2.1 (1.2 - 3.8),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2017-2018,Race and Ethnicity,White NH,2.9 (2.4 - 3.6),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2017-2018,Sex,Female,2.6 (2.0 - 3.3),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2017-2018,Sex,Male,3.0 (2.3 - 3.9),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2017-2018,Total,New York State,2.8 (2.3 - 3.3),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2018-2019,Age Group,12-17 years,1.5 (1.0 - 2.4),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2018-2019,Age Group,18-25 years,4.5 (3.6 - 5.8),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2018-2019,Age Group,26-34 years,4.9 (3.6 - 6.6),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2018-2019,Age Group,35+ years,1.9 (1.4 - 2.6),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Black NH,1.5 (0.8 - 2.8),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Hispanic,3.2 (2.1 - 4.8),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2018-2019,Race and Ethnicity,Other NH,2.2 (1.2 - 3.7),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2018-2019,Race and Ethnicity,White NH,2.9 (2.2 - 3.6),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2018-2019,Sex,Female,2.6 (2.1 - 3.3),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2018-2019,Sex,Male,2.7 (2.0 - 3.5),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2018-2019,Total,New York State,2.7 (2.2 - 3.2),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2019-2020,Age Group,12-17 years,.,Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2019-2020,Age Group,18-25 years,.,Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2019-2020,Age Group,26-34 years,.,Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2019-2020,Age Group,35+ years,.,Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2019-2020,Race and Ethnicity,Black NH,.,Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2019-2020,Race and Ethnicity,Hispanic,.,Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2019-2020,Race and Ethnicity,Other NH,.,Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2019-2020,Race and Ethnicity,White NH,.,Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2019-2020,Total,New York State,.,Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2021-2022,Age Group,12-17 years,2.1 (1.1 - 4.1),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2021-2022,Age Group,18-25 years,2.6 (1.6 - 4.1),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2021-2022,Age Group,26-34 years,3.4 (2.0 - 5.9),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2021-2022,Age Group,35+ years,2.9 (2.0 - 4.2),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2021-2022,Race and Ethnicity,Black NH,3.5 (1.6 - 7.1),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2021-2022,Race and Ethnicity,Hispanic,2.6 (1.4 - 4.6),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2021-2022,Race and Ethnicity,Other NH,3.1 (1.2 - 7.8),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2021-2022,Race and Ethnicity,White NH,2.8 (1.9 - 4.1),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2021-2022,Sex,Female,3.6 (2.0 - 6.4),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2021-2022,Sex,Male,6.8 (4.5 - 10.2),Data Source: National Survey on Drug Use and Health
"Prescription pain reliever misuse in the past year, among persons aged 12 years or older",2021-2022,Total,New York State,2.9 (2.2 - 3.8),Data Source: National Survey on Drug Use and Health
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Age Group,0-17 years,0.8,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Age Group,0-17 years,0.8,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Age Group,18-24 years,8.5,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Age Group,18-24 years,8.5,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Age Group,25-44 years,17,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Age Group,25-44 years,17,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Age Group,45-64 years,10.3,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Age Group,45-64 years,10.3,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Age Group,65+ years,1.7,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Age Group,65+ years,1.7,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Age Group,Unknown,2.2,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Age Group,Unknown,2.2,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Incident Location Type,Public,9.2,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Incident Location Type,Public,9.2,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Incident Location Type,Residential,6.5,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Incident Location Type,Residential,6.5,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Incident Location Type,Unknown,5.2,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Incident Location Type,Unknown,5.2,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Region,NYS Excl NYC,8.3,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Region,NYS Excl NYC,8.3,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Region,New York City,6.7,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Region,New York City,6.7,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Sex,Female,4.1,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Sex,Female,4.1,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Sex,Male,11,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Sex,Male,11,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Sex,Unknown,1.3,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Sex,Unknown,1.3,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Total,New York State,7.5,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Total,New York State,7.5,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Age Group,0-17 years,0.7,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Age Group,0-17 years,0.7,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Age Group,18-24 years,7.4,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Age Group,18-24 years,7.4,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Age Group,25-44 years,16.8,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Age Group,25-44 years,16.8,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Age Group,45-64 years,11.4,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Age Group,45-64 years,11.4,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Age Group,65+ years,1.9,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Age Group,65+ years,1.9,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Age Group,Unknown,4.2,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Age Group,Unknown,4.2,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Incident Location Type,Public,9.6,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Incident Location Type,Public,9.6,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Incident Location Type,Residential,6.4,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Incident Location Type,Residential,6.4,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Incident Location Type,Unknown,5.3,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Incident Location Type,Unknown,5.3,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Region,NYS Excl NYC,7.8,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Region,NYS Excl NYC,7.8,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Region,New York City,7.4,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Region,New York City,7.4,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Sex,Female,4.2,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Sex,Female,4.2,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Sex,Male,11.1,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Sex,Male,11.1,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Sex,Unknown,3,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Sex,Unknown,3,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Total,New York State,7.6,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Total,New York State,7.6,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Age Group,0-17 years,0.9,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Age Group,0-17 years,0.9,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Age Group,18-24 years,6.3,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Age Group,18-24 years,6.3,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Age Group,25-44 years,15.6,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Age Group,25-44 years,15.6,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Age Group,45-64 years,12,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Age Group,45-64 years,12,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Age Group,65+ years,2,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Age Group,65+ years,2,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Age Group,Unknown,3.8,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Age Group,Unknown,3.8,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Incident Location Type,Public,9.5,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Incident Location Type,Public,9.5,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Incident Location Type,Residential,6.3,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Incident Location Type,Residential,6.3,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Incident Location Type,Unknown,4.3,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Incident Location Type,Unknown,4.3,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Region,NYS Excl NYC,7.5,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Region,NYS Excl NYC,7.5,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Region,New York City,7.6,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Region,New York City,7.6,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Sex,Female,4,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Sex,Female,4,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Sex,Male,10.9,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Sex,Male,10.9,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Sex,Unknown,6.1,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Sex,Unknown,6.1,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Total,New York State,7.5,Data Source: NYS EMS Data as of September 2024
"Suspected opioid overdoses by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Total,New York State,7.5,Data Source: NYS EMS Data as of September 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Age Group,12-17 years,43.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Age Group,12-17 years,43.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Age Group,18-24 years,498.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Age Group,18-24 years,498.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Age Group,25-34 years,603.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Age Group,25-34 years,603.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Age Group,35-44 years,681.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Age Group,35-44 years,681.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Age Group,45-54 years,810.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Age Group,45-54 years,810.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Age Group,Age 55+,256.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Age Group,Age 55+,256.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Race and Ethnicity,Black NH,616.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Race and Ethnicity,Black NH,616.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Race and Ethnicity,Hispanic,969,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Race and Ethnicity,Hispanic,969,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Race and Ethnicity,Other NH,125.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Race and Ethnicity,Other NH,125.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Race and Ethnicity,White NH,366.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Race and Ethnicity,White NH,366.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Region,NYS Excl NYC,331.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Region,NYS Excl NYC,331.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Region,New York City,694.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Region,New York City,694.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Sex at Birth,Female,294.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Sex at Birth,Female,294.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Sex at Birth,Male,690.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Sex at Birth,Male,690.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Total,New York State,484.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Total,New York State,484.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Age Group,12-17 years,45.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Age Group,12-17 years,45.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Age Group,18-24 years,555,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Age Group,18-24 years,555,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Age Group,25-34 years,640.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Age Group,25-34 years,640.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Age Group,35-44 years,646.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Age Group,35-44 years,646.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Age Group,45-54 years,790.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Age Group,45-54 years,790.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Age Group,Age 55+,268.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Age Group,Age 55+,268.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Race and Ethnicity,Black NH,600.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Race and Ethnicity,Black NH,600.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Race and Ethnicity,Hispanic,921.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Race and Ethnicity,Hispanic,921.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Race and Ethnicity,Other NH,132.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Race and Ethnicity,Other NH,132.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Race and Ethnicity,White NH,392.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Race and Ethnicity,White NH,392.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Region,NYS Excl NYC,355.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Region,NYS Excl NYC,355.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Region,New York City,675.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Region,New York City,675.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Sex at Birth,Female,305,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Sex at Birth,Female,305,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Sex at Birth,Male,693.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Sex at Birth,Male,693.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Total,New York State,491.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Total,New York State,491.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Age Group,12-17 years,45.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Age Group,12-17 years,45.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Age Group,18-24 years,602.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Age Group,18-24 years,602.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Age Group,25-34 years,705.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Age Group,25-34 years,705.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Age Group,35-44 years,622.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Age Group,35-44 years,622.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Age Group,45-54 years,773.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Age Group,45-54 years,773.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Age Group,Age 55+,282.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Age Group,Age 55+,282.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Race and Ethnicity,Black NH,574.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Race and Ethnicity,Black NH,574.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Race and Ethnicity,Hispanic,896.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Race and Ethnicity,Hispanic,896.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Race and Ethnicity,Other NH,146.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Race and Ethnicity,Other NH,146.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Race and Ethnicity,White NH,424,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Race and Ethnicity,White NH,424,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Region,NYS Excl NYC,386.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Region,NYS Excl NYC,386.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Region,New York City,662.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Region,New York City,662.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Sex at Birth,Female,316,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Sex at Birth,Female,316,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Sex at Birth,Male,706.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Sex at Birth,Male,706.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Total,New York State,503.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Total,New York State,503.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Age Group,12-17 years,42.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Age Group,12-17 years,42.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Age Group,18-24 years,638.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Age Group,18-24 years,638.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Age Group,25-34 years,763.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Age Group,25-34 years,763.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Age Group,35-44 years,626.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Age Group,35-44 years,626.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Age Group,45-54 years,768.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Age Group,45-54 years,768.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Age Group,Age 55+,292.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Age Group,Age 55+,292.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Race and Ethnicity,Black NH,553.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Race and Ethnicity,Black NH,553.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Race and Ethnicity,Hispanic,888.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Race and Ethnicity,Hispanic,888.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Race and Ethnicity,Other NH,159.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Race and Ethnicity,Other NH,159.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Race and Ethnicity,White NH,454.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Race and Ethnicity,White NH,454.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Region,NYS Excl NYC,419.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Region,NYS Excl NYC,419.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Region,New York City,653.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Region,New York City,653.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Sex at Birth,Female,328.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Sex at Birth,Female,328.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Sex at Birth,Male,725.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Sex at Birth,Male,725.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Total,New York State,518.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Total,New York State,518.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Age Group,12-17 years,39,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Age Group,12-17 years,39,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Age Group,18-24 years,647,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Age Group,18-24 years,647,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Age Group,25-34 years,830.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Age Group,25-34 years,830.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Age Group,35-44 years,636.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Age Group,35-44 years,636.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Age Group,45-54 years,765.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Age Group,45-54 years,765.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Age Group,Age 55+,302.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Age Group,Age 55+,302.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Race and Ethnicity,Black NH,542.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Race and Ethnicity,Black NH,542.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Race and Ethnicity,Hispanic,887.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Race and Ethnicity,Hispanic,887.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Race and Ethnicity,Other NH,178.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Race and Ethnicity,Other NH,178.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Race and Ethnicity,White NH,479.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Race and Ethnicity,White NH,479.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Region,NYS Excl NYC,447.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Region,NYS Excl NYC,447.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Region,New York City,648.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Region,New York City,648.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Sex at Birth,Female,338.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Sex at Birth,Female,338.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Sex at Birth,Male,744.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Sex at Birth,Male,744.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Total,New York State,533.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Total,New York State,533.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Age Group,12-17 years,35.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Age Group,12-17 years,35.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Age Group,18-24 years,619.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Age Group,18-24 years,619.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Age Group,25-34 years,918,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Age Group,25-34 years,918,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Age Group,35-44 years,673.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Age Group,35-44 years,673.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Age Group,45-54 years,767.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Age Group,45-54 years,767.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Age Group,Age 55+,316.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Age Group,Age 55+,316.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Race and Ethnicity,Black NH,547.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Race and Ethnicity,Black NH,547.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Race and Ethnicity,Hispanic,890.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Race and Ethnicity,Hispanic,890.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Race and Ethnicity,Other NH,194,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Race and Ethnicity,Other NH,194,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Race and Ethnicity,White NH,508.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Race and Ethnicity,White NH,508.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Region,NYS Excl NYC,481.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Region,NYS Excl NYC,481.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Region,New York City,650.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Region,New York City,650.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Sex at Birth,Female,356.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Sex at Birth,Female,356.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Sex at Birth,Male,766.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Sex at Birth,Male,766.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Total,New York State,553.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Total,New York State,553.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Age Group,12-17 years,26.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Age Group,12-17 years,26.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Age Group,18-24 years,564.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Age Group,18-24 years,564.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Age Group,25-34 years,979.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Age Group,25-34 years,979.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Age Group,35-44 years,721.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Age Group,35-44 years,721.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Age Group,45-54 years,773.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Age Group,45-54 years,773.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Age Group,Age 55+,328.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Age Group,Age 55+,328.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Race and Ethnicity,Black NH,550.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Race and Ethnicity,Black NH,550.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Race and Ethnicity,Hispanic,890.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Race and Ethnicity,Hispanic,890.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Race and Ethnicity,Other NH,193.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Race and Ethnicity,Other NH,193.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Race and Ethnicity,White NH,532.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Race and Ethnicity,White NH,532.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Region,NYS Excl NYC,510.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Region,NYS Excl NYC,510.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Region,New York City,643.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Region,New York City,643.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Sex at Birth,Female,366.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Sex at Birth,Female,366.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Sex at Birth,Male,784.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Sex at Birth,Male,784.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Total,New York State,567.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Total,New York State,567.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Age Group,12-17 years,18.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Age Group,12-17 years,18.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Age Group,18-24 years,479.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Age Group,18-24 years,479.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Age Group,25-34 years,992.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Age Group,25-34 years,992.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Age Group,35-44 years,770.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Age Group,35-44 years,770.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Age Group,45-54 years,768.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Age Group,45-54 years,768.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Age Group,Age 55+,345.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Age Group,Age 55+,345.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Race and Ethnicity,Black NH,559.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Race and Ethnicity,Black NH,559.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Race and Ethnicity,Hispanic,883.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Race and Ethnicity,Hispanic,883.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Race and Ethnicity,Other NH,199.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Race and Ethnicity,Other NH,199.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Race and Ethnicity,White NH,536.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Race and Ethnicity,White NH,536.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Region,NYS Excl NYC,520.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Region,NYS Excl NYC,520.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Region,New York City,637.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Region,New York City,637.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Sex at Birth,Female,372.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Sex at Birth,Female,372.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Sex at Birth,Male,783.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Sex at Birth,Male,783.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Total,New York State,570.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Total,New York State,570.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Age Group,12-17 years,13.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Age Group,12-17 years,13.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Age Group,18-24 years,383.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Age Group,18-24 years,383.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Age Group,25-34 years,969.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Age Group,25-34 years,969.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Age Group,35-44 years,799.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Age Group,35-44 years,799.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Age Group,45-54 years,759,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Age Group,45-54 years,759,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Age Group,Age 55+,357.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Age Group,Age 55+,357.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Race and Ethnicity,Black NH,552.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Race and Ethnicity,Black NH,552.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Race and Ethnicity,Hispanic,881.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Race and Ethnicity,Hispanic,881.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Race and Ethnicity,Other NH,196.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Race and Ethnicity,Other NH,196.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Race and Ethnicity,White NH,523.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Race and Ethnicity,White NH,523.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Region,NYS Excl NYC,516.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Region,NYS Excl NYC,516.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Region,New York City,622.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Region,New York City,622.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Sex at Birth,Female,369.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Sex at Birth,Female,369.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Sex at Birth,Male,769.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Sex at Birth,Male,769.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Total,New York State,561.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Total,New York State,561.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Age Group,12-17 years,10.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Age Group,12-17 years,10.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Age Group,18-24 years,298,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Age Group,18-24 years,298,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Age Group,25-34 years,924.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Age Group,25-34 years,924.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Age Group,35-44 years,831.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Age Group,35-44 years,831.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Age Group,45-54 years,730.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Age Group,45-54 years,730.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Age Group,Age 55+,382.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Age Group,Age 55+,382.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Race and Ethnicity,Black NH,569,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Race and Ethnicity,Black NH,569,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Race and Ethnicity,Hispanic,880.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Race and Ethnicity,Hispanic,880.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Race and Ethnicity,Other NH,202.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Race and Ethnicity,Other NH,202.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Race and Ethnicity,White NH,504,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Race and Ethnicity,White NH,504,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Region,NYS Excl NYC,505.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Region,NYS Excl NYC,505.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Region,New York City,617.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Region,New York City,617.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Sex at Birth,Female,360.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Sex at Birth,Female,360.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Sex at Birth,Male,761.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Sex at Birth,Male,761.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Total,New York State,553.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Total,New York State,553.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Age Group,12-17 years,9.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Age Group,12-17 years,9.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Age Group,18-24 years,219.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Age Group,18-24 years,219.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Age Group,25-34 years,807,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Age Group,25-34 years,807,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Age Group,35-44 years,793.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Age Group,35-44 years,793.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Age Group,45-54 years,639.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Age Group,45-54 years,639.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Age Group,Age 55+,381.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Age Group,Age 55+,381.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Race and Ethnicity,Black NH,501,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Race and Ethnicity,Black NH,501,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Race and Ethnicity,Hispanic,819.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Race and Ethnicity,Hispanic,819.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Race and Ethnicity,Other NH,191.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Race and Ethnicity,Other NH,191.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Race and Ethnicity,White NH,459.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Race and Ethnicity,White NH,459.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Region,NYS Excl NYC,465.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Region,NYS Excl NYC,465.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Region,New York City,558.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Region,New York City,558.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Sex at Birth,Female,328.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Sex at Birth,Female,328.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Sex at Birth,Male,696.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Sex at Birth,Male,696.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Total,New York State,505.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Total,New York State,505.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Age Group,12-17 years,8.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Age Group,12-17 years,8.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Age Group,18-24 years,186.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Age Group,18-24 years,186.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Age Group,25-34 years,790.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Age Group,25-34 years,790.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Age Group,35-44 years,798.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Age Group,35-44 years,798.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Age Group,45-54 years,626.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Age Group,45-54 years,626.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Age Group,Age 55+,373.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Age Group,Age 55+,373.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Race and Ethnicity,Black NH,491.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Race and Ethnicity,Black NH,491.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Race and Ethnicity,Hispanic,760.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Race and Ethnicity,Hispanic,760.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Race and Ethnicity,Other NH,200,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Race and Ethnicity,Other NH,200,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Race and Ethnicity,White NH,465.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Race and Ethnicity,White NH,465.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Region,NYS Excl NYC,467.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Region,NYS Excl NYC,467.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Region,New York City,525.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Region,New York City,525.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Sex at Birth,Female,322.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Sex at Birth,Female,322.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Sex at Birth,Male,672.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Sex at Birth,Male,672.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Total,New York State,492.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Total,New York State,492.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Age Group,12-17 years,12.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Age Group,12-17 years,12.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Age Group,18-24 years,161.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Age Group,18-24 years,161.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Age Group,25-34 years,731.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Age Group,25-34 years,731.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Age Group,35-44 years,814,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Age Group,35-44 years,814,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Age Group,45-54 years,607,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Age Group,45-54 years,607,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Age Group,Age 55+,375.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Age Group,Age 55+,375.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Race and Ethnicity,Black NH,481.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Race and Ethnicity,Black NH,481.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Race and Ethnicity,Hispanic,733.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Race and Ethnicity,Hispanic,733.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Race and Ethnicity,Other NH,199.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Race and Ethnicity,Other NH,199.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Race and Ethnicity,White NH,456.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Race and Ethnicity,White NH,456.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Region,NYS Excl NYC,462.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Region,NYS Excl NYC,462.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Region,New York City,502.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Region,New York City,502.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Sex at Birth,Female,316.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Sex at Birth,Female,316.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Sex at Birth,Male,653.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Sex at Birth,Male,653.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Total,New York State,479.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Total,New York State,479.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Age Group,12-17 years,16,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Age Group,12-17 years,16,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Age Group,18-24 years,141.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Age Group,18-24 years,141.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Age Group,25-34 years,668.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Age Group,25-34 years,668.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Age Group,35-44 years,823.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Age Group,35-44 years,823.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Age Group,45-54 years,591.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Age Group,45-54 years,591.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Age Group,Age 55+,371.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Age Group,Age 55+,371.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Race and Ethnicity,Black NH,464.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Race and Ethnicity,Black NH,464.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Race and Ethnicity,Hispanic,703,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Race and Ethnicity,Hispanic,703,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Race and Ethnicity,Other NH,199.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Race and Ethnicity,Other NH,199.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Race and Ethnicity,White NH,445.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Race and Ethnicity,White NH,445.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Region,NYS Excl NYC,456,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Region,NYS Excl NYC,456,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Region,New York City,477.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Region,New York City,477.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Sex at Birth,Female,307.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Sex at Birth,Female,307.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Sex at Birth,Male,632.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Sex at Birth,Male,632.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Total,New York State,465.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported any opioid (incl. heroin) as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Total,New York State,465.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Age Group,12-17 years,15.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Age Group,18-24 years,296.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Age Group,25-34 years,425.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Age Group,35-44 years,591.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Age Group,45-54 years,742.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Age Group,Age 55+,236.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Race and Ethnicity,Black NH,592.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Race and Ethnicity,Hispanic,938.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Race and Ethnicity,Other NH,99.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Race and Ethnicity,White NH,239.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Region,NYS Excl NYC,208.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Region,New York City,655.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Sex at Birth,Female,227.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Sex at Birth,Male,581,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2010,Total,New York State,397.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Age Group,12-17 years,13.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Age Group,18-24 years,294.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Age Group,25-34 years,420,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Age Group,35-44 years,541.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Age Group,45-54 years,717.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Age Group,Age 55+,245.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Race and Ethnicity,Black NH,570.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Race and Ethnicity,Hispanic,883.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Race and Ethnicity,Other NH,100.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Race and Ethnicity,White NH,238.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Region,NYS Excl NYC,206.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Region,New York City,628.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Sex at Birth,Female,223.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Sex at Birth,Male,560.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2011,Total,New York State,385.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Age Group,12-17 years,18.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Age Group,18-24 years,346.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Age Group,25-34 years,459.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Age Group,35-44 years,509.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Age Group,45-54 years,697.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Age Group,Age 55+,257.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Race and Ethnicity,Black NH,542.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Race and Ethnicity,Hispanic,852.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Race and Ethnicity,Other NH,113.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Race and Ethnicity,White NH,263.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Region,NYS Excl NYC,230.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Region,New York City,613.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Sex at Birth,Female,231.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Sex at Birth,Male,568.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2012,Total,New York State,393,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Age Group,12-17 years,23.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Age Group,18-24 years,431.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Age Group,25-34 years,524.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Age Group,35-44 years,507.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Age Group,45-54 years,696.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Age Group,Age 55+,266.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Race and Ethnicity,Black NH,522.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Race and Ethnicity,Hispanic,847.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Race and Ethnicity,Other NH,124.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Race and Ethnicity,White NH,304.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Region,NYS Excl NYC,272.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Region,New York City,608.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Sex at Birth,Female,245.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Sex at Birth,Male,599.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2013,Total,New York State,415.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Age Group,12-17 years,25,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Age Group,18-24 years,480.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Age Group,25-34 years,609.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Age Group,35-44 years,518.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Age Group,45-54 years,697.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Age Group,Age 55+,277.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Race and Ethnicity,Black NH,512.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Race and Ethnicity,Hispanic,845.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Race and Ethnicity,Other NH,142,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Race and Ethnicity,White NH,345.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Region,NYS Excl NYC,315.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Region,New York City,606.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Sex at Birth,Female,262.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Sex at Birth,Male,630.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2014,Total,New York State,439.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Age Group,12-17 years,22.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Age Group,18-24 years,489.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Age Group,25-34 years,701.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Age Group,35-44 years,551.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Age Group,45-54 years,700,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Age Group,Age 55+,291.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Race and Ethnicity,Black NH,516.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Race and Ethnicity,Hispanic,847.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Race and Ethnicity,Other NH,157.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Race and Ethnicity,White NH,382.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Region,NYS Excl NYC,354.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Region,New York City,611.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Sex at Birth,Female,282.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Sex at Birth,Male,661.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2015,Total,New York State,464.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Age Group,12-17 years,16.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Age Group,18-24 years,458.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Age Group,25-34 years,767.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Age Group,35-44 years,591.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Age Group,45-54 years,700.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Age Group,Age 55+,302.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Race and Ethnicity,Black NH,516.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Race and Ethnicity,Hispanic,844.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Race and Ethnicity,Other NH,158.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Race and Ethnicity,White NH,410.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Region,NYS Excl NYC,385.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Region,New York City,606.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Sex at Birth,Female,294.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Sex at Birth,Male,680.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2016,Total,New York State,480.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Age Group,12-17 years,10.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Age Group,18-24 years,390.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Age Group,25-34 years,786.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Age Group,35-44 years,628.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Age Group,45-54 years,695.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Age Group,Age 55+,318.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Race and Ethnicity,Black NH,520.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Race and Ethnicity,Hispanic,836,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Race and Ethnicity,Other NH,163,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Race and Ethnicity,White NH,416.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Region,NYS Excl NYC,396.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Region,New York City,600,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Sex at Birth,Female,299.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Sex at Birth,Male,682.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2017,Total,New York State,483.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Age Group,12-17 years,6.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Age Group,18-24 years,307.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Age Group,25-34 years,769.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Age Group,35-44 years,650.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Age Group,45-54 years,682.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Age Group,Age 55+,329.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Race and Ethnicity,Black NH,511.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Race and Ethnicity,Hispanic,830.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Race and Ethnicity,Other NH,160.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Race and Ethnicity,White NH,406.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Region,NYS Excl NYC,393,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Region,New York City,587,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Sex at Birth,Female,297.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Sex at Birth,Male,668.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2018,Total,New York State,475.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Age Group,12-17 years,4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Age Group,18-24 years,236.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Age Group,25-34 years,733.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Age Group,35-44 years,669.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Age Group,45-54 years,654.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Age Group,Age 55+,351.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Race and Ethnicity,Black NH,524.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Race and Ethnicity,Hispanic,825.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Race and Ethnicity,Other NH,167.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Race and Ethnicity,White NH,390.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Region,NYS Excl NYC,382.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Region,New York City,583.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Sex at Birth,Female,289.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Sex at Birth,Male,661.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2019,Total,New York State,468.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Age Group,12-17 years,3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Age Group,18-24 years,165.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Age Group,25-34 years,640.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Age Group,35-44 years,639,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Age Group,45-54 years,570.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Age Group,Age 55+,353.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Race and Ethnicity,Black NH,461.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Race and Ethnicity,Hispanic,769.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Race and Ethnicity,Other NH,156.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Race and Ethnicity,White NH,356.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Region,NYS Excl NYC,352.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Region,New York City,528.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Sex at Birth,Female,263.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Sex at Birth,Male,604.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2020,Total,New York State,428,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Age Group,12-17 years,1.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Age Group,18-24 years,126.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Age Group,25-34 years,608.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Age Group,35-44 years,622.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Age Group,45-54 years,549.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Age Group,Age 55+,341.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Race and Ethnicity,Black NH,445.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Race and Ethnicity,Hispanic,705,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Race and Ethnicity,Other NH,154.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Race and Ethnicity,White NH,351.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Region,NYS Excl NYC,343.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Region,New York City,493.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Sex at Birth,Female,252,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Sex at Birth,Male,571.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2021,Total,New York State,407,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Age Group,12-17 years,2.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Age Group,18-24 years,97,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Age Group,25-34 years,549.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Age Group,35-44 years,628.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Age Group,45-54 years,521.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Age Group,Age 55+,342.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Race and Ethnicity,Black NH,431.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Race and Ethnicity,Hispanic,670.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Race and Ethnicity,Other NH,151.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Race and Ethnicity,White NH,339.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Region,NYS Excl NYC,334.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Region,New York City,468.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Sex at Birth,Female,244.7,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Sex at Birth,Male,546.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2022,Total,New York State,391.1,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Age Group,12-17 years,2.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Age Group,18-24 years,71,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Age Group,25-34 years,484.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Age Group,35-44 years,625.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Age Group,45-54 years,496.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Age Group,Age 55+,337.6,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Race and Ethnicity,Black NH,407.5,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Race and Ethnicity,Hispanic,631.2,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Race and Ethnicity,Other NH,146.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Race and Ethnicity,White NH,325.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Region,NYS Excl NYC,321.9,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Region,New York City,440.8,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Sex at Birth,Female,234.4,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Sex at Birth,Male,518.3,Data Source: OASAS Data as of October 2024
"Unique individuals enrolled in OASAS-certified substance use disorder treatment programs who reported heroin as a primary substance, crude rate per 100,000 population - Aged 12+ years",2023,Total,New York State,372.1,Data Source: OASAS Data as of October 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2016,Age Group,0-17 years,0.7,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2016,Age Group,18-24 years,6.9,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2016,Age Group,25-44 years,9.8,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2016,Age Group,45-64 years,6.4,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2016,Age Group,65+ years,1.4,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2016,Age Group,Unknown,0.7,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2016,Incident Location Type,Public,3.6,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2016,Incident Location Type,Residential,5.2,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2016,Incident Location Type,Unknown,6.9,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2016,Region,NYS Excl NYC,5,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2016,Region,New York City,4.5,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2016,Sex,Female,3,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2016,Sex,Male,6.7,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2016,Sex,Unknown,0.4,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2016,Total,New York State,4.7,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2017,Age Group,0-17 years,0.7,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2017,Age Group,18-24 years,6.4,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2017,Age Group,25-44 years,10.9,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2017,Age Group,45-64 years,6.6,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2017,Age Group,65+ years,1.4,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2017,Age Group,Unknown,0.9,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2017,Incident Location Type,Public,4,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2017,Incident Location Type,Residential,5.6,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2017,Incident Location Type,Unknown,5,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2017,Region,NYS Excl NYC,5,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2017,Region,New York City,4.8,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2017,Sex,Female,3.1,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2017,Sex,Male,6.9,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2017,Sex,Unknown,0.9,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2017,Total,New York State,4.9,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2018,Age Group,0-17 years,0.6,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2018,Age Group,18-24 years,4.9,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2018,Age Group,25-44 years,9,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2018,Age Group,45-64 years,5.8,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2018,Age Group,65+ years,1.4,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2018,Age Group,Unknown,1.1,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2018,Incident Location Type,Public,3,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2018,Incident Location Type,Residential,4.5,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2018,Incident Location Type,Unknown,5.6,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2018,Region,NYS Excl NYC,4.4,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2018,Region,New York City,4.1,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2018,Sex,Female,2.7,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2018,Sex,Male,5.9,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2018,Sex,Unknown,0.9,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2018,Total,New York State,4.2,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2019,Age Group,0-17 years,0.5,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2019,Age Group,18-24 years,4.5,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2019,Age Group,25-44 years,8.5,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2019,Age Group,45-64 years,5.4,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2019,Age Group,65+ years,1.2,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2019,Age Group,Unknown,1.2,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2019,Incident Location Type,Public,2.9,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2019,Incident Location Type,Residential,3.8,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2019,Incident Location Type,Unknown,4.7,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2019,Region,NYS Excl NYC,4,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2019,Region,New York City,3.7,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2019,Sex,Female,2.4,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2019,Sex,Male,5.5,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2019,Sex,Unknown,0.8,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2019,Total,New York State,3.8,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2020,Age Group,0-17 years,1,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2020,Age Group,18-24 years,6.7,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2020,Age Group,25-44 years,11.3,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2020,Age Group,45-64 years,7.6,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2020,Age Group,65+ years,1.5,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2020,Age Group,Unknown,1.1,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2020,Incident Location Type,Public,6.1,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2020,Incident Location Type,Residential,4.7,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2020,Incident Location Type,Unknown,8.6,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2020,Region,NYS Excl NYC,5.5,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2020,Region,New York City,5.2,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2020,Sex,Female,3,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2020,Sex,Male,7.6,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2020,Sex,Unknown,1.4,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2020,Total,New York State,5.3,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Age Group,0-17 years,0.7,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Age Group,18-24 years,5.6,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Age Group,25-44 years,11.5,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Age Group,45-64 years,9.1,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Age Group,65+ years,1.9,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Age Group,Unknown,1.3,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Incident Location Type,Public,7.3,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Incident Location Type,Residential,4.9,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Incident Location Type,Unknown,16.2,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Region,NYS Excl NYC,5.3,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Region,New York City,6.4,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Sex,Female,3.2,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Sex,Male,8.6,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Sex,Unknown,0.8,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2021,Total,New York State,5.9,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Age Group,0-17 years,0.7,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Age Group,18-24 years,4.7,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Age Group,25-44 years,11.7,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Age Group,45-64 years,9.9,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Age Group,65+ years,2,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Age Group,Unknown,2.1,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Incident Location Type,Public,7.6,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Incident Location Type,Residential,4.9,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Incident Location Type,Unknown,8.5,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Region,NYS Excl NYC,5,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Region,New York City,7,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Sex,Female,3.3,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Sex,Male,8.8,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Sex,Unknown,2.3,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2022,Total,New York State,6,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Age Group,0-17 years,0.7,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Age Group,18-24 years,4.3,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Age Group,25-44 years,11,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Age Group,45-64 years,10.3,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Age Group,65+ years,2,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Age Group,Unknown,2,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Incident Location Type,Public,7.6,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Incident Location Type,Residential,4.9,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Incident Location Type,Unknown,9.2,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Region,NYS Excl NYC,4.8,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Region,New York City,7.1,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Sex,Female,3.2,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Sex,Male,8.6,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Sex,Unknown,6.7,Data Source: NYS EMS Data as of September 2024
"Unique naloxone administrations by EMS agencies, crude rate per 1,000 unique 911 EMS dispatches",2023,Total,New York State,6,Data Source: NYS EMS Data as of September 2024
